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Carina Fernandes Pereira 
The Influenza A Virus NS1 Protein and Viral mRNA Nuclear Export 
SUMMARY 
Influenza A virus (IAV) replication and transcription occur in the host cell nucleus; a 
feature which means both the viral genome (vRNA) and mRNA must be exported from the 
nucleus to the cytoplasm. The mechanism by which vRNA nuclear export is achieved has 
been well characterised, but how viral mRNAs are exported is poorly understood. The cellular 
NXF1-dependent mRNA export pathway has been shown to be involved in the export of 
some viral mRNAs, but how they are recruited to this pathway is unknown.  
 Prior work from our laboratory showed that segment 7 mRNA was inefficiently 
exported to the cytoplasm in a sub-viral ‘minireplicon’ system, providing the first indication 
that there were viral requirements for IAV mRNA nuclear export. Further addition of 
individual viral polypeptides was tested and the effect on segment 7 mRNA export was 
analysed by fluorescent in situ hybridization (FISH) and confocal microscopy. This identified 
the NS1 protein as the viral factor required for efficient segment 7 nuclear export. 
Mutational studies on NS1 were carried out to unveil the mechanistic role of this 
protein in viral mRNA nuclear export, by plasmid transfection as well as in the context of 
recombinant viruses. These approaches indicated that both functional domains of NS1 were 
necessary to preserve the mRNA export function. Furthermore, these mutant proteins were 
used to examine the association between NS1 and the NXF1-dependent pathway in the 
context of mRNA nuclear export. Protein-protein and protein-RNA binding assays indicated 
that interactions between NXF1 and NS1, and NXF1 and segment 7 mRNA were necessary, 
but not sufficient to promote segment 7 viral mRNA export.  
Lastly, the role of NS1 protein in the nuclear export of viral mRNAs from other 
genome segments was studied. The intracellular localisation of most viral mRNAs was not 
affected by the absence of NS1 or the presence of an export-incompetent NS1 mutant protein. 
However, segment 4 mRNA exhibited a similar phenotype to segment 7 mRNA in showing a 
dependence on NS1 for efficient nuclear export. Overall, the results presented in this 
dissertation suggest that NS1 acts as an adaptor protein between the viral RNA synthesis 
machinery and cellular export pathway. This provides deeper insights for the characterization 
of a recently identified function of the IAV NS1 protein, of being required for the efficient 
nuclear export of mRNA from “late” kinetic class viral genes.  
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CHAPTER 1 – GENERAL INTRODUCTION 
___________________________________________________________________________ 
1.1 Influenza virus 
The influenza A virus (IAV) belongs to the Orthomyxoviridae family, which also includes 
influenza B, C and D viruses, as well as Thogoto, infectious salmon anaemia (ISA) and 
Quaranja viruses. This virus family is characterized by having a genome organised as discrete 
segments of negative sense, single-stranded RNA (Palese and Shaw, 2007).  
The host range of this family varies amongst its members. For example, Thogoto virus is a 
tick borne virus that infects vertebrates including humans while ISA is a salmon virus 
(Rimstad and Mjaaland, 2002). IAV is able to infect a wide range of mammalian and avian 
hosts while influenza B virus has so far only been detected in humans and seals and influenza 
C virus in humans and pigs (Guo et al., 1983). Recently, a new virus was discovered in cattle 
and pigs which was distant enough from influenza C to be proposed as influenza D virus, a 
new genus to the Orthomyxoviridae family (Hause et al., 2014; Hause et al., 2013). Even 
though the majority of influenza viruses are capable of infecting humans, IAV causes the 
most significant levels of serious and widespread disease, making it the major pathogen of the 
Orthomyxoviridae family.  
IAV combines certain features that contribute to a high evolution rate. The viral 
polymerase is error-prone as it lacks a proof-reading ability, resulting in the accumulation of 
mutations which under selection give rise to antigenic drift. This equates to changes in the 
viral surface proteins that, in time, will be enough to make them unrecognisable by a pre-
existing humoral immune response, thus effectively renewing the pool of susceptible hosts 
and resulting in seasonal epidemics. IAV is also capable of antigenic shift that can occur 
when different strains of virus infect a single cell, allowing the exchange of whole genome 
segments during the formation of new virus particles (Palese and Shaw, 2007). This 
phenomenon can result in the emergence of a new virus subtype, for which there is no 
widespread immunity, possibly resulting in a pandemic. Pandemics can potentially also occur 
upon adaptation of completely avian viruses to human hosts (Taubenberger et al., 2005). IAV 
caused several pandemics throughout the 20th century, the most notorious being the “Spanish” 
1918 pandemic which has been estimated to have infected one third of the population at the 
time (~500 million people) and to have been fatal to ~50 million people worldwide 
(Taubenberger and Morens, 2006). The only pandemic (so far) of the 21st century involved a 
new variant of H1N1 influenza virus; “swine flu” occurring in 2009. This new strain of the 
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virus appears relatively mild in terms of pathogenicity, but is highly transmissible (Peiris et 
al., 2009; Sullivan et al., 2010). Although the World Health Organisation (WHO) confirmed 
18,500 deaths during the pandemic phase, it has been estimated that “swine flu” was 
responsible for 284,500 mortalities (Dawood et al., 2012).  
The evolutionary potential that influenza A virus has due to its rapid ability to change 
together with its vast host range, keeps the threat of new pandemics resulting from highly 
pathogenic new strains alive. 
 
1.2 Influenza A virus proteins 
The eight segments of influenza A virus have been shown to encode at least 17 
polypeptides. Each segment encodes at least one essential “core” polypeptide (segments 7 and 
8 encode two) but most other segments can produce alternative non-essential polypeptides, 
often in a virus strain-dependent manner. Segment 1 encodes PB2 (polymerase basic 2) which 
is part of the viral polymerase heterotrimer and has pre-mRNA cap binding activity (Li et al., 
2001; Plotch et al., 1981). PB2 has also been shown to be imported to mitochondria and to 
associate with the mitochondrial antiviral signalling (MAVS) protein resulting in the 
inhibition of beta interferon, thereby affecting the virus virulence (Graef et al., 2010; Long 
and Fodor, 2016). Some strains of IAV additionally produce a minor PB2-related polypeptide, 
PB2-S1, of unknown function from a spliced transcript (Yamayoshi et al., 2015). Segment 2 
primarily codes for PB1 (polymerase basic 1) which is a second constituent of the trimeric 
viral polymerase and the one that contains the RNA polymerase catalytic domain (Biswas and 
Nayak, 1994; Braam et al., 1983). A truncated form of PB1 is also encoded by this segment, 
producing the PB1-N40 protein. This protein has been shown to interact with the polymerase 
complex in the cell nucleus, although its function remains unknown (Wise et al., 2009). A 
second overlapping open reading frame in segment 2 encodes a third protein, PB1-F2, which 
has been associated with a variety of roles including pathogenesis, apoptosis and transmission 
(Chen et al., 2001; Conenello and Palese, 2007; James et al., 2016). Segment 3 encodes the 
final protein part of the polymerase complex; PA (polymerase acidic) and contains both RNA 
endonuclease and suggested protease activities (Hara et al., 2001; Sanz-Ezquerro et al., 1996; 
Yuan et al., 2009; Zhao et al., 2009). Truncated forms of PA have been identified, PA-N155 
and PA-N182 proteins, whose functions are unknown, but have been shown to lack 
polymerase activity (Muramoto et al., 2013). This segment also encodes the PA-X protein, 
produced via a +1 ribosomal frameshifting event, which has been shown to modulate the host 
response to IAV infection in vivo (Jagger et al., 2012).  
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Segment 4 encodes the viral transmembrane surface glycoprotein haemagglutinin (HA), 
which is responsible for binding sialic acid residues on host cell receptors as well as inducing 
fusion of the viral envelope and endosomal membrane during entry (Skehel and Wiley, 2000). 
Segment 5 encodes NP (nucleoprotein), whose main function is to encapsidate vRNA and 
cRNA (Shapiro and Krug, 1988) and which is also required for viral genome transcription and 
replication (Honda et al., 1988; Huang et al., 1990). Segment 6 encodes the viral 
transmembrane surface glycoprotein neuraminidase (NA), which is responsible for digesting 
sialic acid residues on host cell surface allowing the release of viral particles from the infected 
cell (Palese et al., 1974).  
Segment 7 encodes primarily two proteins produced from two different species of the 
same mRNA; an unspliced form that encodes M1 (matrix 1) and a spliced form which 
encodes M2 (matrix 2). M1 protein is a major virion structural protein that links vRNPs to the 
viral envelope. This protein is also responsible for vRNP nuclear export upon binding firstly 
NP protein and secondly NS2 (non-structural 2) (Martin and Helenius, 1991; O'Neill et al., 
1998). M2 protein is a membrane protein that acts as an ion channel in the viral envelope 
(Pinto et al., 1992), allowing the acidification of the virus particle interior necessary for 
uncoating (Bukrinskaya et al., 1982; Hay et al., 1985). A third protein, M42, can also be 
encoded by segment 7. This protein is M2-related, carrying an antigenically different 
ectodomain and has been shown to be a functional substitute for M2 protein (Wise et al., 
2012).  
Segment 8 also produces different mRNA species resulting from splicing. The unspliced 
mRNA species encodes NS1 (non-structural 1) to which numerous functions have been 
attributed, the main one being an interferon antagonist (Hale et al., 2008b). NS2 (also known 
as NEP, for nuclear export protein) is encoded by the spliced mRNA species and is 
responsible for vRNPs nuclear export upon M1 binding as mentioned above (Neumann et al., 
2000; O'Neill et al., 1998). Further proteins encoded by segment 8 have been recently 
identified. These include NS3 (non-structural 3), which is an alternatively spliced variant of 
NS1 that has been linked to host switching (Selman et al., 2012) and more recently, N-
terminally deleted versions (tNS1; starting at codons 79 and/or 81) which may play a role in 




1.3 Influenza A virus structure 
Influenza A virions range from 60-100 nm in diameter to more than 10 µm in length 
depending on whether their shape is spherical or filamentous (Bourmakina and Garcia-Sastre, 
2003; Bruce et al., 2010; Dadonaite et al., 2016). Each particle (shown in a diagrammatic 
representation in Figure 1.1) is enveloped with a lipid membrane acquired from the host cell 
plasma membrane upon budding and release. The viral glycoproteins HA and NA are present 
on the particle surface (Fujiyoshi et al., 1994; Harris et al., 2006; Yamaguchi et al., 2008) and 
the viral ion-channel protein M2 is also incorporated into the envelope (Pinto et al., 1992).  
 
 
Figure 1.1 The IAV particle. In the core of the virion the segmented viral genome is packaged into vRNPs, each 
RNA being encapsidated with multiple copies of NP and attached to a trimeric polymerase consisting of PB2, 
PB1 and PA. The viral protein M1 links the vRNPs to the lipid envelope where the M2 ion channel and the 
glycoproteins HA and NA sit. Taken from (Kaiser, 2006)  
 
The interior of the virion contains one copy of each of the eight negative sense, single 
strands of the RNA viral genome (Hutchinson et al., 2010). Every segment is encapsidated 
with multiple copies of NP protein, each monomer covering 20-24 vRNA nucleotides 
(Compans et al., 1972). Furthermore, each individual segment is associated with one copy of 
the viral encoded polymerase complex consisting of PB2, PB1 and PA proteins. The viral 
RNA together with NP protein and the trimeric viral polymerase form a viral 
ribonucleoprotein (vRNP). All eight IAV segments are enclosed by the viral protein M1 
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which is positioned beneath the envelope linking it to the vRNPs. The viral NS2 protein and, 
more recently NS1 protein, have also been shown to be incorporated in low copy number into 
the virion (Hutchinson et al., 2014; Richardson and Akkina, 1991). 
 
1.4 Influenza A virus life cycle 
 The IAV virus life cycle (a representation of which is shown in Figure 1.2) is 
relatively short (8-10 h in cell culture) and starts with the entry of the virus into the target cell, 
followed by its uncoating. Transcription and replication of the viral genome take place in the 
cell nucleus, which is a relatively uncommon feature for an RNA virus. Expression of viral 
proteins is followed by assembly of new virions and the life cycle ends with the release of the 
newly produced virus particles from the host cell.  
 
 
Figure 1.2 The IAV life cycle. Infection is initiated with the attachment of HA to sialic acid residues present on 
the surface of the host cell, triggering endocytosis. Acidification of the endosome results in fusion of viral and 
endosomal membranes, as well as the uncoating and release of the vRNPs into the cytoplasm which are imported 
to the cell nucleus. Transcription occurs is the nucleus and mRNAs are subsequently exported to the cytoplasm 
where they are translated into new viral proteins. Replication of the genome occurs via the production of an 
intermediate positive-sense cRNA which is used as a template for the synthesis of new, full-length, negative 
sense vRNA molecules which are packaged with NP protein. The vRNPs are then exported to the cytoplasm and 
trafficked to the apical cell surface where a single copy of each of the eight segments is packaged into a new 
virion which buds from the cell surface and is thereby released from the host cell. 
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1.4.1 Viral entry into the host cell 
IAV entry is achieved by the binding of the viral glycoprotein HA to sialic residues 
present on the surface of target cells. This interaction triggers receptor-mediated endocytosis, 
resulting in the internalisation of the virus particle (Gottschalk, 1959; Marsh and Helenius, 
2006; Matlin et al., 1981; Rust et al., 2004; Sieczkarski and Whittaker, 2005). The 
acidification of the endosomes carrying virus particles stimulates a conformational change of 
HA, exposing a fusion peptide which upon insertion into the endosomal membrane leads to its 
fusion with the viral envelope (Skehel and Wiley, 2000). Endosome acidification also results 
in the influx of protons into the viral particle through the viral ion channel M2 (Pinto et al., 
1992). The pH drop inside the viral particle results in the dissociation of M1 and vRNPs, 
making them competent for nuclear import upon release into the cell cytoplasm (Martin and 
Helenius, 1991).  
Viral RNP size determines that nuclear import must occur via active processes. 
Nuclear localisation signals (NLS) present on NP protein are thought to mediate vRNP import 
into the nucleus by interacting with the importin alpha/beta pathway and nuclear pore 
complex components (Cros et al., 2005; Cros and Palese, 2003; O'Neill et al., 1998; Wu and 
Pante, 2009). 
 
1.4.2 Genome transcription 
Transcription of the viral genome takes place in the host cell nucleus and starts once 
vRNPs are imported to this compartment from the cytoplasm (Herz et al., 1981). The viral 
mRNAs resemble cellular ones and possess 5’-cap structures and 3’-poly(A) tails (York and 
Fodor, 2013). 
 Contrary to the non-segmented, negative-strand RNA viruses, the IAV polymerase 
does not carry methyltransferase activity, which means that it is incapable of 5’ capping viral 
RNA transcripts (Plotch et al., 1979). Instead, IAV utilises host mRNAs as a source for 
capped primers in order to initiate viral transcription via a ‘cap-snatching’ mechanism (Plotch 
et al., 1981). The viral polymerase complex binds both ends of the viral genome that, 
annealed into a panhandle structure, form the promoter for viral transcription initiation (Fodor 
et al., 1994; Hagen et al., 1994; Tiley et al., 1994). This activates the cap-binding activity of 
the viral polymerase subunit PB2 which interacts with the 5’ m7G-caps of cellular pre-
mRNAs (Blaas et al., 1982; Braam et al., 1983; Fechter et al., 2003; Guilligay et al., 2008). 
Host encoded pre-mRNAs are then cleaved 10-13 nucleotides downstream of the cap 
structure by PA which possesses RNA endonuclease activity (Crepin et al., 2010; Dias et al., 
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2009; Hara et al., 2001; Plotch et al., 1981; Yuan et al., 2009). The transcription reaction is 
catalysed by PB1 upon binding capped cellular pre-mRNA fragments which are used as 
primers for synthesis of the viral transcripts (Cianci et al., 1995; Li et al., 1998a; Plotch et al., 
1981; Ulmanen et al., 1981). This intricate set of interactions and enzymatic reactions has 
long been suspected to involve a series of conformational changes in the polymerase trimer. 
This supposition has recently been much strengthened by a series of crystallographic 
structures of the IAV as well as influenza B and C virus polymerase complexes which provide 
direct evidence of P protein domain movements between different activity states (Hengrung et 
al., 2015; Pflug et al., 2014; Reich et al., 2014). 
 
Viral transcripts are polyadenylated at the 3’ end as are host mRNAs; however, the 3’ 
end processing of both types of pre-mRNAs is achieved via distinct mechanisms. Host pre-
mRNA polyadenylation occurs using the cellular polyadenylation machinery. Eukaryotic 
cellular mRNAs contain a conserved signal sequence (AAUAAA) preceding poly(A) sites 
that is recognised by the cleavage polyadenylation specificity factor complex (CPSF), which 
is required for both the cleavage and polyadenylation reactions (Zhao et al., 1999). Following 
endonucleolytic cleavage, addition of adenosine residues to the mRNA is catalysed by a 
poly(A) polymerase (PAP), although the rapid elongation and control of the poly(A) tail 
length require the participation of poly(A)-binding protein II (PAB II). PAB II also stabilises 
the polyadenylation complex via its interaction with CPSF-30, a 30- kDa subunit of CPSF 
(Zhao et al., 1999). In contrast, IAV transcripts acquire poly(A) tails via the stuttering of the 
viral polymerase on a poly(U) stretch at the 5’ end of the vRNA (Robertson et al., 1981). The 
poly(U) stretch at the 5’ end of the viral segments has been shown to be required for mRNA 
synthesis and moving it resulted in loss of function of the motif (Luo et al., 1991). 
Replacement of uridines to adenines in the template vRNA resulted in poly-uridylated 
mRNAs, strongly supporting a model proposing that as mRNAs are being synthesized, the 
loop of transcribed vRNA gets shorter, eventually leading to the polymerase stuttering at the 
5’ end of the vRNA where the uridine motif is located because of steric hindrance (Poon et 
al., 2000; Poon et al., 1998). Furthermore, whereas vRNPs have been shown to be able to 
replicate in trans, transcription only occurs in cis, suggesting that the viral polymerase is 
required to remain bound to the 5’ end of the template for the stuttering on the poly(U) stretch 




IAV produces three different classes of mRNA which can be intronless (in most IAV 
strains, segments 1-6), spliced or unspliced (segments 7 and 8). Viral transcripts can also be 
categorised according to the kinetics of their gene product’s expression during infection. 
Segments, 1-3, 5 and the unspliced segment 8 fall into the ‘early’ category while segments 4, 
6, 7 and spliced segment 8 would be classified as ‘late’ gene mRNAs (Hatada et al., 1989; 
Inglis and Mahy, 1979; Lamb et al., 1978; Skehel, 1972). 
While it has long been accepted that IAV uses the cell host machinery for the splicing 
of its mRNAs (Lamb and Horvath, 1991), the regulation of this process remains to be fully 
elucidated.  
Segment 8 can give rise to NS1 or NS2 proteins depending on whether the unspliced 
or spliced transcripts are synthesised, respectively (Inglis et al., 1979; Lamb et al., 1980; 
Lamb and Lai, 1980). More recently, a novel protein - NS3 - has been shown to result from 
alternative splicing of segment 8 mRNA through the mutational activation of a different splice 
donor site. All strains of IAV are expected to make NS1 and NS2, while NS3 is a rare variant. 
Splicing of segment 8 mRNA has been proposed to be regulated by viral factors which 
include NS1 (Chua et al., 2013; Garaigorta and Ortin, 2007; Smith and Inglis, 1985). 
Furthermore, the nuclear export of unspliced NS1 mRNA was suggested to play a role in 
regulating the extent of NS1 mRNA splicing (Alonso-Caplen and Krug, 1991). However, 
other studies have found NS1 not to alter the levels of NS2 spliced transcript accumulation 
while reducing the levels of spliced cellular mRNAs, suggesting that splicing of IAV segment 
8 is independent of NS1 (Robb et al., 2010). This study is in agreement to a previous one that 
suggested that while NS1 inhibited splicing of cellular mRNAs, NS1 mRNA itself was 
resistant to this inhibition (Lu et al., 1994). More recently, an exonic splicing enhancer motif 
(ESE) has been identified in the NS2 mRNA which was shown to interact with host splicing 
regulator SF2 and thereby regulate segment 8 mRNA splicing (Huang et al., 2017). IAV has 
also been proposed to use suboptimal splicing (Lamb and Lai, 1984) as a strategy to 
coordinate the timing of infection, ensuring the slow accumulation of NS2 while high levels 
of NS1 are produced (Chua et al., 2013). 
Segment 7 on the other hand has been shown to produce up to four different 
transcripts (Figure 1.3) and will be described in greater detail as this dissertation focuses 
mainly on the nuclear export of the unspliced mRNA produced from this segment (Inglis and 
Brown, 1981; Lamb and Choppin, 1981; Lamb et al., 1981; Shih et al., 1998; Wise et al., 
2012). The unspliced mRNA1 encodes M1 protein, while spliced mRNA2 encodes M2 
protein. mRNA4 has been shown to encode M42, an M2-related protein that can functionally 
replace M2 (Wise et al., 2012). This mRNA has also been hypothesised to encode another 
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protein, M4, although this polypeptide has not yet been detected (Shih et al., 1998). The 
remaining spliced transcript, mRNA3, is thought to play a role in regulating the levels of 
segment 7 spliced products. In particular, the blockage of mRNA3 5’ splice site by the viral 
polymerase binding to the 5’-promoter sequence was shown to result in preferential usage of 
the mRNA2 5’ splice site, enabling the production of mRNA2 (Shih et al., 1995). Although 
mRNA3 has the coding potential for a 9 amino acid peptide, this remains to be identified 
(Lamb et al., 1981). Segment 7 spliced mRNAs have one feature in common in that they use 
the same 3’ splice acceptor site and each uses a specific 5’ donor splice site (Figure 1.3). 
Similarly to splicing of segment 8, most if not all IAV strains will produce mRNAs 1 and 2, 
whereas the production of mRNAs 3 and especially 4 are more strain-specific (Shih et al., 
1998; Wise et al., 2012).  
 
The regulation of splicing events in segment 7 transcripts has been studied extensively 
over decades and yet, much is still unknown about how IAV ensures that each mRNA is 
produced in the required amounts at different times of infection. In addition to the potential 
 
Figure 1.3 IAV segment 7 mRNA splice variants. 5’-splice donor (SD) and 3’-splice acceptor (SA) site 
positions are indicated and total sizes (a.a.) of the proteins they originate are specified on the right. The potential 
ORFs are colour coded with yellow corresponding to sequences in common with M1, blue to sequences specific 
to M2 and red to the sequence specific to M42. Adapted from (Wise et al., 2012). 
 
role for the viral polymerase in regulating splicing mentioned above, it is clear that single 
nucleotide differences in the regions of the various splice donor sites can have large effects on 
their relative usage (Hutchinson et al., 2008; Shih et al., 1995; Wise et al., 2012). It is also 
possible that other sequences within segment 7 mRNA can influence the levels of splicing. 
For example, the identification of two possible RNA conformations in the region of the 3’ 
splice site of segment 7, a hairpin or a pseudoknot, lead to the suggestion that a 
conformational switch that would expose or hide the splice site could play a role in segment 7 
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splicing regulation (Moss et al., 2012). The viral protein NS1 has been suggested to play a 
role in regulation of segment 7 splicing although not all studies are in agreement. For 
instance, NS1 has been proposed to inhibit splicing of segment 7 mRNA (Lu et al., 1994) 
while no effect on segment 7 splicing was observed in the absence of NS1 in another report 
(Salvatore et al., 2002). Conversely, one study has shown that the absence of NS1 did alter the 
accumulation of segment 7 spliced mRNAs, suggesting that NS1 played a regulatory role in 
segment 7 splicing (Robb and Fodor, 2012). More recently, further evidence has emerged in 
support of NS1 regulating segment 7 splicing by mediating the trafficking of segment 7 
mRNA through host nuclear speckles (Mor et al., 2016). In this study, NS1 was proposed to 
interact with NS1-BP and direct unspliced segment 7 mRNA to nuclear speckles, which are 
storage sites for cellular splicing factors. Both segment 7 spliced mRNA2 and mRNA3 were 
found in nuclear speckles and this localisation was reduced in the absence of NS1 protein. 
According to this model, NS1 promotes post-transcriptional splicing of M1 mRNA during 
infection in a heterogeneous nuclear ribonucleoprotein K (hnRNP K)-dependent manner. 
Reduced levels of NS1-BP and hnRNP K were previously found to alter M2/M1 mRNA and 
protein ratios (Tsai et al., 2013). 
Since IAV transcription occurs in the cell nucleus, mature viral mRNAs must be 
exported to the cytoplasm in order to be translated into proteins. IAV mRNAs have been 
suggested to require the cellular export pathway TAP/NXF1 in order to be exported from the 
nucleus (Hao et al., 2008; Read and Digard, 2010; Satterly et al., 2007; Wang et al., 2008). 
Since this thesis focuses on IAV mRNA export, both cellular and viral mRNA export 
mechanisms will be discussed in detail in individual sections, later in this chapter.  
 
1.4.3 Genome replication  
 Once vRNPs are imported into the cell nucleus, replication of the genome can 
commence, in a two-step process. In the first step, a positive-sense intermediate “cRNA” 
molecule is synthesised and used in the second step as a template for the production of exact 
copies of the genomic vRNA (Neumann et al., 2004; Te Velthuis and Fodor, 2016). 
 The polymerase subunit PB1 initiates cRNA synthesis at the 3’ end of vRNA 
(Gonzalez and Ortin, 1999; Li et al., 1998a) and catalyses the chain elongation reaction 
(Braam et al., 1983). Unlike mRNA, cRNA synthesis occurs in a primer-independent fashion 
(Hay et al., 1982) and does not involve premature termination or polyadenylation. Therefore, 
the resulting cRNA molecules are full-length copies of the vRNA containing non-coding 
regions at both ends that will act as promoters for vRNA synthesis (Palese and Shaw, 2007).  
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 In the second step of replication, vRNA is synthesised using cRNA molecules as 
template. Unlike initiation from a vRNA template which is primer-independent, initiation 
from a cRNA template occurs via the synthesis of a dinucleotide (ApG) within the 3’ 
promoter region. The dinucleotide is then realigned to the 3’ end of the cRNA to act as a 
primer for full-length vRNA synthesis (Deng et al., 2006). Furthermore, replication from a 
cRNA template in vitro relies on the presence of a second RdRp that is not required to be 
catalytically active and thus thought to be responsible for the trans-activation of the resident 
RdRp (York et al., 2013). 
 Since both genome transcription and replication are carried out by the viral 
polymerase, a regulation of these processes is necessary to ensure that levels of mRNA, 
cRNA and vRNA are produced in sufficient amounts and at the appropriate times. It has been 
proposed that soluble NP could be a factor required for this switch (Beaton and Krug, 1986; 
Shapiro and Krug, 1988). However, another model suggests that the initiation of mRNA or 
cRNA synthesis could be a stochastic process that does not depend on a switch to regulate the 
transition between transcription and replication. Rather, NP and the RdRp would stabilise 
nascent cRNA molecules that would otherwise be degraded by host cell nucleases (Vreede et 
al., 2004). While several viral and cellular factors have been implicated or associated with 
viral RNA synthesis (Te Velthuis and Fodor, 2016), the mechanism by which the transition 
between transcription and replication occurs remains unclear. 
 
1.4.4 Nuclear export of vRNPs 
 Following genome replication, progeny vRNPs are exported into the cytoplasm in a 
process that involves the participation of M1 and NS2 proteins (Cros and Palese, 2003). 
vRNPs are far too large to simply diffuse through nuclear pores, so instead the virus hijacks 
the cellular chromosome region maintenance 1 (CRM1) nuclear export pathway. Both M1 and 
NS2 are essential to this process, acting as a two-component adaptor between vRNPs and 
CRM1. M1 has long been known to bind to vRNPs (Zvonarjev and Ghendon, 1980) and in 
the absence of M1, vRNP export fails (Martin and Helenius, 1991). Although M1 is not 
required for vRNP formation (Huang et al., 1990), it has been proposed to promote the 
assembly of vRNPs into an export-competent conformation (Huang et al., 2001). The NS2 
protein on the other hand, has been shown to interact with the CRM1 export receptor 
(Neumann et al., 2000), nucleoporins (O'Neill et al., 1998) and M1 protein (Akarsu et al., 
2003; Yasuda et al., 1993). It has been thus proposed that a complex of vRNP, M1 and NS2 is 
formed and exported to the cytoplasm via the cellular export pathway CRM1 (Neumann et al., 
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2000; O'Neill et al., 1998). The necessity of CRM1 for RNP export was established primarily 
by studies using a specific fungal inhibitor of it, Leptomycin B (LMB), which found that cells 
treated with this drug failed to export RNPs (Elton et al., 2001; Ma et al., 2001; Watanabe et 
al., 2001). Once exported from the nucleus, vRNPs are directed to the pericentriolar recycling 
endosome to get access to the cellular Rab-11 dependent vesicular transport pathway towards 
the apical plasma membrane (Amorim et al., 2011; Chutiwitoonchai and Aida, 2016; 
Kawaguchi et al., 2012; Momose et al., 2011). 
 
1.4.5 Assembly and budding  
 Following replication of vRNA, transcription of viral mRNA and translation of viral 
proteins, the components that will form new virions must be assembled and packaged into 
individual viral particles. These processes are crucial for the release of progeny virions, 
through budding which occurs from the apical membrane of infected cells (Rodriguez Boulan 
and Sabatini, 1978).  
 The viral proteins that are found in the viral envelope: HA, NA and M2 are 
synthesised by membrane-bound ribosomes in the rough endoplasmic reticulum (Doms et al., 
1993). HA and NA proteins are glycosylated in the Golgi network and use the trans-Golgi 
membrane to reach the apical plasma membrane where they accumulate in lipid raft 
microdomains (Barman et al., 2001; Scheiffele et al., 1999; Zhang et al., 2000). M2 is also a 
transmembrane protein found at the surface of infected cells (Lamb et al., 1985), but not in the 
lipid microdomains where HA and NA concentrate (Leser and Lamb, 2005; Zhang et al., 
2000). Rather, M2 has been found in the periphery of lipid raft domains (Rossman et al., 
2010; Thaa et al., 2011) still associated with the budding sites of infected cells (Rossman et 
al., 2010; Schroeder et al., 2005). The remaining virion components are thought to reach the 
site of viral assembly using the actin cytoskeleton and/or the microtubule network (Amorim et 
al., 2011; Avalos et al., 1997; Bucher et al., 1989; Digard et al., 1999). NS2 protein was 
initially thought to be a non-structural protein but was later found in virus particles 
(Richardson and Akkina, 1991; Yasuda et al., 1993); something that may reflect its 
association with RNPs and its role in their nuclear export. 
 The interior structure of the virion is thought to be formed via interactions between 
M1 and the cytoplasmic tails of HA and NA that then serves as a docking site for vRNP 
recruitment (Ali et al., 2000; Rossman and Lamb, 2011; Zhang et al., 2000). An interaction 
between M1 and the cytoplasmic tail of M2 has also been demonstrated and proposed to play 
an important role in viral assembly (Chen et al., 2008). M1 has furthermore been shown to 
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bind NP, in the form of vRNPs (Bui et al., 1996; Noton et al., 2007); thus being proposed to 
act as a bridge between vRNPs in the inner core of the virion and the membrane proteins at 
the surface (Nayak et al., 2004; Schmitt and Lamb, 2005). While vRNPs are believed to reach 
to apical plasma membrane using the cellular Rab-11 pathway (Amorim et al., 2011; Momose 
et al., 2011), one copy of each of the eight IAV genomic segments must be incorporated in the 
new virion. The selection of individual segments is thought to be mediated by cis-acting RNA 
sequences at the termini of vRNAs that act as packaging signals (Hutchinson et al., 2010). 
More recently, NS1 protein was identified in purified virions and suggested to also be part of 
the composition of the virus even though it has long been considered a non-structural protein 
(Hutchinson et al., 2014). However, how NS1 is recruited to the plasma membrane and what 
role it plays in viral assembly and/or budding remains unclear. In addition to viral 
components, a wide range of cellular factors have also been shown to be incorporated into 
virions (Hutchinson et al., 2014; Shaw et al., 2008), although this aspect of the viral assembly 
is still poorly understood. 
 
 Budding from the plasma membrane takes place once all the viral components have 
been assembled and results in the virions acquiring their final envelope when membrane 
scission occurs and the virions are released (Nayak et al., 2004; Schmitt and Lamb, 2005). 
Budding of IAV has been shown to require the Rab-11 pathway as virus particles failed to 
pinch-off from the plasma membrane in cells depleted of Rab11 (Bruce et al., 2010). 
Furthermore, the viral protein M2 has also been demonstrated to play a role in the final steps 
of the budding process, as mutations in this protein resulted in failure of membrane scission 
and virion release (Rossman et al., 2010). Finally, detachment of progeny virions from the 
host cell is ensured by the cleavage of sialic acid from cellular and viral membranes by NA, 
thereby preventing HA from binding the cell surface again through its interaction with sialic 
acid residues (Palese et al., 1974). 
 
1.5 Cellular mRNA export 
 Protein synthesis primarily takes place in the cell cytoplasm and results from the 
translation of mRNAs which are produced in the nucleus. Hence once transcription is 
completed, mRNAs must be exported to the cytoplasm. However, prior to being fit for 
nuclear export, precursor mRNAs (pre-mRNAs) must turn into mature transcripts which 
involves undergoing multiple processing steps which are thought to occur co-transcriptionally 
(Bentley, 2002; Bentley, 2005). These processing steps include 5’ end capping, removal of 
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introns through splicing mechanisms, cleavage and polyadenylation at the 3’ end. All of them 
are carried out by the many different components of the mRNA processing machinery that 
join the RNA polymerase II transcription machine at ‘transcription factories’ (Bentley, 2002; 
Bentley, 2005; Howe, 2002). During mRNA processing, the transcript is always bound to a 
plethora of different proteins, forming messenger ribonucleoprotein particles (mRNPs). The 
proteins that are associated to the mRNA change throughout the maturation of the mRNA. 
For example, heterogeneous ribonucleoproteins associate with pre-mRNA, forming 
heterogeneous ribonucleoprotein particles (hnRNPs) during transcription and regulate 
splicing. Once splicing of the pre-mRNA has been carried out, the hnRNP proteins remain 
mainly associated to the spliced introns (Muller-McNicoll and Neugebauer, 2013).  
 
 Efficient mRNA nuclear export is coupled to processing steps through a series of 
protein-protein and protein-RNA interactions and the protein composition of a mature mRNA 
gives it the appropriate coating to undergo nuclear export, thereby ensuring that only mature 
mRNPs reach the cytoplasm for translation. The mechanism of cellular mRNA export has 
been extensively studied and defined in yeast and the pathway was found to be evolutionary 
conserved, being broadly applicable to higher eukaryotes (Okamura et al., 2015).  
The transcription-export complex (TREX) has been suggested to have a conserved 
role in coupling transcription to mRNA export. In particular, TREX has been shown to be 
specifically recruited to nascent pre-mRNAs during transcription elongation (Strasser et al., 
2002; Zenklusen et al., 2002). The TREX complex is formed by proteins Aly (THOC4), 
UAP56 (BAT1) and the human counterparts of a protein complex known to be involved in 
transcription in yeast, the THO complex (Strasser et al., 2002). Aly has been shown to interact 
with the nuclear RNA export factor 1 (NXF1), being recruited during splicing and resulting in 
an increased export efficiency for spliced mRNAs (Stutz et al., 2000; Zhou et al., 2000).  
 
NXF1 has been identified as a bulk mRNA nuclear export factor as its overexpression 
in cell culture or microinjection into Xenopus oocytes stimulated efficient mRNA nuclear 
export (Braun et al., 2001; Herold et al., 2000; Yang et al., 2001). In order to promote the 
directional transport of mRNA across the nuclear pore complex (NPC), NXF1 forms a 
heterodimer with its co-factor Nxt1 (p15) to associate with nucleoporins at the NPC (Braun et 
al., 2002). It has been suggested that an intramolecular interaction inhibits NXF1’s own RNA-
binding activity and that its interaction with the Aly and Thoc5 components of the TREX 
complex results in a conformational change that exposes its RNA-binding domain and thus 
enables RNA-binding (Viphakone et al., 2012). Another TREX component that has also been 
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shown to be required for mRNA nuclear export is the helicase UAP56, which functions 
during spliceosome assembly (Fleckner et al., 1997; Zhang and Green, 2001). UAP56 has 
been demonstrated to interact specifically with Aly and both were found to be present 
together in spliced mRNPs, suggesting that one recruited the other (Luo et al., 2001). 
Inhibition of the interaction between UAP56 and Aly prevented the latter from being recruited 
to the mRNP (Luo et al., 2001). This is in line with other reports that couple mRNA nuclear 
export with a further mRNA processing step, splicing (Huang and Steitz, 2001; Luo and 
Reed, 1999; Zhou et al., 2000). Furthermore, UAP56 was shown to be required for the ATP-
dependent interaction between Aly and THO and thus, UAP56 has been considered the core 
component of TREX (Dufu et al., 2010). In addition, both Aly and UAP56 have been 
associated with the Exon Junction Complex (EJC) which is deposited 20-24 nucleotides 
upstream of an exon-exon junction generated from intron removal (Le Hir et al., 2000). 
UAP56 has been shown to preferentially interact with spliced mRNAs carrying the EJC 
(Gatfield et al., 2001), while Aly is a component of the EJC which has been proposed to 
provide a binding platform for factors involved with mRNA export (Le Hir et al., 2001). 
Hence, the association of the TREX complex with the EJC was proposed to be the functional 
link between splicing and mRNA export (Strasser et al., 2002). UAP56 has also been linked 
to the NXF1/Nxt1 export pathway as a genome-wide analysis of nuclear mRNA export 
pathways in Drosophila revealed striking similarities in the mRNA expression profiles in 
NXF1, Nxt1 and UAP56  knock-out cells, indicating that these proteins operated in the same 
pathway (Herold et al., 2003). However, Aly has been found to be dispensable for mRNA 
nuclear export in metazoan (specifically, Drosophila) cells while NXF1 and UAP56 were 
found to be essential, indicating that other proteins other than Aly may act as adaptor proteins 
in this pathway (Gatfield and Izaurralde, 2002). In addition to transcription and splicing, the 
recruitment of TREX complex is also a cap-dependent process, as only 5’ capped mRNAs 
were found associated with TREX (Cheng et al., 2006). The interaction found between Aly 
and the large subunit of the nuclear cap-binding complex (CBC), cap-binding protein 80 
(CBP80) was suggested to recruit the TREX complex. The association between CBP80 and 
the TREX complex mediated by Aly would position TREX at the 5’ end of the mRNA, 
resulting in its export through the nuclear pore in a 5’ to 3’ direction (Cheng et al., 2006).  
 
Nuclear export of cellular mRNAs has also been linked to the 3’ end processing of the 
mRNA that involves cleavage and polyadenylation of transcripts, although the precise 
mechanisms behind this association remain poorly understood. Abrogation of poly(A) 
synthesis at the mRNA 3’ end has been shown to inhibit mRNA export in yeast and 
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mammalian cells (Dower et al., 2004; Huang and Carmichael, 1996; Libri et al., 2002). 
Furthermore, the deletion of cis-acting sequences in the 3’ UTR of pre-mRNA required to 
couple 3’ processing and termination in yeast resulted in transcripts failing to be exported 
from the nucleus (Hammell et al., 2002). In addition, several, but not all, export mutant 
mRNAs analysed in the same study were found to be improperly 3’ processed transcripts 
(Hammell et al., 2002). Conversely, mutation of several mRNA export proteins in 
Saccharomyces cerevisiae resulted in hyperadenylation of transcripts, resulting in pre-
mRNAs with longer poly(A) tails that rapidly accumulated in the nucleus at transcription 
sites, suggesting that mRNA maturation events determine mRNA export competence (Jensen 
et al., 2001). Moreover, the action of the THO and its associated helicase Sub2p (the yeast 
counterpart of human UAP56) has been suggested to occur after commitment to 3’ end 
processing, which would coordinate events leading to efficient mRNA nuclear export 
(Rougemaille et al., 2008). In particular, this study found that THO/Subp2 mutations resulted 
in the specific sequestration of the 3’ ends of a subset of genes within stalled RNP 
intermediates. Further evidence connecting mRNA export and 3’ end processing emerged 
from a report suggesting that Yra1 (the yeast counterpart of Aly) was recruited by a direct 
interaction with the 3’ end processing factor Pcf11, thereby coordinating export with 3’ end 
processing (Johnson et al., 2009). Finally, NXF1 has been shown to interact with cleavage 
and polyadenylation specificity factor 6 (CPSF6) that is involved in mRNA polyadenylation 
(Ruepp et al., 2011). This export model is summarised in Figure 1.4 and applies to the bulk 
of cellular mRNAs, which are, in their vast majority, spliced.  
 
 
Figure 1.4 Summary of the current model for bulk mRNA nuclear export, which is achieved by the NXF1/Nxt1 
export pathway in a sequential series of steps. Per this model, UAP56 recruits Aly which subsequently recruits 
and, acting as an adaptor protein, hands over the mRNA to NXF1, marking the mature transcript for nuclear 
export through the nuclear pore complex into the cell cytoplasm. Adapted from (Carmody and Wente, 2009). 
 
 
However, there are also cellular mRNAs which do not contain introns and mRNAs 
which have been shown to not use the NXF1/Nxt1 export pathway. The export of cellular 
mRNAs can be selective and dependent on specific cis-acting RNA elements and interactions 
with specific adaptor proteins (Delaleau and Borden, 2015). For instance, CRM1 is a member 
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of the importin β superfamily of nuclear transport receptors and has been established as 
required for the nuclear export of many RNAs (Fukuda et al., 1997; Hutten and Kehlenbach, 
2007; Stade et al., 1997; Watanabe et al., 1999). While NXF1 requires an adaptor protein to 
increase its affinity with RNA (Viphakone et al., 2012), CRM1 is thought to interact directly 
with its mRNA cargoes via cis-acting RNA export elements (Fukuda et al., 1997; Popa et al., 
2002). It has been suggested the RNA length could dictate which export pathway is used. In 
particular, it was found that sequences greater than 300 nucleotides, like mRNAs, almost 
exclusively use the NXF1 pathway, while sequences shorter than 120 nucleotides, such as U 
spliceosomal small nuclear RNAs (snRNAs), used a CRM1 pathway (Masuyama et al., 2004).  
 
Other export strategies have been found for intronless transcripts and viral mRNAs are 
often used as tools to study the export mechanisms of this type of transcript. The metazoan 
replication-dependent histone mRNAs are not spliced or polyadenylated, but rather present a 
highly conserved stem-loop structure at the 3’ end (Marzluff, 1992, 2005; Marzluff et al., 
2008). The cytoplasmic accumulation of such mRNAs has been shown to be facilitated by a 
short cis-acting element in the protein coding region of the mRNA that facilitates their 
cytoplasmic accumulation, with a function analogous to the human immunodeficiency virus 
(HIV) protein Rev (Huang and Carmichael, 1997). Furthermore, when inserted into the 5’ 
untranslated region of a human β-globin cDNA construct, this cis-acting sequence was shown 
to act as a polyadenylation enhancer and a potent inhibitor of splicing in addition to 
promoting mRNA export (Huang et al., 1999). The cellular stem-loop binding protein (SLBP) 
has been identified as a factor necessary for the nuclear export of histone mRNAs. SLBP has 
been demonstrated to interact with the histone mRNA and SLBP knockdown human bone 
osteosarcoma epithelial (U2OS) cells resulted in retention of the mRNA in the cell nucleus 
(Pandey et al., 1994; Sullivan et al., 2009). The NXF1 pathway has also been shown to be 
used for the export of intronless transcripts. It has been suggested that an unstructured RNA 
sequence is capable of recruiting EJC elements and thus the NXF1 export pathway, as adding 
300-350 nucleotides of random mRNA exon sequences into U1 snRNAs resulted in the 
hybrid RNAs being exported like mRNAs (via NXF1) rather than like U1 snRNAs which are 
exported via the CRM1 pathway (Ohno et al., 2002). Furthermore, it has been proposed that 
intronless mRNAs, other than histone mRNAs, contain specific sequences that result in their 
efficient integration into the TREX mRNA complex and that the cytoplasmic accumulation of 
naturally intronless transcripts requires a polyadenylation signal, TREX components and 
NXF1 (Lei et al., 2011). Thus, even though the NXF1 pathway is mostly associated with the 
export of spliced mRNAs, splicing is not an absolute requirement for this pathway to be used. 
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1.6 IAV mRNA export 
 IAV genome replication and transcription occur in the cell nucleus which creates the 
necessity for both vRNA and mRNA to be exported to the cytoplasm. The nuclear export of 
vRNPs is well studied and, as described above, is achieved using the CRM1 cellular export 
pathway with the participation of viral proteins M1 and NS2 (Elton et al., 2001; Neumann et 
al., 2000; O'Neill et al., 1998; Paterson and Fodor, 2012). However, how IAV mRNAs reach 
the cell cytoplasm remains less understood. Viral mRNAs have a similar structure to cellular 
mRNAs as they possess a 5’ cap structure and a 3’ poly(A), tail although these features are 
acquired through different mechanisms (York and Fodor, 2013). As detailed in the previous 
section, cellular mRNA maturation that includes 5’ capping, splicing and 3’ end processing of 
active transcripts is coupled to their nuclear export. It is then possible that viral mRNAs 
mimic the structure of cellular mRNAs to gain access to the cellular export machinery, as well 
as to ensure their successful translation by ribosomes. In support of this view, IAV mRNA 
export has been shown to require the ongoing activity of RNAP II, as its inhibition resulted in 
mRNA nuclear retention (Amorim et al., 2007; Vogel et al., 1994). RNAP II was further 
demonstrated to interact with the IAV polymerase resulting in the ubiquitylation of RNAP II 
leading to its subsequent degradation in infected cells (Vreede and Fodor 2010). The 
association between the two polymerases would not only place transcribing viral RNPs in the 
correct sites in the nucleus to acquire 5’ cap structures by snatching them from cellular 
mRNA, but also to be in close proximity with export cellular factors, namely NXF1. It is 
established that IAV mRNAs do not use the CRM1 pathway for their nuclear export (Amorim 
et al., 2007; Elton et al., 2001; Larsen et al., 2014; Read and Digard, 2010). Instead, the view 
is that the virus uses the NXF1/Nxt1 export pathway, as several reports provide mounting 
evidence for its involvement. Initial evidence came from a Drosophila cell-based screen for 
host genes involved in IAV replication which indicated the involvement of NXF1 in IAV 
replication (Hao et al., 2008). NXF1 has been shown to interact with several, but not all, IAV 
mRNAs (Larsen et al., 2014; Satterly et al., 2007; Wang et al., 2008). Furthermore, siRNA-
mediated depletion of NXF1 has been demonstrated to result in the inhibition of nuclear 
export of selected IAV transcripts and/or overall virus replication (Hao et al., 2008; Larsen et 
al., 2014; Read and Digard, 2010). Reduced levels of UAP56, which participates in the 
NXF1/Nxt1 export pathway, was also shown to result in defective nuclear export of some 
IAV transcripts (Mor et al., 2016; Read and Digard, 2010). The requirement of Aly for IAV 
mRNA export is less consensual, as one study found that that depletion of Aly had little effect 
on mRNA export (Read and Digard, 2010) while another suggested that the knockdown of 
Aly inhibited export of M1 and M2 mRNAs (Mor et al., 2016). A further study found that 
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IAV segment 6 mRNA interacted with both the CBC and Aly, again suggesting that viral 
mRNAs followed the same pathway for nuclear export as cellular mRNAs (Bier et al., 2011).  
 
While the involvement of NXF1 in IAV mRNA nuclear export is established, there is 
also evidence that this cellular factor is not absolutely required for the export of all IAV 
mRNAs and that mRNAs from different segments use different strategies to reach the 
cytoplasm. For instance, the various IAV mRNAs have shown distinct degrees of sensitivity 
to the depletion of NXF1. While the nuclear export of intronless late gene transcripts from 
segments 4 and 6 as well as unspliced segment 7 showed a high degree of dependence on 
NXF1, export of intronless early gene mRNAs from segments 1, 2, 3 and 5 showed little 
dependency on this factor (Larsen et al., 2014; Read and Digard, 2010). The use of selective 
mRNA export mechanisms by different segments is also in line with a previous study that 
showed that the ongoing activity of RNAP II was required for the nuclear export of segment 7 
but not segment 5 mRNA (Amorim et al., 2007). Presumably the selection of mRNA export 
strategy is related to interactions between viral mRNAs and particular cellular factors, likely 
dictated by cis-acting sequences specific to each transcript, but this remains to be elucidated. 
More recently, it has been proposed that the RNA helicase DDX19 (normally resident on the 
cytoplasmic face of the NPC) is recruited by the viral polymerase to promote the nuclear 
export of all classes of viral transcripts, intronless, spliced and unspliced (Diot et al., 2016). 
This study suggested that the viral polymerase recruits DDX19 in an RNA-independent 
manner and that the latter associated with viral transcripts to enhance their export, as DDX19 
depletion resulted in highly reduced levels of cytoplasmic viral mRNA. However, depletion 
of DDX19 also reduced overall levels of viral transcription and the exact involvement of 
DDX19 in the nuclear export of IAV mRNAs is unclear. 
 
 The viral protein NS1 has also been hypothesised to participate in IAV mRNA nuclear 
export (Schneider and Wolff, 2009) and its involvement in this process is the main focus of 
this dissertation. NS1 has been shown to interact and co-localise with NXF1 and IAV 
transcripts, suggesting that it could play a role in IAV mRNA nuclear export (Wang et al., 
2008). Recently (after the work reported here was completed), it has been proposed that NS1 
mediates M1 mRNA transport through nuclear speckles, promoting the splicing of segment 7 
and the nuclear export of M2 mRNA (Mor et al., 2016). However, it remains unclear how 
NS1 could play a role in the nuclear export of intronless or unspliced mRNAs. Even though 
NS1 has been suggested to play a role in IAV mRNA nuclear export before (Schneider and 
Wolff, 2009) and some subsequent reports support this argument, there are also several 
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studies suggesting that NS1 has the opposite effect on nuclear export of cellular mRNAs 
(Fortes et al., 1994; Garaigorta and Ortin, 2007; Qian et al., 1994; Qiu and Krug, 1994). 
Specifically, NS1 was shown to inhibit the nuclear export of mRNAs containing a poly(A) 
tail (Qiu and Krug, 1994), potentially by interacting with CPSF30 and thereby inhibiting the 
3’ end formation of cellular mRNAs (Nemeroff et al., 1998). Another report suggested that 
NS1 interacted with poly(A) binding protein II (PABPII) which resulted in inhibition of the 
poly(A) tail elongation (Chen et al., 1999). In general, these results can be summarised as 
reflecting an export block resulting from inhibition of pre-mRNA maturation, rather than a 
direct effect on the mRNA export apparatus itself. However, more recently, NS1 has been 
proposed to directly target the cellular mRNA export machinery and the nuclear pore complex 
with the function of inhibiting transport of cellular mRNAs (Satterly et al., 2007). In this 
study, results indicated that NS1 could interact with NXF1, Nxt1 and other components of the 
RNA nuclear export machinery such as Rae1 and E1B-AP5. The analysis of NS1 deletion 
mutants revealed that Nxt1 interacted with the carboxyl-terminal domain of NS1 while NS1 
interaction with NXF1, Rae and E1B-AP5 required both the amino- and carboxyl-terminal 
domains of NS1. All these interactions aside from the one between NS1 and E1B-AP5 were 
shown to occur in an RNA-independent manner. In addition, an interaction between 
nucleoporin98 (Nup98) and NS1 was also demonstrated (Satterly et al., 2007). 
Nevertheless, the thought that NS1 could act as an adaptor protein with the role of 
promoting viral mRNA through a cellular export pathway is not unfounded and has 
precedents, as other viruses have been shown to use similar strategies to export their mRNAs. 
The classic example of this is the human immunodeficiency virus- 1 (HIV-1) utilising its Rev 
protein as an adaptor to direct its singly-spliced and unspliced mRNAs into the CRM1 export 
pathway (Cullen, 2003). Potentially more relevant to IAV and its reliance on the NXF1/Nxt1 
pathway, herpes simplex virus type 1 (HSV-1) protein ICP27 was shown to promote the 
nuclear export of intronless viral mRNAs by interacting with Aly in order to access the 
NXF1/Nxt1 export pathway (Chen et al., 2002). However, Aly was subsequently found to be 
dispensable for the export of HSV-1 intronless mRNAs (Johnson et al., 2009), indicating that 
redundant mechanisms may be used by viruses to export their mRNAs. An example of such a 
redundant mechanism was found in Kaposi's sarcoma-associated herpesvirus (KSHV) where, 
in the absence of Aly, ORF57 (the homologue of HSV-1 ICP27) was able to interact with 
another cellular protein, UIF, and thereby recruit the TREX complex and NXF1 onto KSHV 
intronless mRNAs (Jackson et al., 2011). 
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1.7 IAV NS1 protein 
 NS1 protein is the gene product resulting from segment 8 unspliced mRNA translation 
(Figure 1.5). It is commonly referred to as a multifunctional protein due to the plethora of 
roles and functions attributed to it, often in a virus strain-dependent manner (Hale et al., 
2008b). Its length varies according to the virus strain, generally ranging from 218-237 a.a. 
(although shorter forms are found) and it shares ten N-terminal a.a. with NS2, the gene 
product of segment 8 spliced mRNA (Abdelwhab el et al., 2016; Lamb and Lai, 1980; Palese 
and Shaw, 2007). It was accepted for many years that NS1 is a non-structural component of 
IAV virions, hence its name. However, this has been recently disputed as NS1 was identified 
in preparations of purified virions, suggesting that it is present in the core structure of the 
virus (Hutchinson et al., 2014). In infected cells, the amount of NS2 mRNA was found to be 
10% compared to levels of NS1 mRNA (Lamb et al., 1980). As discussed above, NS1 has 
been suggested to regulate splicing from the very segment it originates from in order to 
control the amounts of NS1 and NS2 proteins produced during infection (Chua et al., 2013; 
Garaigorta and Ortin, 2007). Two distinct functional domains have been identified in NS1, an 
N-terminal RNA binding domain (residues 1-73) and a C-terminal effector domain (residues 
74-230) (Hale et al., 2008b). These domains were originally defined biochemically and 
functionally, but have since been resolved at the atomic level in a variety of high resolution 
structures that collectively show an alpha-helical RNA binding domain separated from an 
effector domain, largely comprised of beta-sheet, by a short linker region (Bornholdt and 
Prasad, 2006; Dundon and Capua, 2009; Kerry et al., 2011b; Liu et al., 1997).  
 
The RNA-binding domain has been shown to interact with several RNA species such 
as double-stranded RNAs, snRNAs, viral genomic RNAs and viral mRNAs (Chien et al., 
1997; Hatada and Fukuda, 1992; Hatada et al., 1997; Hatada et al., 1992; Marion et al., 1997; 
Qiu et al., 1995; Wang and Krug, 1998; Wang et al., 1999). Two residues were identified as 
essential for this domain to remain active: an arginine at position 38 and a lysine at position 
41, as substitution of these residues was shown to abrogate the NS1 RNA-binding activity 
(Wang et al., 1999). The effector domain is thought to be mainly responsible for mediating 
interactions with host factors and it has also been shown to stabilise the RNA-binding 
domain, while both domains contribute to the multimerisation of full-length NS1 (Hale et al., 
2008a; Nemeroff et al., 1995; Wang et al., 2002). During infection, NS1 can be found both in 
the cell nucleus and in the cytoplasm (Greenspan et al., 1988; Newby et al., 2007). The 
presence of both nuclear localisation sequences (NLS) (Greenspan et al., 1988; Melen et al., 
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2007) as well as a nuclear export signal (NES) (Li et al., 1998b) in NS1 suggests that it may 




Figure 1.5 Representation of IAV NS1 protein. The dashed lines indicate the boundaries of the functional 
domains of the protein and their positions (a.a.) specified on the top, along with the signals of the NLSs, a 
nucleolar localisation signal (NoLS) and NES. Known interactions between NS1 and cellular factors are depicted 
at the relative position of the residues thought to be critical for each particular interaction. The N-terminus of 
NS1 includes the RNA-binding domain which interacts with multiple RNA species. The C-terminus 
encompasses the effector domain which is responsible for the majority of the known interactions between NS1 
and cellular factors. This domain is followed by around 20 a.a. which are possibly unstructured and referred to as 
a “disordered tail”, also associated with interactions with components of the cellular machinery. Figure taken 
from (Hale et al., 2008b). 
 
The major function credited to NS1 is the one of antagonizing host immune responses 
(Egorov et al., 1998; Garcia-Sastre et al., 1998; Kochs et al., 2007). It was found that 
influenza A viruses that did not express NS1 induced large amounts of interferon (IFN) and 
replicated more efficiently in IFN-α/β deficient systems such as Vero cells, even though their 
virus titres were still lower when compared to WT viruses expressing NS1 (Garcia-Sastre et 
al., 1998; Kochs et al., 2007). Although antagonism of innate immune functions is regarded as 
the primary role of NS1, it has been shown to play many other roles throughout the IAV life 
cycle, through numerous protein-RNA and protein-protein interactions. For instance, NS1 
interferes with many host processes at different stages of viral infection (Khaperskyy and 
McCormick, 2015). As already discussed, early in infection, NS1 has been shown to interfere 
with the 3’ end processing of cellular mRNAs, resulting in the inhibition of mRNA 
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polyadenylation in the cell nucleus (Nemeroff et al., 1998). Later in infection, NS1 can also 
be found in the cytoplasm where it inhibits the antiviral proteins 2′-5′ oligo(A) synthetase 
(OAS) and protein kinase R (PKR) by interfering with their ability to bind dsRNA (Garcia et 
al., 2006; Silverman, 2007). NS1 has been demonstrated to out-compete OAS for interaction 
with dsRNA (Min and Krug, 2006) and proposed to interact with PKR and thereby inhibit the 
conformational change thought to be necessary for PKR auto-inhibition (Li et al., 2006). 
Residues at positions 35 and 36 in NS1 have recently been identified as critical for blocking 
the activation of PKR, as their mutation abrogates the ability of NS1 to interact with PKR and 
dsRNA (Schierhorn et al., 2017). Both these NS1 interactions protect viral mRNA from being 
targeted for degradation, ensuring their undisturbed translation in the cell cytoplasm.  
 
NS1 protein has also been linked to actively enhancing translation of viral mRNAs. In 
support of this view, a study showed that the presence of NS1 resulted in higher accumulation 
levels of viral proteins NP and M1 in the cell cytoplasm and this NS1-mediated effect was 
attributed to an increase in the translation initiation rate (de la Luna et al., 1995). 
Subsequently, IAV gene expression was shown to be stimulated by the presence of NS1 in a 
study where a short sequence upstream of the initiation codon on segment 7 was found to be 
required for this NS1-associated effect (Enami et al., 1994). In this instance, it was suggested 
that NS1 acted at the level of translation since the amounts of M1 mRNA were not altered by 
NS1 expression. However, a direct effect on translation specifically as opposed to post-
transcriptional processes was not demonstrated. NS1 was further shown to interact with the 
eukaryotic initiation factor 4GI (eIF4GI) which is the large subunit of the cytoplasmic CBC, 
eIF4F, in an RNA-independent manner (Aragon et al., 2000). This study proposed that NS1 
recruits eIF4GI to the 5’UTR of IAV mRNAs, thereby favouring their translation. On the 
other hand, it has also been reported that viral mRNA translation was not significantly 
impaired in cells infected with an influenza virus that did not express NS1 in IFN-deficient 
systems (Salvatore et al., 2002). The findings in this study suggest that, while NS1 may 
enhance viral mRNA translation, this role is not essential for the replication of the virus. 
 
Another role attributed to NS1 is the ability to activate the PI3K signalling pathway. 
NS1 was found to interact with the p85β regulatory isoform of PI3K and several residues in 
NS1 have been implicated in this interaction (Hale et al., 2006; Li et al., 2008; Shin et al., 
2007). Inhibition of PI3K was found to result in impaired propagation of IAV and greater 
induction of apoptosis in infected cells (Ehrhardt et al., 2006; Ehrhardt et al., 2007; Hale et 
al., 2006; Zhirnov and Klenk, 2007). NS1 could then play a role in limiting host-cell 
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apoptosis and thus favouring viral proliferation, although the implication of PI3K activation 
in the context of IAV infection remains poorly understood and warrants further investigation.  
 
Even though the NS1 functions described above are considered the main ones, several 
other roles and multiple interactions with cellular factors have been associated to this viral 
protein (Hale et al., 2008b; Marc, 2014). In this dissertation, the role of NS1 in viral mRNA 
export was explored using several mutant NS1 proteins predicted to have loss of function (or 
in one case, gain of function) phenotypes affecting their ability to interfere with the various 
cellular functions above. Further details on these mutant polypeptides are given later in 
Chapter 3.  
 
1.8 Aims of this study 
 This study is the continuity and further expansion of previous work performed in our 
laboratory (Amorim et al., 2007; Read and Digard, 2010). It focuses on understanding how 
IAV transcripts are exported from the host cell nucleus to the cytoplasm, starting from the 
hypothesis that NS1 could act as an adaptor between viral mRNAs and the cellular 
NXF1/Nxt1 mRNA export pathway. The overall goal of this dissertation was to determine the 
viral requirements for mRNA nuclear export and try to determine which cellular components 
are involved in the viral mRNA export mechanism. One chapter of this dissertation is aimed 
at identifying the viral requirements for segment 7 mRNA export, by analysing the cellular 
localisation of the mRNA by fluorescence in situ hybridisation (FISH) in the absence or 
presence of different viral proteins. The next two chapters of this dissertation are aimed at 
understanding the mechanism by which nuclear export of segment 7 occurs by using mutant 
viruses and testing interactions between viral proteins, viral mRNA and cellular proteins. The 
final chapter of this dissertation focuses on the goal of determining whether the viral and 
cellular requirements for segment 7 nuclear export are shared with other segments. 
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CHAPTER 2 – INVESTIGATING THE VIRAL 
REQUIREMENTS FOR mRNA NUCLEAR EXPORT 
_________________________________________________________________________ 
2.1 Introduction 
 IAV mRNA nuclear export is currently poorly understood and, in comparison to other 
aspects, not much is known about the requirements or the mechanisms for this vital process in 
the virus life cycle. 
 It has been established that IAV utilizes cellular machinery to export its transcripts. 
For instance, nuclear export of viral late gene mRNAs was shown to require the ongoing 
activity of DNA-dependent-RNA-polymerase II (RNAP II) at a post-transcriptional level. 
Inhibition of processive transcription by RNAP II using the drug DRB rather than the 
complete activity of the protein suggested that RNAP II was necessary not just to provide a 
source of 5’-cap structures for the viral polymerase but also played a role in facilitating viral 
mRNA export (Amorim et al., 2007). Consistent with this, the NXF1 pathway has been 
proposed to be involved in influenza A viral mRNA nuclear export (Hao et al., 2008; Read 
and Digard, 2010; Satterly et al., 2007; Wang et al., 2008). However, different segments 
showed different levels of dependence on NXF1 to achieve export (Larsen et al., 2014; Read 
and Digard, 2010) and how NXF1 is recruited to viral mRNAs remained unknown. 
Previous work from the Digard lab suggested that the intracellular localisation of 
segment 7 mRNA analysed by fluorescent in situ hybridization (FISH) in the context of an 
RNP reconstitution assay was different from the one observed in infected cells. In infected 
cells, the mRNA was found in the cytoplasm as would be expected (Amorim et al., 2007; 
Read and Digard, 2010). However, it was seen to be retained in the cell nucleus when 
expressed in a minireplicon system utilising segment 7 as a vRNA template (Read, 2010), 
suggesting that a viral factor found in infected cells, but not in the minireplicon system, might 
be necessary for efficient export. 
The aim of the research in this chapter was therefore to investigate potential role(s) for 





2.2.1 Segment 7 mRNA localisation in infected vs. transfected cells 
As outlined above, preliminary evidence (from a previous PhD student in the group) 
suggested that segment 7 mRNA localisation might differ between authentic virus infection 
and a minireplicon setting that expresses only a subset of the viral polypeptides. To test if this 
finding was reproducible, 293T cells were either infected with wild type A/PR/8/34 (WT 
PR8) virus or transfected with the basic minireplicon components (PB2, PB1, PA and NP) 
and a plasmid expressing segment 7 as the vRNA template. Cells were fixed and processed 
for FISH using a fluorescently labelled RNA probe to detect segment 7 positive sense RNA 
molecules. IAV produces two types of positive sense RNA – mRNA and cRNA – and the 
probes used are thus capable of hybridizing with both. However, since 90-95% of positive 
sense IAV RNA is estimated to correspond to mRNA transcripts (Elton et al., 2006), these are 
expected to be the majority of molecules detected by the probes. In addition, segment 7 is a 
spliced segment and several mRNAs can be synthesised from it: an unspliced transcript 
encoding for M1 protein and three spliced ones (mRNAs 2-4) (Inglis and Brown, 1981; Lamb 
and Choppin, 1981; Lamb et al., 1981; Shih et al., 1998). The spliced mRNA2 and mRNA4 
have been shown to encode for the M2 and M42 proteins respectively while no gene product 
is known for mRNA3 (Wise et al., 2012). A probe specific to positive sense RNA from 
segment 7 will hybridise with all mRNAs generated from this segment but the majority of 
transcripts produced correspond to the unspliced mRNA (Lamb et al., 1981; Shih et al., 1998; 
Wise et al., 2012). Cells were also stained with DAPI to define the nucleus. In mock infected 
cells, no red staining was observed confirming that the FISH signal was specific to viral and 
not cellular mRNA (Figure 2.1A). PR8 infected cells showed abundant staining mainly of the 
cytoplasm, confirming successful infection and the expected (Amorim et al., 2007; Read and 
Digard, 2010) localisation of the segment 7 mRNA. When cells were transfected with four of 
the five minireplicon components (missing PB2 as a ‘2PNP’ negative control in which no 
mRNA synthesis is possible), only background levels of staining were observed (Figure 
2.1B). In contrast, with the complete minireplicon set (3PNP), FISH signal was readily 
detected. In this sample however, segment 7 mRNA was largely retained in the cell nucleus. 
These results were in agreement with the initial observation made in the Digard laboratory 
and constituted the base for this dissertation. The fact that segment 7 mRNA was cytoplasmic 
in infected cells but retained in the cell nucleus upon transfection strongly suggested that there 
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was a viral factor missing from the minireplicon set that was required for efficient segment 7 
mRNA nuclear export. 
 
 
Figure 2.1 Intracellular localisation of segment 7 mRNA in virus infected cells versus cells transfected with 
plasmids for RNP reconstitution. A) 293T cells were either mock or infected with WT PR8 at an MOI of 5. B) 
293T cells were co-transfected with plasmids expressing each of the IAV polymerase proteins and NP protein 
(3PNP), or plasmids expressing PB1, PA and NP protein (2PNP), along with a plasmid expressing an artificial 
segment 7 vRNA. At 6 h.p.i. (A) and 24 h.p.t (B) cells were processed for FISH analysis using Cy3 labelled 
RNA probes for positive sense viral RNAs from segment 7 (red) and counterstained with DAPI (blue) to indicate 
the position of the nucleus. Images were captured using a Leica-TCS confocal microscope and Leica TCS 
analysis software. Scale-bar indicates 10 µm. 
 
2.2.2 Segment 7 mRNA localisation in the presence of further viral components 
Starting from the premise that a viral factor that was not included in the basic 
minireplicon set was required for efficient segment 7 mRNA nuclear export, further viral 
components were added to the basic segment 7 minireplicon system. Missing components 
were products from segments 4, 6 and 8. Each of these segments was added (as plasmids with 
the appropriate cDNA under the control of a Pol I promoter) to the transfection mix 
individually and the effect of each addition on segment 7 mRNA localisation analysed by 
FISH. As before, a 2PNP negative control lacking PB2 was included and no red staining 
corresponding to segment 7 mRNA was observed in this sample (Figure 2.2A). A sample 
with the basic segment 7 set without further additions was used as a positive control and here, 
the FISH signal was mostly visible in the nucleus as shown previously (Figure 2.1.B). 
Subsequent addition of either segment 4 or 6 had no effect on segment 7 mRNA localisation 
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(Figure 2.2A) and thus the gene products from these segments were incapable of restoring the 
cytoplasmic mRNA phenotype seen in PR8 infected cells. Addition of segment 8 however 
resulted in a marked shift of segment 7 mRNA from the nucleus to the cell cytoplasm. To 
 
 
Figure 2.2 Testing the effect of individual segment additions to the segment 7 RNP reconstitution assay on the 
localisation of segment 7 mRNA. A) 293T cells were co-transfected with plasmids expressing each of the 
influenza polymerase proteins and NP protein (3PNP) or plasmids expressing PB1, PA and NP proteins (2PNP) 
alongside plasmids expressing vRNAs of the indicated segments. Cells were incubated and 24 h subsequently 
processed for FISH analysis using Cy3 labelled RNA probes for segment 7 positive sense RNAs (red). Images 
were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. Scale-bar indicates 10 
µm. B) Cells expressing segment 7 mRNA were counted and scored according to the cellular localization of this 
mRNA: predominantly nuclear, a mixture of nuclear and cytoplasmic (nuc/cyt) or predominantly cytoplasmic. A 
minimum of 100 cells were scored for each sample. Data are the mean ± SEM from two to six independent 
experiments. 
 
provide a numerical estimate of the reproducibility of these effects, multiple cells from 
replicate experiments were scored as displaying predominantly nuclear, nuclear/cytoplasmic 
or predominantly cytoplasmic localisation of segment 7 RNA (Figure 2.2B). 80% of cells 
transfected with 3PNP and segment 7 on its own showed mRNA nuclear retention, ~15% had 
the mRNA localised to both the nucleus and the cytoplasm and the mRNA was found only in 
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the cytoplasm in very few (~5%) cells. After adding segment 4 to the set ~75% of transfected 
cells contained segment 7 mRNA in the nucleus, less than 20% had the mRNA in both 
cellular compartments and just over 5% of cells showed a cytoplasmic localization. Similar 
results were also obtained with segment 6. However, adding segment 8 to the RNP 
reconstitution assay caused a shift in localisation such that only ~15% of transfected cells 
showed segment 7 mRNA nuclear retention, ~15% of cells had the mRNA in both 
compartments and ~70 % had segment 7 mRNA localised mainly to the cytoplasm. Thus, the 
addition of segment 8 alone to the basic segment 7 RNP was sufficient to restore efficient 
nuclear export of segment 7 mRNA. The viral factor required for segment 7 mRNA nuclear 
export therefore lay within segment 8. 
 
2.2.3 NS1 protein is required for efficient segment 7 mRNA nuclear export 
IAV segment 8 encodes two proteins, NS1 and NS2, from unspliced and spliced 
mRNAs, respectively (Inglis et al., 1979; Lamb and Lai, 1980). Both of these would be 
expressed when segment 8 was added to the basic minireplicon set. Thus it was unknown 
which protein, specifically, was responsible for the shift in the cellular localisation of segment 
7 mRNA observed in Figure 2. To distinguish between the effects of NS1 and NS2 
expression on segment 7 mRNA localization, expression vectors for each of the proteins were 
separately added to the minireplicon set. The mRNA localisation was analysed by FISH as 
before. No staining was detected in the negative control 2PNP lacking the polymerase subunit 
PB2 and as before, segment 7 mRNA (stained in red) was seen to be retained in the nucleus 
when transcribed form only the 3PNP set of plasmids (Figure 2.3A). When IAV NS2 (NS2A) 
was added, segment 7 mRNA remained nuclear, indicating that NS2A protein was not 
sufficient to drive mRNA nuclear export. Upon addition of IAV NS1 (NS1A) however, a 
clear shift of segment 7 mRNA from the nucleus to the cytoplasm was observed, suggesting 
that NS1A protein was the IAV factor necessary to promote segment 7 mRNA nuclear export. 
In order to investigate whether the ability of the IAV NS1 protein to promote segment 
7 mRNA export was virus species-specific, an influenza B virus NS1 (NS1B) expression 
vector was tested. However, segment 7 mRNA staining was still detected in the cell nucleus 
after expression of NS1B (Figure 2.3A), indicating that it was not capable of promoting IAV 
mRNA export.  
As mentioned above, segment 7 produces different forms of mRNAs due to splicing. 
While it is technically difficult to synthesize RNA probes specific to spliced mRNAs, it was 
possible to synthesise a probe that only contained the intron sequence of segment 7. This 
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allowed the study of M1 mRNA localisation in particular and thus to test whether there were 
differences between using a probe that was theoretically capable of hybridizing with all 
segment mRNA species and a probe that would only bind to the unspliced, M1 mRNA. 
 
 
Figure 2.3 Testing the effect of NS1 and NS2 on segment 7 mRNA localisation. A) 293T cells were co-
transfected with plasmids expressing each of the influenza polymerase proteins and NP protein (3PNP), or 
plasmids expressing PB1, PA and NP protein (2PNP), along with a plasmid expressing an artificial segment 7 
vRNA. Additional plasmids expressing influenza A NS2 and NS1 (NS2A and NS1A, respectively) proteins or 
influenza B NS1 (NS1B) protein were added where indicated. Cells were incubated for 24 h and subsequently 
processed for FISH analysis using Cy3 labelled RNA probes for positive sense segment 7 RNAs (red) and Cy5 
labelled probes for the intron sequence of segment 7 (grey). Images were captured using a Leica-TCS confocal 
microscope and Leica TCS analysis software. Scale-bar indicates 10 µm. B) Cells expressing segment 7 mRNA 
were counted and scored according to the cellular localization of this mRNA: predominantly nuclear, nuclear 
and cytoplasmic (nuc/cyt) or predominantly cytoplasmic. A minimum of 100 cells were scored for each sample. 
Error bars represent the mean ± SEM of at least 3 independent experiments. The data for segment 7 without any 
further additions corresponds to the data shown before in Figure 2.2. 
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The mRNA localisation phenotypes observed with the intron-specific probe (grey 
staining) were indiscernible from the patterns obtained when using a probe able to detect all 
mRNA forms (Figure 2.3A). M1 mRNA was retained in the nucleus when segment 7 was on 
its own, with NS2A and NS1B, but released to the cytoplasm in the presence of NS1A 
(Figure 2.3A). These results indicated that NS1A protein is the viral factor required for the 
efficient nuclear export of M1 mRNA, specifically.  
To put these observations on a more quantitative footing, cells were also scored 
according to segment 7 mRNA localisation upon the addition of either NS1A, NS2A or 
NS1B. On its own, or together with NS2A or NS1B, segment 7 mRNA was detected in the 
nucleus of 70-80 % of cells scored, in the cytoplasm of ~5% of cells and the remainder 
showed mRNA staining in both cellular compartments (Figure 2.3B). In the presence of 
NS1A, the shift in segment 7 mRNA localisation was very clear across the population of 
cells. More than 60% of cells showed cytoplasmic staining and nuclear-only staining was 
observed in less than 10% of scored cells. This quantification strengthened the observations 
made under the microscope and showed a very significant shift in segment 7 mRNA 
localisation in the presence of NS1A protein. 
Taken together these results indicated that NS1A protein is required for segment 7 
mRNA export, in particular M1 mRNA, using an orthomyxovirus species-specific 
mechanism. 
 
2.2.4 Protein expression analysis in the context of the minireplicon assay 
Nuclear export of mRNA is a pre-requisite for protein synthesis since the 
overwhelming majority of bona fide translation occurs in the cytoplasm (Baboo and Cook, 
2014; Dolan et al., 2010). Hence, any correlation between segment 7 M1 and M2 protein 
levels and the segment mRNA export was investigated. 293T cells were transfected with the 
basic segment 7 RNP set together with other viral components, separately added. Total cell 
lysates were harvested and analysed by western blotting 24 hours post-transfection (h p.t.). 
NP levels were comparable in all samples, indicating reasonable transfection efficiencies, 
while tubulin levels were similar, confirming equal gel loading (Figure 2.4). The expression 
of NS1A, NS2A and NS2B was confirmed by their detection in the expected lanes (Figure 
2.4, lanes 5-8; note the V5 tag on the NS1A and NS1B proteins). M1 and M2 proteins were 
not detected in the negative control 2PNP as expected, since segment 7 mRNA synthesis was 
blocked due to the missing PB2 gene (lane 1). M1 and M2 were detected in all other samples, 
although not to the same extent for the different conditions. The addition of segments 4 and 6 
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did not impact on M1 and M2 expression, showing similar levels to segment 7 on its own 
(lanes 2-4). NS2A presence however, resulted in decreased expression of M1 and M2 proteins 
(lane 7). M1 and M2 protein expression levels were clearly increased in the presence of 
segment 8 (which produces both NS1 and NS2) as well as NS1A protein (lanes 5 and 6). This 
increase in M1 and M2 accumulation in the presence of NS1 was consistent with the more 
efficient release of segment 7 mRNA to the cytoplasm seen by FISH, as well as with the 
ability of NS1 to increase translation of viral mRNAs (Enami et al., 1994). However, NS1B 
also notably increased expression of the segment 7 polypeptides (lane 8), despite its lack of 
effect on mRNA localisation. 
 
 
Figure 2.4 Viral protein expression in RNP reconstitution assays. 293T cells were co-transfected with plasmids 
expressing each of the influenza polymerase proteins and NP protein (3PNP) or plasmids expressing PB1, PA 
and NP proteins (2PNP) alongside plasmids expressing vRNAs of the indicated segments. 24 h.p.t. cell lysates 
were harvested in Laemmli’s sample buffer and analysed by SDS-PAGE and western blotting for the indicated 
proteins. Western blots were imaged using a Licor Biosciences imaging platform and associated Odyssey v3.0 
software. Results are representative of at least three independent experiments. 
 
 
2.2.5 Increased levels of NS1A protein expression lead to higher segment 7 mRNA 
export efficiency and M1 protein expression levels 
 In order to further establish NS1A protein as the viral factor required for efficient 
nuclear export of segment 7 mRNA, the effect of increasing the amounts of NS1A protein on 
mRNA localisation were tested. 293T cells were transfected with the basic segment 7 
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minireplicon set and increasing amounts of NS1A-expressing plasmid, ranging from 8 to 800 
ng. As further controls, additional samples had either segment 8 or NS2 only transfected. 
Segment 7 mRNA localisation was then analysed by FISH and NS1 expression by indirect 
immunofluorescence (IF) (Figure 2.5A). Red FISH signal corresponding to mRNA could not 
be detected in the negative control 2PNP and was found in the cytoplasm upon addition of 
segment 8 and retained in the nucleus in the presence of NS2A protein. Increasing the 
amounts of NS1A protein resulted in a clear gradual shift of segment 7 mRNA localisation. 
The mRNA was markedly retained in the cell nucleus when only 8 ng of the plasmid were 
added and became increasingly more cytoplasmic with increasing amounts of NS1A. When 
800 ng of NS1A was added, transfected cells displayed segment 7 mRNA mainly in the 
cytoplasm (Figure 2.5A). Even though the IF signal (in green) obtained with our NS1A 
serum was not very strong, NS1A protein could be detected when 80 ng of NS1 plasmid was 
added and the signal became more evident with higher amounts of NS1A. The fact that there 
was green staining detected also in the presence of segment 8, but not NS2 showed that the 
antibody used was specific to NS1A (Figure 2.5A). 
 Alongside the mRNA localisation assessed by FISH, protein expression levels were 
also analysed to confirm the gradual increase of NS1A protein levels as well as to observe the 
effect of such an increase on M1 and M2 expression levels. 293T cell lysates were harvested 
for each sample and western blotting analysis was carried out (Figure 2.5B). All samples 
showed comparable levels of NP and tubulin, confirming similar transfection efficiency and 
equal gel loading for each condition, respectively. The continued increase of NS1A protein 
expression was notable with the corresponding band becoming faintly but increasingly visible 
from 80 ng of plasmid transfected onwards. NS1A was also detected in the presence of 
segment 8 (note that the V5 tag accounts for the size difference between the protein produced 
by the NS1A expression vector and the untagged NS1A produced from segment 8) but not the 
NS2A protein used as controls for this experiment (lanes 7-8). M1 and M2 proteins were not 
detected in the 2PNP negative control lacking PB2 but were otherwise present in all samples. 
M1 levels were substantially higher in the presence of even the lowest amount of NS1A and 
then generally increased along with increasing amounts of NS1A. M2 accumulation was also 
increased by the lowest amount of NS1A plasmid tested, but thereafter levels showed, if 
anything, a negative correlation with NS1 amount. Overall, these results showed a positive 
correlation between higher amounts of NS1A and more efficient segment 7 mRNA nuclear 






Figure 2.5 Titration of NS1 protein and its effect on the localisation of segment 7 mRNA. 293T cells were co-
transfected with plasmids expressing each of the influenza polymerase proteins and NP protein (3PNP), or 
plasmids expressing PB1, PA and NP protein (2PNP), along with a plasmid to express segment 7 vRNA. Further 
plasmids expressing either segment 8 vRNA (seg 8), NS2 protein or different amounts of NS1A-expressing 
plasmid were added as indicated. A) Cells were incubated and 24 h subsequently processed for FISH analysis 
using Cy3 labelled RNA probes for positive sense segment 7 RNAs (red) and counterstained for NS1 protein 
(green). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. Scale-
bar indicates 10 µm. B) At 24 h.p.t. cell lysates were harvested and subsequently analysed by SDS-PAGE 
followed by western blotting for the proteins indicated. Western blots were imaged using a Licor Biosciences 
imaging platform and associated Odyssey v3.0 software. 
 
 
2.2.6 NS1 and NS2 protein export activities are not altered by the addition of an 
EGFP tag 
 With the aim of expanding the studies regarding the role of NS1A protein on viral 
mRNA export, the development of an enhanced green fluorescent protein (EGFP)-tagged 
form of NS1 was explored. This had the aim of solving the problem that our NS1A serum did 
not give a very strong signal in IF after FISH, as well as providing an affinity “hook” for 
biochemical assays. An EGFP-tagged NS2A construct was also produced to be used as a 
negative control. These constructs were produced by conventional PCR-cloning and then 
tested by transfecting them, separately, with the segment 7 minireplicon set in 293T cells to 
check for their expression and their effect on segment 7 mRNA localisation by FISH (Figure 
2.6). EGFP expression was confirmed (green staining) in cells transfected with EGFP alone or 
with either NS1 or NS2 EGFP-tagged constructs while no green signal was detected in the 
2PNP negative control omitting PB2. EGFP and NS2-EGFP displayed a predominantly 
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nuclear localisation while NS1-EGFP expression was found both in the nucleus as well as 
more prominently in the cytoplasm. No red staining corresponding to segment 7 mRNA was 
detected in the negative control and the mRNA was largely nuclear when segment 7 was on 
its own and transfected with either EGFP alone or NS2A-EGFP. When NS1A-EGFP was 
added however, the mRNA displayed a clear cytoplasmic localisation (Figure 2.6). These 
results showed that the EGFP tag did not obviously alter the phenotype obtained with the 
addition of untagged NS2A and NS1A proteins (Figure 2.3) and therefore did not mask the 
previous results. These constructs were thus used in many of the experiments that follow 
throughout this dissertation. Western blot validation that they produced polypeptides of the 
expected sizes is shown in the next chapter. 
 
 
Figure 2.6 Testing the effect of EGFP-tagged NS2A and NS1A proteins on segment 7 mRNA nuclear export. 
293T cells were co-transfected with plasmids expressing each of the influenza polymerase proteins and NP 
protein (3PNP), or plasmids expressing PB1, PA and NP protein (2PNP), alongside an artificial segment 7 
vRNA-expressing plasmid. Further plasmids expressing either EGFP, NS1-EGFP or NS2-EGFP were added as 
indicated. At 24 h.p.t. cells were processed for FISH analysis using Cy3 labelled RNA probes for positive sense 
viral RNAs of segment 7 (red) and counterstained with DAPI (blue) before imaging for Cy3, DAPI and EGFP 
(green). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. Scale-




2.2.7 NS1A does not override the negative effect of a poly(U) signal 
Data shown so far suggested that NS1A protein is required for the efficient nuclear 
export of segment 7 mRNA and the question that naturally followed was therefore whether it 
was sufficient. There is strong evidence suggesting the use of cellular machinery to 
accomplish nuclear export for the majority of IAV mRNAs (Amorim et al., 2007; Hao et al., 
2008; Larsen et al., 2014; Mor et al., 2016; Read and Digard, 2010; Wang et al., 2008). Viral 
mRNAs are structurally similar to cellular mRNAs in that they both possess a 5’ cap structure 
and a 3’ poly(A) tail. However, the mechanisms by which both types of mRNAs acquire these 
structures differ substantially. Viral mRNAs acquire a 5’cap structure using a cap-snatching 
mechanism (Bouloy et al., 1979; Bouloy et al., 1978; Krug et al., 1979; Plotch et al., 1979) 
and their poly(A) tails are produced by the stuttering of the viral polymerase on a poly(U) 
stretch at the 5’ end of the vRNA at the time of transcription (Poon et al., 2000; Poon et al., 
1998; Robertson et al., 1981). The poly(A) tails on IAV NA and NP mRNAs have been 
shown to be required for efficient mRNA nuclear export, as their substitution by a poly(U) tail 
through the mutation of the vRNA 5’end poly(U) stretch resulted in a substantial decrease in  
cytoplasmic mRNA (Poon et al., 2000; Read, 2010). Furthermore, NS1 has been 
demonstrated to interact with poly(A)-binding protein II (PABPII) as well as with CPSF 
(Chen et al., 1999; Nemeroff et al., 1998) and to viral mRNAs (Wang et al., 2008). It was 
therefore possible to conjecture that NS1 could facilitate segment 7 mRNA nuclear export by 
interacting directly or indirectly with its poly(A) tail or poly(A) tail-interacting proteins. 
Hence, the potential ability of NS1 to override the lack of a poly(A) signal and maintain its 
capability of supporting mRNA nuclear export of a segment 7 transcript containing a poly(U) 
instead of a poly(A) tail was assessed. To this end, a mutated segment 7 vRNA containing a 
poly(A) instead of a poly(U) stretch was used. The stuttering of the viral polymerase on the 
stretch of this construct would be expected to result in the production of a poly(U)-tailed 
mRNA. 293T cells were transfected with the mutant segment 7 vRNA-like template (7polyU) 
in a minireplicon assay in the presence or absence of NS1A-EGFP and the cellular 
localisation of this poly(U) mRNA was analysed by FISH (Figure 2.7A). In the absence of 
NS1A-EGFP, segment 7polyU mRNA (stained in purple) was retained in the nucleus as 
expected. However, when NS1A-EGFP was added the mRNA remained markedly nuclear. 
NP protein staining (in red) showed no differences in localisation in the presence or absence 
of NS1A protein, while GFP fluorescence confirmed expression of the NS1A fusion protein 
in cells that also contained active viral RNPs. Cells were scored according to the cellular 
localisation of the mRNA as before (Figure 2.7B). In the absence of NS1A-EGFP, ~85% of 
cells had segment 7polyU mRNA retained in the nucleus, similar to the ~80% nuclear 
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retention observed with a poly(A)-containing mRNA in the same conditions. Contrary to what 
was observed with a poly(A) segment 7 mRNA however, addition of NS1A-EGFP to a 
segment 7polyU sample did not result in a clear shift of mRNA localisation. In the presence 
of NS1-EGFP ~65% of cells had the mRNA in the nucleus, though the percentage of cells 
displaying a cytoplasmic localisation (20%) was higher than when no NS1A-EGFP was 
added. These results suggested that even though NS1A was required for the efficient export of 
segment 7 mRNA it was not sufficient, which is in line with studies showing that cellular 
factors play a role in viral mRNA nuclear export (Amorim et al., 2007; Mor et al., 2016; Read 
and Digard, 2010; Satterly et al., 2007; Wang et al., 2008).  
 
 
Figure 2.7 Testing whether poly(A) tails are required for influenza A segment 7 mRNA nuclear export. 293T 
cells were co-transfected with plasmids expressing each of the influenza polymerase proteins and NP protein 
(3PNP), or plasmids expressing PB1, PA and NP protein (2PNP), alongside a plasmid expressing a mutated 
segment 7 vRNA analogue with the 5’ oligoU sequence replaced with an oligoA sequence (7polyU). A plasmid 
expressing NS1-EGFP was added where indicated. A) At 24 h.p.t. cells were processed for FISH analysis using 
cy5 labelled probes for segment 7 positive sense RNA (purple) and counterstained for NP protein (red) and 
DAPI (blue). NS1-EGFP expression is indicated in green. Images were captured using a Leica-TCS confocal 
microscope and Leica TCS analysis software. Scale-bar indicates 10 µm. B) Cells expressing segment 7 mRNA 
were counted and scored according to the cellular localization of the 7polyU mRNA: nuclear, nuclear and 
cytoplasmic (nuc/cyt) or cytoplasmic. A minimum of 100 cells were scored for each sample. Error bars represent 
the mean ± SEM of at least 3 independent transfections. The data for WT segment 7 without any further 
additions corresponds to the data shown previously in Figure 2.2. 
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2.2.8 Effects of NS1A on segment 7 mRNA splicing 
The mechanism by which cellular mRNAs achieve nuclear export is closely linked to 
the mRNA splicing machinery, as splicing factors are recruited to the mRNA via TREX 
components (Strasser et al., 2002). In influenza A infected cells, NS1 protein has been 
reported to interfere with cellular mRNA export by blocking the 3’ end processing of cellular 
transcripts (Nemeroff et al., 1998). NS1A has also been implicated in the regulation of 
segment 7 mRNA splicing in some (but not all) studies (Fortes et al., 1994; Lu et al., 1994; 
Robb and Fodor, 2012). It was therefore conceivable that, if the M1 and M2 mRNAs have 
intrinsic differences in transport efficiency, NS1 could indirectly promote segment 7 mRNA 
export by changing the balance between spliced and unspliced products. To test this 
hypothesis, 293T cells were transfected with the minireplicon assay basic set of constructs, a 
segment 7 vRNA template and constructs expressing components of segments 4 and 8 were 
added separately. At 24 h p.t., cells were harvested, total RNA was extracted and segment 7 




Figure 2.8 Analysis of segment 7 mRNA species produced in RNP reconstitution assays. 293T cells were co-
transfected with plasmids expressing each of the IAV polymerase proteins and NP (3PNP: +), or plasmids 
expressing PB1, PA and NP protein (3PNP: -), alongside a plasmid expressing segment 7 vRNA. Plasmids 
expressing vRNA from segments 4 and 8 or NS1 or NS2 proteins were added as indicated. A) At 24 h.p.t cells 
were harvested, RNA extracted and analysed by primer extension using 32P-labelled oligonucleotides for plus or 
negative sense segment 7 RNAs as well as cellular 5S rRNA as a loading control. Samples were separated by 6% 
7M urea-acrylamide gel and visualised by autoradiography. Regions from a single autoradiogram showing 
products corresponding to the indicated species are shown. B) The intensity of products corresponding to 
segment 7 mRNAs 1, 2 and 3 was quantified for each sample using ImageJ software. Error bars represent the 
mean ± SEM of at least 3 independent experiments. 
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No segment 7 RNA species were detected in the 2PNP sample which lacked the 
polymerase subunit PB2 and acted as a negative control (lane 1). Segment 7 vRNA levels 
were present in similar levels in all 3PNP samples indicating equivalent transfection 
efficiencies (lanes 2-6). Cellular 5S rRNA presence was also determined to indicate total 
RNA amounts isolated from each sample. In the RNP reconstitution system, M1 and M2 
mRNAs accumulated to approximately equal amounts in the absence of NS1, while mRNA3 
formed a minority species (lanes 2, 3 and 6). However, expression of NS1 had variable and 
generally modest effects on the overall levels of segment 7 splicing; in fact less than NS2, 
which did not promote cytoplasmic accumulation of the transcripts. Segment 7 mRNA 
species were also quantified and their ratios determined from replicate experiments (Figure 
2.8B). M1 mRNA was the most abundant species in all samples (above 50%) except in the 
presence of NS2 alone, which was the only instance where a shift between the amounts of M1 
mRNA and M2 mRNA was observed. The absence of NS1 did not have a substantial effect 
on the levels of any individual segment mRNA and did not per se result in a shift of ratios. 
Overall, these results indicated that the NS1 protein promotes efficient nuclear export of 
segment 7 mRNAs without major effects on their differential splicing or overall 
accumulation. 
 
2.2.9 Effect of blocking cellular splicing on segment 7 mRNA nuclear export  
Although the results above suggested that NS1 protein did not promote nuclear export 
of segment 7 mRNA by skewing the balance of spliced and unspliced segment 7 mRNA 
species, the involvement of the cellular splicing machinery in nuclear export of this segment’s 
transcripts could not be discarded. Because the mRNAs contain splice donor and acceptor 
sites, it remained plausible that splicing components could be recruited to the viral mRNA to 
either facilitate or hinder its export from the nucleus. To address this question, the drug 
Spliceostatin was used; a compound that inhibits splicing by binding SF3b and blocking 
spliceosome formation (Kaida et al., 2007). 293T cells were infected at an M.O.I. of 5 with 
either wild type PR8 virus (WT) or a PR8-NS1 mutant virus (NS1-N81) in which a stop 
codon was introduced at position 82 and thus is unable to synthesise a full NS1 protein 
(provided by Dr Helen Wise in the group). Spliceostatin was added (or not) at the time of 
infection and at 6 h p.i., segment 7 mRNA localisation was observed by FISH, while protein 
expression and RNA levels were analysed by western blotting and primer extension, 





Figure 2.9 Testing the effect of splicing inhibition on segment 7 mRNA export. 293T cells were infected (or 
mock infected) with either WT PR8 or NS1-N81 at an MOI of 5, and incubated from 1 h p.i. in the absence or 
presence of 100 µg/ml Spliceostatin A. At 6 h.p.i. cells were A) processed for FISH analysis using Cy3 labelled 
RNA probes for positive sense segment 7 viral RNAs (red). Images were captured using a Leica-TCS confocal 
microscope and Leica TCS analysis software after counterstaining with DAPI (blue). Scale-bar indicates 10 µm. 
B) cell lysates were harvested in Laemmli’s sample buffer and subsequently analysed by SDS-PAGE and 
western blotting for the indicated proteins. Western blots were imaged using a Licor Biosciences imaging 
platform and associated Odyssey v3.0 software. C) RNA was extracted and analysed by primer extension using a 
32P-labelled oligonucleotide for segment 7 mRNAs 1 and 2 (mM1 and mM2, respectively) as well as cellular 5S 





In the absence of Spliceostatin, no mRNA staining was detected in mock infected cells 
while segment 7 mRNA was in the cytoplasm in WT infected cells as expected. In cells 
infected with the mutant virus NS1-N81 however, segment 7 mRNA-staining was markedly 
nuclear (Figure 2.9A). The latter observation showed that the lack of an intact NS1 protein 
resulted in nuclear retention of segment 7 mRNA not only in an RNP reconstitution assay, but 
also in the context of infection, further validating the role of this protein in promoting 
segment 7 mRNA nuclear export. When Spliceostatin was added, again no mRNA staining 
was observed in mock infected cells. Cells infected with WT virus still had the mRNA in the 
cytoplasm and cells infected with NS1-N81 still showed a clear retention of segment 7 mRNA 
in the nucleus (Figure 2.9A). Hence, phenotypes regarding segment 7 mRNA localisation did 
not change upon cell infection with either WT or NS1-N81 virus when splicing was inhibited. 
In order to make sure that the Spliceostatin treatment had worked and inhibited splicing, viral 
protein expression was analysed by western blotting. Mock infected cells were negative for 
viral proteins (Figure 2.9B, lanes 1 and 4) and loading amounts were checked through tubulin 
expression levels which were comparable between all samples (lanes 1-6). Full-length NS1 
protein was not detected in NS1-N81 infected cells, showing that this mutant virus was indeed 
NS1-deficient (lanes 2 and 5). NS1 was however detected in WT infected cells in the absence 
or presence of the drug, to similar levels (lanes 3 and 6).  M1 protein was detected in all 
infected samples and expression levels were higher in WT infected cells than in NS1-81 
infected cells, irrespective of the drug being present or not (lanes 2, 3, 5 and 6). M2 protein 
(produced from a spliced segment 7 mRNA) was present in cells infected with WT and NS1-
N81 (lanes 2 and 3) with expression levels being higher upon WT infection. In the presence of 
Spliceostatin however, M2 protein was no longer detected, consistent with splicing inhibition 
(lanes 5 and 6). Expression levels of NS2 protein, (also synthesised from a spliced mRNA), 
further confirmed that the drug had worked, since this protein was detected in the absence of 
Spliceostatin but not in its presence (lanes 2, 3, 5 and 6). Furthermore, analysis of NS2 protein 
expression showed that even though NS1-N81 mutant virus was incapable of producing full-
length NS1, synthesis of NS2 was not compromised, with equivalent amounts produced by 
both viruses (lanes 2 and 3). NP protein is produced from an intronless mRNA and was 
present in equivalent amounts in the presence or absence of Spliceostatin as well as upon 
infection with WT and NS1-N81 (lanes 2, 3, 5 and 6). The loss of expression of proteins 
produced from spliced mRNAs was a good but indirect indicator that Spliceostatin had 
worked. Therefore, in order to determine directly which mRNAs were being produced, 
radiolabelled primer reverse transcription analyses were performed. Gel loading was certified 
as comparable between all samples through the inclusion of a primer specific for cellular 5S 
 43 
rRNA (Figure 2.9C). Mock infected samples were negative for the presence of viral mRNAs 
(lanes 1 and 4). Unspliced M1 mRNA was detected in samples infected with both WT and 
NS1-N81 and the levels of this mRNA were higher in the presence of Spliceostatin (lanes 2, 
3, 5 and 6). Spliced M2 mRNA however, was only detectable in the absence of the drug; 
confirming that splicing was inhibited by the addition of Spliceostatin (lanes 5 and 6). 
Overall, these results further indicated that nuclear export of segment 7 mRNA occurred in a 
splicing-independent fashion. In addition, the data also supported the role of NS1 protein in 
segment 7 mRNA nuclear export in an infection context. 
 
2.3 Discussion 
The aim of the work presented in this chapter was to determine whether specific IAV 
proteins played a role in viral mRNA nuclear export. IAV synthesizes a relatively small 
number of polypeptides and thus utilises the host machinery for many processes of its life 
cycle. Nevertheless, its proteins have a broad spectrum of functions and are not limited to 
structural purposes. They can be the main contributor in a viral life cycle step, as is the case 
for viral replication and transcription which is accomplished by the viral polymerase 
(Neumann et al., 2004) or they can have a more indirect role and act as a bridge between viral 
components and the host cell machinery. For instance, recruitment of various cellular 
pathways via viral proteins has been shown for IAV; for example, in the nuclear export of the 
viral genome (Elton et al., 2001; Martin and Helenius, 1991; Neumann et al., 2000; O'Neill et 
al., 1998) as well as in cytosolic vRNP trafficking (Amorim et al., 2011; Eisfeld et al., 2011; 
Momose et al., 2011). The cellular NXF1 pathway used to export the bulk of cellular mRNA 
(Herold et al., 2001) has been shown to be required for IAV mRNA export (Larsen et al., 
2014; Read and Digard, 2010). However, how the individual species of viral mRNA are 
recruited to this pathway remains unclear. Other viruses like HIV and herpesviruses have 
been shown to use viral proteins as adapters to feed viral mRNAs into the necessary cellular 
pathways in order to achieve nuclear export (Boyne et al., 2010; Chen et al., 2002; Colgan et 
al., 2009; Cullen, 2003; Sandri-Goldin, 1998). Hence it was reasonable to postulate that IAV 
mRNA nuclear export could be achieved (at least in part) with the participation of a viral 
protein. This hypothesis gained sustenance from an observation made in the Digard laboratory 
prior to the commencement of this work (recapitulated in Figure 2.1) in which segment 7 
mRNA was found to be retained in the cell nucleus in an RNP reconstitution assay (Read, 
2010). Since the mRNA was cytoplasmic in infected cells (Amorim et al., 2007; Larsen et al., 
2014; Mor et al., 2016; Read and Digard, 2010) it was plausible that a viral component that 
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was absent from the RNP reconstitution assay was necessary for efficient segment 7 mRNA 
nuclear export. The results presented in this chapter validated this hypothesis and revealed 
NS1 protein as this viral factor. In addition to increasing our understanding of viral mRNA 
export the results of this chapter also suggest a novel function of the NS1 protein. 
 
The approach used to determine the viral requirements for segment 7 mRNA export 
was based on the observation of its localisation in an RNP reconstitution context upon the 
presence or absence of a particular viral component. The role of NS1 protein in promoting 
efficient viral mRNA export was suggested by the observation of a clear shift in mRNA 
localisation from the nucleus to the cytoplasm achieved solely by the introduction of this 
polypeptide in the RNP reconstitution assay (Figure 2.3). These data do not rule out the 
involvement of viral proteins that are part of the RNP (PB2, PB1, PA and NP or 3PNP) in 
segment 7 transcript nuclear export, but together they were clearly not sufficient. The same 
reasoning applies to the viral accessory polypeptides that are synthesised from the 3PNP 
segments: PB1-F2, PB1-N40, PA-X, PA-N155 (Chen et al., 2001; Jagger et al., 2012; 
Muramoto et al., 2013; Wise et al., 2009). The capability of promoting viral mRNA export 
was specific to the NS1 protein since it was the only addition that resulted in the shift of 
segment 7 mRNA from the nucleus to the cytoplasm. HA and NA are expressed at later times 
in infection (Palese and Shaw, 2007) and thus were perhaps unlikely candidates to be 
involved in mRNA export. Nevertheless, the addition of these proteins was also tested and 
neither found to be able to rescue segment 7 mRNA from the confines of the nucleus (Figure 
2.2). There is the caveat however, that expression of neither polypeptide was confirmed. The 
data also suggested that the mechanism by which viral mRNA export is achieved might be 
specific at the level of individual orthomyxovirus species, since addition of NS1B to the 
minireplicon assay did not promote segment 7 mRNA export (Figure 2.3). It is however 
possible that NS1B could promote the export of influenza B viral mRNAs. In fact, both NS1A 
and NS1B have previously been suggested to have the potential to play a role in mRNA 
export  (Schneider and Wolff, 2009).  
 
Analysis of viral protein expression in the context of the minireplicon assay revealed 
points to take into consideration. Surprisingly, the expression of M1 and M2 proteins could be 
easily detected by western blotting even in samples where FISH suggested the mRNA was 
largely retained in the nucleus (Figure 2.4; lanes 2, 3, 4, 7 and 8). The higher than anticipated 
levels of M1 and M2 proteins produced in cells with a low level of mRNA nuclear export 
could perhaps be due to FISH assays detecting nuclear mRNA better than cytoplasmic 
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transcripts. The occurrence of nuclear translation of viral mRNAs is another possibility which 
has been reported to occur in IAV infected cells (Dolan et al., 2010). Nevertheless, M1 and 
M2 protein levels were considerably higher in the presence of NS1 either when the whole 
segment 8 or just NS1A were added. This was consistent with NS1 promoting mRNA nuclear 
export as higher amounts of mRNA being transported to the cytoplasm would result in higher 
protein expression levels.  
 
In addition to the possible factors considered above, it has also been suggested that 
NS1A can stimulate the translation of viral mRNAs (Burgui et al., 2003; de la Luna et al., 
1995; Enami et al., 1994; Park and Katze, 1995). The presence of NS1A protein was shown to 
result in increased M1 protein expression even though transcription levels were unaltered 
indicating that NS1A had a post-transcriptional role (Enami et al., 1994). Another study 
showed that the presence of NS1A not only resulted in increased viral mRNA and protein 
accumulation, but also in the increase in size of NP-specific polysomes when NP was co-
expressed with NS1A, indicating a role at the translational level (de la Luna et al., 1995). 
Furthermore, NS1 has been shown to interact with the eIF4GI subunit of the eIF4F translation 
initiation factor and both were shown to interact with poly(A)-binding protein I (PABPI) 
suggesting that these proteins could form a complex that could potentially promote the 
recruitment of 43S initiation complexes to viral mRNAs (Burgui et al., 2003). It is however 
plausible that at least some of the effects of NS1A observed in these studies could be due to 
the ability of NS1A facilitating mRNA export rather than having a direct role on viral 
mRNAs translation.   
 
In the system used here, addition of NS1A alone resulted in more M1 being produced 
than when the whole segment 8 was added. This could be due to the pPolI segment 8 and 
NS1A plasmids having different expression efficiencies since the backbone vector is not the 
same and the cytomegalovirus immediate early promoter present in the latter construct is 
considered a strong expression method. However, expression of NS1 from the complete 
segment 8 will also be driven by the viral polymerase and in fact western blot analysis 
showed similar levels of NS1 expression from the two approaches (Figure 2.4, lanes 5 and 6). 
It is also possible that NS2 protein could have an antagonistic effect since the expression of 
NS2 alone apparently repressed M1 and M2 expression (Figure 2.4, lane 7), while the FISH 
phenotype was also clearer when adding just NS1A as opposed to adding segment 8. The 
presence or absence of NS2 protein expression in a minireplicon assay that uses segment 7 as 
viral template is likely to makes a considerable difference since M1 and NS2 proteins are used 
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for vRNA nuclear export (Martin and Helenius, 1991; Neumann et al., 2000; O'Neill et al., 
1998). As a consequence, when segment 7 is transfected together with the whole segment 8 
that expresses NS1 and NS2, both mRNA and vRNA molecules are exported from the 
nucleus in the cytoplasm (Amorim et al., 2011). However, when NS1 is present, but not NS2, 
segment 7 mRNA can be exported but not vRNA. Hence, it is conceivable that when NS2 is 
present the balance between transcription and replication might be affected by the fact that 
vRNA export is occurring, possibly further downregulating mRNA production and thus 
affecting protein expression levels. NS2 protein has in fact been reported to regulate the 
switch between transcription and replication of IAV by reducing the amounts of mRNA and 
increasing the accumulation of vRNA. It was suggested that NS2 acted directly on the viral 
replication machinery since NS2 was shown to affect mRNA and vRNA levels in a virus type 
specific manner (Bullido et al., 2001; Robb et al., 2009). This NS2-dependent switch from 
transcription to replication in IAV may reflect regulation by small viral RNAs (svRNAs). 
These are short molecules comprising 22-27 nucleotides from the 5’ end of each viral 
segment and their expression was associated with a bias in the viral polymerase activity from 
transcription toward replication. RNP reconstitution assays showed that svRNA expression 
required the viral polymerase, NP and NS2 proteins (Perez et al., 2010). The reports 
suggesting a role for NS2 in regulating, directly or indirectly, the switch from transcription to 
replication are supported by our data and provide with a plausible explanation for the poor M1 
and M2 protein expression levels observed in a minireplicon assay where NS2 is present and 
NS1 is absent (Figure 2.4).  
 
The strategy used to make the FISH probes used here could not provide direct 
evidence for the requirements of M2 mRNA export, but it was possible to show that NS1 
promoted the efficient nuclear export of M1 mRNA using an intron specific probe. Since M1 
is an unspliced mRNA it was conceivable that the export of this transcript could be 
interlinked with splicing. NS1 could, in theory, facilitate M1 mRNA export by releasing the 
mRNA from the cell splicing machinery. The data however, indicated that nuclear export of 
M1 mRNA occurs via NS1 in a splicing-independent fashion (Figures 2.8 and Figure 2.9). 
Analysis of the relative ratios of mRNA3, M1 and M2 mRNAs in the context of a 
minireplicon assay showed that the presence or absence of NS1 protein did not alter 
substantially the balance of spliced and unspliced transcripts; something that might have been 
expected if NS1 functioned by removing mRNA otherwise destined for splicing (Figure 2.8). 
In addition, the use of Spliceostatin A which inhibits pre-mRNA splicing by interacting with 
SF3b, an essential component of the spliceosome and thus preventing its assembly (Kaida et 
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al., 2007), provided strong evidence that the splicing machinery did not influence segment 7 
mRNA export. Spliceostatin A treatment did not change the cytoplasmic localization of 
segment 7 mRNA in WT infected cells nor the nuclear retention in cells infected with N81, an 
NS1-deficient virus. At the time this work was performed, NS1 had already been 
hypothesized as being somehow involved in IAV mRNA nuclear export (Schneider and 
Wolff, 2009). The discoveries that NS1 could interact both with NXF1, components of the 
nuclear pore complex (Satterly et al., 2007) and with viral mRNAs (Park and Katze, 1995; 
Wang et al., 2008) lead to the proposal that IAV could utilise the NXF1/Nxt1 cellular 
pathway for the export of its mRNAs with the participation of NS1 (Wang et al., 2008). 
However, there was no direct evidence that indeed NS1 had an effect on the export of viral 
mRNAs and the mechanism of IAV mRNA nuclear export was poorly understood. After the 
experimental work described in this dissertation was finalised, but before its submission, one 
study was published that made a more concrete link between NS1 and segment 7 mRNA 
export (Mor et al., 2016). In this study, NS1 was found to promote M1 mRNA localisation at 
nuclear speckles where splicing of segment 7 mRNA was shown to occur. The authors also 
found TREX components localising to nuclear speckles and proposed that both splicing and 
initial steps of mRNA export occurred in these cellular structures. The data described in this 
chapter are in agreement with the Mor et. al., study in finding that NS1 plays a role in 
segment 7 mRNA export. However, the potential link between nuclear export and mRNA 
splicing was examined in this dissertation and indicated that NS1 being able to promote 
efficient nuclear export of segment 7 mRNA did not depend on transcript splicing (Figure 
2.9).  
 
One of the many functions attributed to NS1 protein (Hale et al., 2008b) is to actually 
block cellular mRNA nuclear export (Nemeroff et al., 1998; Qian et al., 1994; Qiu and Krug, 
1994; Satterly et al., 2007). NS1 has been shown to interact with the 30 KDa subunit of CPSF 
thereby inhibiting the 3’ end processing of cellular mRNAs (Nemeroff et al., 1998). Although 
viral mRNAs are structurally similar to cellular mRNAs, the acquisition of the 5’ cap 
structure as well as the 3’ end poly(A) tail is done differently. Viral mRNAs have a poly(U) 
stretch in the genome in which the viral polymerase stutters resulting in a poly(A) tail 
(Neumann et al., 2004) with no involvement of the cellular 3’end mRNA processing. Hence 
NS1 would have opposite effects on cellular and viral mRNAs which could be a viral 
regulation mechanism. It has been suggested that inhibition of cellular mRNA export via NS1 
would provide with a larger source of 5’ cap structures to be scavenged by the viral 
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polymerase. Using the same reasoning it can be speculated that retention of cellular mRNAs 
would decrease the competition for the cellular machinery involved in mRNA export. 
 
Taken together, the data presented in this chapter showed that NS1 protein is required 
for efficient nuclear export of segment 7 mRNA, specifically the M1 transcript. NS1 was 
shown to be necessary for segment 7 mRNA export both in the context of minireplicon assays 
and viral infection. Furthermore, the data suggested that the export function of NS1 is specific 
within the influenza A and B lineages, and discouraged the hypothesis of the cellular splicing 
machinery being involved in the export mechanism.  
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CHAPTER 3 – MECHANISTIC INSIGHTS INTO THE ROLE 
OF NS1 IN SEGMENT 7 mRNA NUCLEAR EXPORT 
_________________________________________________________________________ 
3.1 Introduction 
Various nuclear-replicating viruses have been shown to accomplish export of their 
transcripts through the recruitment of cellular pathways via specific viral proteins. The HIV-1 
regulatory protein Rev has been shown to trans-activate the nuclear export of unspliced 
mRNAs by targeting specific cis-acting RNA sequences – Rev response elements (RRE) in 
the viral mRNA (Malim et al., 1989). Rev then interacts with CRM1 which targets 
components of the nuclear pore complex to accomplish mRNA transport to the cytoplasm 
(Cullen, 2003). Herpes simplex virus (HSV) on the other hand, uses the viral protein ICP27 to 
bind the mostly intronless viral mRNAs (Sandri-Goldin, 1998) and activates nuclear export 
through a direct interaction between ICP27 and Aly, acting as a viral homolog of UAP56 and 
thus introduces viral mRNAs into the cellular NXF1 nuclear export pathway (Chen et al., 
2002). The use of the CRM1 pathway has been discounted for IAV mRNA nuclear export 
since inhibition of this pathway using Leptomycin B did not affect viral gene expression or 
mRNA cellular localisation (Elton et al., 2001; Larsen et al., 2014; Ma et al., 2001; Read and 
Digard, 2010; Watanabe et al., 2001).  Repression of NXF1 expression by siRNA treatment 
however, revealed that this cellular protein was necessary for IAV mRNA export although not 
necessarily to same degree for all the segments (Larsen et al., 2014; Read and Digard, 2010). 
Furthermore NXF1 has been shown to interact with IAV mRNAs (Satterly et al., 2007; Wang 
et al., 2008) strengthening the hypothesis that this pathway might be used for viral mRNA 
export although how the viral transcripts could be recruited to this pathway remains to be 
elucidated.  
The previous chapter provided data showing that the viral protein NS1 is required for 
the efficient nuclear export of segment 7 mRNA. Hence, the aim of this chapter was to 
understand the specific role of NS1 in promoting mRNA nuclear export and to test the 





3.2.1 Identification of NS1 functional domains necessary for segment 7 mRNA 
export in RNP reconstitution assays 
 As discussed in the previous chapter, NS1 protein was shown to be required for the 
efficient nuclear export of segment 7 mRNA. A significant number of functions have been 
attributed to this protein, the main one being to antagonize the interferon response (Hale et al., 
2008b). The multifunctional NS1 protein has two functional domains: an N-terminal RNA-
binding domain and a C-terminal effector domain to which particular and different roles are 
ascribed (Hale et al., 2008b). In order to determine whether the segment 7 mRNA export 
function could be localised specifically to one of the two functional domains of the protein, 
mutant forms of the protein fused with EGFP were used in the minireplicon system.  To study 
the impact of the effector domain, most of it was deleted by introducing a stop codon at 
position 82 of NS1. This mutant construct produced a truncated form of NS1 encompassing 
the first 81 a.a. of the protein and the synthesis of NS2 was not compromised (Zurcher et al., 
2000). The same approach could not be used to study the RNA-binding domain of NS1 as 
deleting the entire domain would interfere with the production of NS2 due to sequence 
overlap. Instead, a.a. substitutions accepted in the literature as inhibiting this functional 
domain were used. Since two specific residues, at positions 38 and 41, were identified as 
necessary for NS1 RNA-binding activity (Wang et al., 1999), both single mutants carrying 
only one substitution (of the normally positively charged residue to alanine) as well a double 
mutant carrying both were used. As an additional control, a “gain-of-function” NS1 mutant 
protein that was not expected to negatively affect nuclear export (NS1-S+I) was added. The 
mutations present in this polypeptide restored the ability of NS1 to bind CPSF, an interaction 
that does not exist in the PR8 strain used as template to create the NS1 mutant proteins 
(Kochs et al., 2007).  
293T cells were transfected with plasmids encoding the three viral polymerase 
subunits (PB2, PB1, PA), NP, a viral template for segment 7 and either EGFP, NS1-EGFP, or 
a mutant NS1-EGFP. The negative control used in this experiment lacked the PB2 polymerase 
subunits so transcription and replication of segment 7 would not occur. 24 h p.t. cells were 
fixed and processed for FISH in order to observe segment 7 mRNA localisation (Figure 3.1). 
As expected, in the negative control lacking PB2 (2PNP), no mRNA staining (red) could be 




Figure 3.1 Analysis of segment 7 mRNA localisation in the presence of NS1 mutant proteins in transfected cells. 
293T cells were co-transfected with plasmids expressing each of the influenza polymerase proteins and NP 
protein (3PNP) or plasmids expressing PB1, PA and NP proteins (2PNP) alongside plasmids expressing segment 
7 vRNA. Plasmids expressing GFP, NS1-GFP or GFP-tagged NS1 mutant protein were added as indicated. Cells 
were incubated at 37 ºC and processed for FISH analysis at 24 h p.t. using Cy3 labelled RNA probes for the 
detection of positive sense viral RNA from segment 7 (red) and GFP expression was detected by confocal 
microscopy (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis 
software. Scale-bar indicates 10 µm. 
 
basic components for RNP reconstitution were present, segment 7 mRNA could be detected 
predominantly in the cell nucleus and even when EGFP was added, the nuclear retention of 
the mRNA persisted. In the presence of NS1-EGFP, the shift in mRNA localisation from the 
nucleus to the cytoplasm was evident, as expected from work shown in the previous chapter. 
When an NS1-N81 mutant protein which lacked the entire effector domain was used however, 
the mRNA was again found to be mostly retained in the nucleus, indicating that if this domain 
was missing, the ability of NS1 to promote mRNA export was lost (Figure 3.1). Analysis of 
the effect of adding an NS1 RNA-binding mutant (NS1-R+K) showed a similar outcome; the 
mRNA was found mainly in the nucleus, suggesting that a functional N-terminal domain is 
also required in order for NS1 to be capable of promoting efficient export of segment 7 
mRNA (Figure 3.1). In the presence of NS1-S+I, segment 7 mRNA was localised largely in 
the cytoplasm (Figure 3.1). This supported the conclusion that the phenotype observed with 
the addition of NS1-N81 and NS1-R+K were due to the specific mutations introduced. The 
presence of each NS1 mutant protein was confirmed by EGFP expression (green). All NS1 
constructs were found both in the nucleus and the cytoplasm, but the WT polypeptide showed 
a greater bias towards cytoplasmic localisation than the mutants, especially NS1-N81 where 
the fluorescence was observed mainly in the cell nucleus. Taken together, these data indicated 
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that, in order to preserve its mRNA export function, NS1 protein required both functional 
domains to be present. 
 
 
3.2.2 Analysis of minireplicon-driven viral protein expression in the presence of 
mutant NS1 proteins 
 In the previous chapter it was shown that inclusion of the NS1 protein in a segment 7 
RNP reconstitution assay led to more efficient nuclear export of the viral mRNA and to higher 
expression of the segment-encoded proteins, M1 and M2. Further analysis (above) showed 
that certain NS1 mutant proteins had lost the ability of promoting mRNA export. To test if the 
correlation between mRNA export and protein expression efficiency was maintained, their 
effects on the production of segment 7 gene products was analysed by western blotting of 




Figure 3.2 Analysis of the effect of NS1 mutations on M1 and M2 expression in the RNP reconstitution assay. 
293T cells were co-transfected with plasmids expressing each of the influenza polymerase proteins and NP 
protein (3PNP) or plasmids expressing PB1, PA and NP proteins (2PNP) alongside a plasmid expressing 
segment 7 vRNA. Plasmids expressing GFP, NS1-GFP or a GFP-tagged NS1 mutant protein were added as 
indicated. Cells were incubated at 37 ºC and at 24 h p.t., cells were harvested and cell lysates analysed by 
western blotting for the proteins indicated. A molecular mass marker is included on the left side of the GFP 
panel with the sizes of each of the bands indicated, to confirm that the GFP-tagged constructs produced proteins 
of the expected sizes. 
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the loading was equivalent between all samples. The expression of NS2, NS1 and NS1 
mutants was confirmed by blotting using an antibody against EGFP (lanes 2-7). It is to be 
noted that the size for NS1-N81 was lower since this mutant produces a truncated form of 
NS1 containing only the first 81 a.a. (lane 5). An RNP-reconstitution negative control that 
lacked PB2 showed no M1 or M2 expression as expected, since viral transcription and 
replication were blocked due to the missing polymerase subunit (lane 1). Otherwise, M1 and 
M2 protein expression was detected in all samples. As seen and discussed previously, M1 and 
M2 levels were lower in the presence of NS2 (lane 4) as well as in the absence of any 
additional segment 8 protein (lane 2). When analysing M1 and M2 expression levels 
according to the NS1 protein present, it was clear that the levels of M1 protein were lower in 
samples containing NS1 mutants that did not have the ability to export segment 7 mRNA 
(lanes 5 and 6). Conversely, higher levels of M1 were detected in the sample containing WT 
NS1 (lane 3) and the positive control NS1 mutant, NS1-S+I (lane 7). Expression of M2, 
however, did not appear to be decreased in the presence of NS1 export-incompetent proteins 
(lanes 5 and 6), in fact presenting levels of accumulation similar to WT NS1 and NS1-S+I 
(lanes 3 and 7). These results are in agreement with the finding discussed previously showing 
that the presence of NS1 resulted in higher expression levels of M1. Taken together, the data 
established a correlation between an export-competent NS1 and higher M1 protein expression 




3.2.3 The effect of NS1 mutant proteins on segment 7 mRNA localisation in the 
context of viral infection  
 In order to validate the effect of NS1 mutations on segment 7 mRNA nuclear export 
observed in minireplicon assays (Figure 3.1), infection experiments were performed using 
PR8 mutant viruses carrying the same changes in NS1 as the EGFP-tagged constructs used in 
the transfection-based assays. 293T cells were either mock infected, infected with WT PR8 
(WT) or a mutant virus carrying a lesion in the coding region of NS1 (that left the NS2 
protein unchanged) at an M.O.I. of 5. Cells were fixed at 6 h.p.i. and processed for FISH 
analysis to determine the localisation of segment 7 mRNA. Subsequently, cells (including 
ones from independent replicate experiments) were scored according to the cellular 
localisation of the mRNA for all samples and the results were quantified in terms of 
percentage of cells counted. No viral mRNA signal (green) was detected in the mock-infected 
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sample while DAPI staining (blue) indicated the presence of cells (Figure 3.3A). Cells 
infected with WT virus had segment 7 mRNA in the cytoplasm and cells infected with NS1-
N81 presented the viral mRNA retained in the cell nucleus (Figure 3.3A), as shown in the 
previous chapter. Cytoplasmic mRNA localization was evident in approximately 85% of WT 
infected cells, with the remainder showing segment 7 mRNA in both nucleus and the 
cytoplasm (Figure 3.3B). In cells infected with the NS1-N81 mutant virus, the mRNA 
nuclear retention phenotype was also clear; mRNA was observed in the cell nucleus in more 
than 80% of cells scored, in both nucleus and cytoplasm of 15% of cells, and mainly in the  
 
 
Figure 3.3 Cellular localisation of segment 7 mRNA in cells infected with NS1 mutant viruses. 293T cells were 
mock infected or infected with the indicated viruses at an M.O.I. of 5. A) At 6 h p.i., cells were processed for 
FISH and stained for segment 7 mRNA using a specific RNA fluorescent probe (green) and for DNA using 
DAPI (blue). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. 
Scale-bar indicates 10 µm. B) Individual cells were scored according to the predominant cellular localisation of 
segment 7 mRNA, considering three phenotypes: nuclear, cytoplasmic or mixed. Values are the mean ± SEM 
from three to six independent experiments. 
 
cytoplasm of less than 5% of cells. Analysis of the NS1 RNA-binding single mutants (NS1-
R38A and NS1-K41A) showed an overall nuclear retention phenotype, as only ~10% and 
~20% of cells presented largely cytoplasmic mRNA staining respectively. However, the 
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percentage of cells with mRNA in both cellular compartments was higher in these samples 
(~40-50%) than in cells infected with NS1-N81, where the majority of cells scored displayed 
the mRNA mainly only in the cell nucleus. Cells infected with the RNA-binding domain 
double mutant (NS1-R+K) showed a phenotype more similar to the NS1-N81 mutant, as 
segment 7 mRNA was found mainly in the nucleus (~70%) and only ~5% of cells presented 
cytoplasmic mRNA. Lastly, analysis of the NS1-S+I mutant, used as a control since the 
change in this mutant virus restored the CPSF binding ability lacking in the WT virus, showed 
no mRNA nuclear retention, as expected. Infection with this mutant resulted in the vast 
majority (>95%) of cells displaying viral mRNA in the cytoplasm; the same phenotype 
observed upon infection with WT. These results provided further validation that the 
minireplicon system could be used as a reliable tool for the study of viral mRNA transport, 
since equivalent results were obtained in the two contexts; of infection using NS1 mutant 
viruses and plasmid-based reconstitution assays. The data also showed that the nuclear 
retention previously ascribed to the absence of NS1 protein in the context of transfection was 
maintained upon infection. In addition, the RNA-binding domain single mutants NS1-R38A 
and NS1-K41A showed an intermediate phenotype compared to the double mutant NS1-R+K.  
 
 
3.2.4 Protein expression analysis in IAV infected cells where mRNA nuclear 
export was enabled or inhibited 
 Analysis of viral protein expression in transfection assays in which the nuclear export 
of segment 7 mRNA was modulated showed that the production of M1 and to some extent, 
M2 proteins decreased when NS1 was absent or one of its functional domains was mutated.  
Next, this correlation between segment 7 mRNA export and protein synthesis, potentially 
determined by NS1 protein promoting a more efficient mRNA export, was tested in the 
context of viral infection by examining protein accumulation in infected cell lysates. 293T 
cells were infected (or mock infected) with either WT PR8 or the NS1 mutant viruses at an 
M.O.I. of 5. Cell lysates were harvested at 6 h p.i. and analysed by western blotting for M1, 
M2, NS1 and NP (Figure 3.4A). Mock infected cells were used as a negative control and did 
not show any viral protein expression (lane 1). NP levels were similar in all infected samples 
confirming comparable levels of infection, while tubulin levels showed that the loading 
amounts were equivalent in all samples. The presence of NS1 was confirmed in all samples 
with the exception of mock infected (lane 1) cells. Cells infected with NS1-N81, which 
produced a truncated form of NS1 not recognised by the antisera used that bound to the C-
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terminal domain of the protein, produced a trace of full length NS1 (lane 3), most likely 
resulting from reversion of the stop codon. M1 and M2 expression was detected in all infected 
samples but generally lower levels of both proteins were present in samples infected with NS1 
mutant viruses that failed to normally export segment 7 mRNA (compare lanes 3-6 with lane 
2). Cells infected with the NS1-S+I mutant which allowed mRNA export to occur efficiently 
showed higher accumulation of M1 and M2 polypeptides compared to WT (lane 7). 
Quantification of replicate experiments showed that poor nuclear export of segment 7 mRNA 
corresponded to around a 3- to 5-fold reduction in the quantity of M1 relative to that of NP, 
and 2- to 3-fold reductions in the amount of M2 (Figure 3.4B). These results from viral 
infections are in line with the ones obtained using the minireplicon assay (Figure 3.2) and 
further validated the correlation observed between NS1-promoted mRNA export and 




Figure 3.4 Analysis of viral protein expression in cells infected with NS1 mutant viruses. 293T cells were mock 
infected or infected with the indicated viruses at an M.O.I. of 5. A) At 6 h p.i., cells were harvested and lysed for 
western blotting analysis for the indicated polypeptides. B) M1 and M2 accumulation from replicate experiments 
were quantified and expressed as a ratio relative to NP expression. Values plotted are normalised to the ratio 




3.2.5 Ability of mutant NS1 proteins incapable of promoting efficient segment 7 
mRNA nuclear export to interact with cellular protein NXF1 
 The use of the cellular NFX1 export pathway by IAV to transport its mRNAs from the 
host cell nucleus to the cytoplasm has been proposed in multiple studies (Hao et al., 2008; 
Larsen et al., 2014; Read and Digard, 2010; Wang et al., 2008). NS1 protein has also been 
hypothesised to play a role in viral mRNA nuclear export, since its interaction with NXF1 
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was demonstrated previously (Larsen et al., 2014; Satterly et al., 2007; Wang et al., 2008). It 
was then relevant in the context of this study to verify that the interaction between NXF1 and 
NS1 existed under the specific conditions used here. Furthermore, since certain mutant NS1 
proteins were found to be unable to promote efficient nuclear export of segment 7 mRNA, it 





Figure 3.5 Interaction between NXF1 and NS1. 293T cells were transfected with plasmids encoding GFP or 
GFP-NXF1 and 48 h later either mock infected or infected with the indicated NS1 mutant viruses at an M.O.I. of 
5. Cells were harvested at 6 h p.i. and cell lysates were examined by western blotting for the indicated proteins 
before (Total) or after (Bound) being subjected to GFP-Trap pulldown assays. 
 
 
To test this, 293T cells were transfected with either GFP or GFP-NXF1 and 48 h later 
mock infected or infected with the WT or the various NS1 mutant viruses at an M.O.I. of 5. 
At 6 h p.i. cells were collected and lysed, and the supernatants were subjected to GFP-Trap 
pulldown. Western blot analyses of total and bound fractions showed that GFP-NXF1 and 
GFP were expressed as expected and bound well to the affinity matrix (Figure 3.5). NS1 was 
present in all infected samples, including that with the truncated N81 protein, although 
detection of this last polypeptide required use of an RNA-binding domain-specific antiserum 
and was inefficient (lanes 1 and 2 and lanes 4 to 8). Consistent with previous reports (Larsen 
et al., 2014; Satterly et al., 2007; Wang et al., 2008), WT NS1 co-precipitated with NXF1, as 
did the NS1 S+I mutant (lanes 10 and 16). This binding was specific, since no interaction of 
WT NS1 with GFP only was seen (lane 9). However, none of the NS1 RNA-binding domain 
mutants bound to detectable levels (lanes 13 to 15). Similarly, the effector domain-deleted 
N81 protein was not apparent in the bound fraction (lane 12), suggesting that (within the 
limits of detection of the antibody) the truncated protein did not bind NXF1. Thus, there was a 
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good correlation between the ability of NS1 to promote segment 7 mRNA export and its 
ability to bind NXF1. This positive correlation supported the hypothesis that NS1 could 
indeed act as an adaptor protein between segment 7 mRNA and the cellular mRNA export 
machinery via an interaction with NXF1. 
 
 
3.2.6 Analysis of the interaction between NXF1 and segment 7 mRNA in the 
presence of NS1 protein 
NXF1 has been shown to bind M1 mRNA in WT virus-infected cells (Wang et al., 2008). 
Therefore, it was plausible to conjecture that NS1 could facilitate this interaction, acting as an 
adaptor protein between the viral mRNA and the main cellular mRNA export pathway. To 
test this, 293T cells were transfected with the plasmids needed to recreate segment 7 RNPs (or 
with a 2P negative control) along with GFP-NXF1 and, additionally, with or without NS1. 
Cells were lysed at 48 h p.t. and segment 7 mRNA accumulation was examined by primer 
extension before or after GFP-Trap affinity purification. Abundant quantities of M1 mRNA 
and lesser amounts of spliced mRNA2 were present in the total cell lysates from the 3PNP but 
not the 2P control samples, while examination of cellular 5S rRNA confirmed the extraction 
of equal cell numbers (Figure 3.6, lanes 1 to 3). When the bound fractions were analysed, no 
M2 mRNA was detected and only trace amounts of M1 mRNA were observed in the absence 
 
Figure 3.6 Effect of NS1 on the interaction between NXF1 and segment 7 mRNA. 293T cells were transfected 
with plasmids to recreate segment 7 RNPs (3PNP+) or, as a negative control, with a 2PNP combination lacking a 
plasmid expressing PB2 (3PNP-) along with GFP-NXF1 and with or without NS1 as indicated. At 48 h p.t, cells 
were harvested and GFP-Trap pulldown assays were carried out. Subsequently, RNA was extracted and analysed 
by radioactive reverse transcriptase with primers specific for segment 7 mRNAs and 5S rRNA followed by urea-
PAGE and autoradiography. 
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of NS1. However, upon the presence of NS1, mM1 mRNA was readily detectable (lane 6). 
M2 could also be detected in the presence of NS1 (lane 6) although to a much lesser extent, 
suggesting a weaker interaction between NXF1 and M2 mRNA. This suggested that NS1 
promoted a stable interaction of NXF1 and segment 7, particularly M1, mRNA. 
Having reproduced an NXF1-M1 mRNA interaction and found evidence that NS1 
influenced this, the question that naturally followed was whether there was a correlation 
between the ability of mutant NS1 proteins to promote NXF1-segment 7 mRNA interactions 
and their mRNA export activity. 293T cells were transfected with either GFP or GFP-NXF1 
and 48 h later infected with the panel of WT and NS1 mutant viruses. At 6 h p.i., total RNA 
was extracted before or after the lysates had been subjected to GFP-Trap pulldown, and 
primer extension reactions were carried out to assay segment 7 mRNAs and vRNA, as well as 
5S rRNA as a loading control. Viral RNAs were detected in the total fraction of every 
infected sample (Figure 3.7, lanes 1 to 7) but only 5S rRNA was detected in mock-infected 
cells (lane 8). Analysis of the bound fractions from WT virus-infected cells showed that both 




Figure 3.7 Interaction between segment 7 mRNA and NXF1 in the presence of NS1 mutant proteins. 293T cells 
were transfected with GFP-NXF1 (+) or with GFP alone (-) and 48 h later either mock infected or infected with 
the indicated viruses at an M.O.I. of 10, in duplicate sets. At 6 h p.i., cells were harvested and total cellular RNA 
was extracted from one set while the second set was subjected to GFP-Trap pulldown assays prior to total RNA 
extraction. RNA was analysed by radioactive reverse transcriptase with primers specific for segment 7 mRNAs 
and vRNA as well as cellular 5S rRNA followed by urea-PAGE and autoradiography. 
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genomic vRNA did not precipitate with GFP-NXF1 (lane 10) while none of the viral RNA 
species bound to GFP only (lane 9). A similar outcome was obtained with the export-
competent NS1 (S+I) mutant virus (lane 15). However, only trace quantities of M1 or M2 
mRNAs bound NXF1 in cells infected with the N81 or R+K NS1 mutant virus (lanes 11 and 
14), while reduced amounts co-precipitated from cells infected with the single RNA-binding 
domain R38 and K41 mutants (lanes 12 and 13). Thus, the ability of NS1 polypeptides to 
direct efficient export of segment 7 mRNA showed a good correlation with their ability to 




3.2.7 Ability of NS1 mutant proteins to interact with segment 7 mRNA  
Previous work has shown that NS1 binds segment 7 mRNA in vitro and co-
precipitates it from infected cells (Burgui et al., 2003; Park and Katze, 1995; Wang et al., 
2008). It therefore seemed reasonable to test whether the strength of this interaction correlated 
with the ability of NS1 mutants to promote efficient export of M1 mRNA. First, an RNP 
reconstitution assay was used to recreate segment 7 RNPs, with or without the addition of WT 
or mutant GFP-NS1 polypeptides, before fractionating cell lysates over GFP-Trap beads and 
analysing the amounts of bound segment 7 mRNA. Examination of aliquots of total cell lysate 
showed the expected presence of M1 and M2 mRNA species in all samples transfected with 
all four RNP polypeptides but not in 2P (PB1 and PA) control samples (Figure 3.8, lanes 1 to 
10). No detectable mRNA co-precipitated with GFP, but easily detectable amounts of both 
mRNA1 and mRNA2 bound to duplicate samples co-transfected with WT GFP-NS1 or (S+I)-
GFP-NS1 (lanes 14, 15, and 20). However, the export-incompetent N81, R38, K41, and R+K 
mutants all failed to detectably bind M1 mRNA and/or bound greatly reduced amounts of M2 
mRNA (lanes 16 to 19). These results suggested that mutant NS1 proteins that failed to 
promote the efficient nuclear export of segment 7 mRNA were also unable to bind segment 7 




Figure 3.8 Interaction between NS1 and segment 7 mRNA. 293T cells were transfected with plasmids to 
recreate segment 7 RNPs (3PNP+) or, as a negative control with a 2PNP combination that excluded a plasmid 
expressing PB2 (3PNP-) together with the indicated NS1-GFP polypeptides (NS1-GFP+) or with GFP (NS1-
GFP-), in duplicate sets. At 48 h p.t., cells were harvested and total cellular RNA was extracted from one set 
while the second set was subjected to GFP-Trap pulldown assays prior to total RNA extraction. RNA was 
analysed by radioactive reverse transcriptase with primers specific for segment 7 mRNAs and vRNA as well as 
cellular 5S rRNA followed by urea-PAGE and autoradiography. 
 
 
3.2.8 Ability of NS1 effector domain mutant proteins to promote efficient export 
of segment 7 mRNA using the minireplicon system 
The evidence so far supported the hypothesis of NS1 acting as an adaptor protein to 
feed viral segment 7 mRNA(s) to the cellular NXF1 export pathway. To further test the 
correlation between NS1 export activity and ability to bridge between (or at least bind to both) 
viral mRNA and NXF1, a set of point mutations in the effector domain of NS1 protein were 
tested. Mutation of specific amino-acids in the NS1 domain has been shown to result in the 
loss of several functions attributed to this multifunctional protein (Hale et al., 2008b). The 
mutants studied here were: NS1-Y89A and NS1-Y89F, both of which prevent NS1 from 
binding PI3K (Aramini et al., 2011; Hale et al., 2006) NS1-E96/7A preventing NS1 from 
binding Trim25 (Gack et al., 2009) and NS1-W187R inhibiting the dimerization of NS1 (Hale 
et al., 2008a). 
Firstly, the behaviour of this set of mutant NS1 proteins was analysed in the context of 
the minireplicon system. 293T cells were transfected as before with plasmids to produce 
segment 7 RNPs as well as with either WT or mutant NS1-EGFPs. Cells were fixed and 
processed for FISH at 24 h p.t. in order to observe segment 7 mRNA localisation in the 
presence of the different NS1 mutant proteins (Figure 3.9A). NS1 expression was confirmed 
by the detection of GFP signal (green) and was found localised predominantly in the 
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cytoplasm for WT and all mutants except NS1-W187R which presented a mixed phenotype 
being found both in the nucleus and the cytoplasm. As expected, no mRNA staining (red) was 
detected in the negative control lacking PB2 (2PNP). When all the basic components for RNP 
reconstitution were present, segment 7 mRNA could be detected primarily in the cell nucleus, 
while in the presence of NS1-EGFP, mRNA was found in the cytoplasm. When either of the 
PI3K-binding mutants NS1-Y89A or NS1-Y89F, were present however, segment 7 mRNA 
was again found to be clearly retained in the nucleus, indicating that the mutations also 
resulted in the loss of the ability to promote efficient nuclear export of segment 7 mRNA. 
Similarly, in the presence 
 
 
Figure 3.9 Effect of mutations in the NS1 effector domain on segment 7 mRNA localisation. A) 293T cells were 
co-transfected with plasmids to recreate segment 7 RNPs or, as a negative control with a combination that 
excluded a plasmid expressing PB2 (2PNP), together with the indicated NS1-GFP polypeptides. Cells were 
incubated at 37 ºC and processed for FISH analysis at 24 h p.t. using Cy3 labelled RNA probes for the detection 
of positive sense viral RNAs of segment 7 (red) and GFP expression was detected by confocal microscopy 
(green). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. Scale-
bar indicates 10 µm. B) Individual cells were scored according to the predominant cellular localisation of 
segment 7 mRNA considering three phenotypes: nuclear, cytoplasmic or mixed. Values are the mean ± SEM 
from two independent experiments. 
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of the TRIM25-interaction mutant, NS1-E96/7A, the mRNA was also found to be mainly in 
the nucleus. In contrast, the dimerization mutant NS1-W187R still caused segment 7 mRNA 
to be localised largely in the cytoplasm, suggesting that the ability of NS1 to dimerise via its 
effector domain was not required to promote efficient mRNA nuclear export. Cells were 
counted and scored according to the predominant cellular localisation of segment 7 mRNA 
(nuclear, cytoplasmic or both), in the presence of the various NS1 mutant proteins (Figure 
3.9B). These data showed that in the absence of NS1, segment 7 was found in mainly in the 
nucleus of ~80% of cells scored, while the remaining cells presented mRNA staining both in 
the nucleus and the cytoplasm. The presence of NS1-E96/7A, NS1-Y89A and NS1-Y89F 
resulted in a similar outcome with a clear majority of cells displaying segment 7 mRNA in the 
nucleus. However, more cells transfected with NS1-Y89A and NS1-Y89F displayed 
cytoplasmic segment 7 mRNA (~10%) than in the complete absence of NS1 or cells 
transfected with NS1-E96/7A. When WT NS1 or NS1-W187R were present, the clear shift of 
segment 7 mRNA localisation from the nucleus to the cytoplasm was confirmed. The mRNA 
was found in the cytoplasm in ~75% of cells and in both cellular compartments in ~20% 
while less than 10% of cells presented the mRNA solely in the nucleus. 
Overall, analysis of this set of mutants confirmed that the effector domain of NS1 is 
required for the function of mRNA nuclear export, since three NS1 polypeptides with 
mutations in this domain (NS1-Y89A, NS1-Y89F and NS1-E96/7A) were unable to promote 
cytoplasmic accumulation of segment 7 mRNA. Furthermore, the results obtained with the 
NS1-W187R mutant showed that mutations in the effector domain that did not disrupt the 
nuclear export function were possible, indicating some specificity. Taken together, these data 
showed that the NS1 effector domain is necessary for the export function and suggested a 
specific role in viral mRNA nuclear export. 
 
 
3.2.9 The effect of NS1 effector domain mutant proteins on segment 7 mRNA 
localisation in the context of viral infection  
 To further test the mRNA export activity of the NS1 effector domain mutants, their 
phenotype was examined in the context of virus infection. To this end, 293T cells were mock 
infected or infected with either WT PR8 or the NS1 mutant viruses NS1-Y89A, NS1-Y89F, 
NS1-E96/7A and NS1-W187R at an M.O.I. of 5. At 6 h p.i., cells were fixed and processed 
for FISH analysis to determine the cellular localisation of segment 7 mRNA. In addition, cells 
were stained by indirect immunofluorescence for NS1 (Figure 3.10). All viruses presented 
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NS1 signal (green) above the uninfected cell background that was generally cytoplasmic, 
although the staining in cells infected with NS1-Y89 and NS1-E96/7A mutants was 
noticeably fainter than the WT and W187R viruses. No viral mRNA signal (red) was detected 





Figure 3.10 Segment 7 mRNA cellular localisation in cells infected with NS1 effector domain mutant viruses. 
293T cells were mock infected or infected with the indicated viruses at an M.O.I. of 5. At 6 h p.i., cells were 
processed for FISH and stained for segment 7 mRNA using a specific RNA fluorescent probe (red) and for DNA 
using DAPI (blue). Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis 
software. Scale-bar indicates 10 µm. 
 
 
largely found in the cell cytoplasm. In cells infected with the PI3K-binding mutants, NS1-
Y89A and NS1-Y89F, segment 7 mRNA was found located predominantly in the cell 
nucleus. This was also the case in cells infected with the Trim25-interaction mutant NS1-
E96/7A, where nuclear retention of segment 7 mRNA was evident. Conversely, analysis of 
the dimerisation mutant NS1-W187R showed a positive nuclear export phenotype as segment 
7 mRNA was mostly found in the cytoplasm, even if some signal was also visible in the cell 
nucleus. Overall, these results validated the results obtained in the minireplicon setting, as the 
mRNA export phenotypes of the NS1 mutants were reproduced in the context of viral 
infection. Furthermore, these data confirmed that not only did NS1 require both functional 
domains to be able to promote efficient nuclear export of segment 7 mRNA, but also that the 
introduction of smaller changes in the effector domain could interfere with the export 
function. The cytoplasmic localisation of segment 7 mRNA in the presence of the NS1-
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W187R mutant indicated, however, that NS1 dimerisation was not required in order for NS1 
to promote segment 7 mRNA nuclear export.  
 
3.2.10 Analysis of M1 and M2 expression in the presence of effector domain 
mutant NS1 proteins 
Thus far, results indicated a positive correlation between NS1-promoted nuclear 
export of segment 7 mRNA and higher expression levels of its gene products. In order to 
determine whether this correlation was maintained with the effector domain mutants, 293T 
cells were transfected with segment 7 RNPs and the different EGFP-tagged NS1 mutants as 
before. Western blotting analyses were then performed on cell lysates collected 24 h.p.t.. 
Equivalent tubulin levels showed that loaded amounts were comparable between all samples 
(Figure 3.11A). The expression of WT and mutant NS1 polypeptides was confirmed by 
blotting using an antibody against EGFP. Levels of EGFP detected were similar for all the 




Figure 3.11 Analysis of M1 and M2 expression in the presence of NS1 effector domain mutant proteins. A) 
293T cells were co-transfected with plasmids expressing each of the influenza polymerase proteins and NP 
protein (3PNP) or plasmids expressing PB1, PA and NP proteins (2PNP) along with a plasmid expressing a 
segment 7 vRNA. Plasmids expressing GFP, NS1-GFP or a GFP-tagged NS1 mutant protein were added as 
indicated. Cells were incubated at 37 ºC, harvested at 24 h p.t. and cell lysates were analysed by western blotting 
for the proteins indicated. B) 293T cells were either mock infected or infected with NS1 mutant viruses as 
indicated at an M.O.I. of 5. At 6 h p.i., cells were harvested and cell lysates were analysed by western blotting 
for the proteins indicated.  
 
 
Reduced expression of NS1-E96/7A-EGFP was a consistent feature (see later), suggestive of 
reduced protein stability. A negative control lacking PB2 showed no M gene protein 
expression as expected (lane 1), but otherwise M1 and M2 expression was readily detected in 
all samples. As previously, M1 and M2 levels were lower in the absence of NS1 (compare 
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lanes 2 and 3). When the different NS1 effector domain mutant proteins were present, M2 
levels were similar to those seen with WT NS1 (compare lanes 4-7 with lane 3). M1 
accumulation was generally intermediate; higher than in the absence of NS1, but lower than in 
the presence of the WT polypeptide. Notably, there was no obvious difference in M1 
accumulation between the mRNA export-competent W187R polypeptide and the inactive Y89 
and E96/7 mutants. Thus the correlation between segment 7 mRNA export efficiency and 
segment protein expression was not maintained when NS1 effector domain mutants were 
examined in minireplicon reconstitution assays. The next question then was to test whether 
this correlation also was less evident in the context of viral infection.  
 To tackle this, 293T cells were mock infected or infected with either WT PR8 or one 
of the NS1 mutant viruses, at an MOI of 5 and cell lysates harvested at 6 h p.i for western 
blotting analysis (Figure 3.11B). In mock infected cells, no expression of viral proteins was 
detected, (lane 1) while all viral proteins analysed were present in infected samples (lanes 2-
11). Equivalent levels of tubulin were detected in all samples, indicating that the amount of 
cells collected, lysed and loaded was comparable. While some variability was observed in NP 
levels across the set of mutants, this variation could not be correlated to the mRNA export 
phenotype of the mutant viruses and was more likely due to slight discrepancies in the M.O.I. 
of the viruses. Conversely to the results obtained in minireplicon assays (Figure 3.11A), 
expression of M1 protein showed similar results to previous experiments reported in this 
dissertation, i.e., lower expression levels were observed in cells infected with viruses carrying 
an export-incompetent NS1 protein (Figure 3.11B, lanes, 3-6 and 8-10). M2 expression 
levels, however, were lower in cells infected with WT than with most NS1 mutant virus (lane 
2). Levels of NS1 protein varied across the different mutant viruses. However, this variation 
in protein expression levels did not correlate with the ability of NS1 protein to promote 
efficient export of segment 7 mRNA. For instance, export-incompetent NS1-R38A mutant 
displayed NS1 levels comparable to WT NS1 whereas export competent NS1-(S+I) showed 
lower levels of NS1 protein, when compared to WT NS1 (lanes 1, 4 and 7). This indicated 
that the amount of NS1 protein produced by a virus did not necessarily affect its ability or 
lack of ability to promote efficient export of segment 7 mRNA. NS2 protein levels were also 
analysed since segment 8 was mutated to produce the panel of NS1 mutant viruses. All 
mutant viruses produced higher levels of NS2 compared to WT NS1, so expression levels of 
NS2 did not appear to be negatively affected by the NS1 mutations or efficient export of 
segment 7 mRNA being enabled or impaired.  
Overall, these results presented the first instance where the results obtained using the 
minireplicon assay were not in their entirety confirmed by assays of viral infection. 
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Nevertheless, in the context of viral infection, the correlation between higher levels of M1 




3.2.11 Ability of NS1 effector domain mutant proteins to interact with cellular 
protein NXF1 
Earlier in this chapter, correlative evidence was provided supporting the hypothesis 
that NS1 acted as an adaptor protein between segment 7 viral mRNA and the cellular mRNA 
export machinery via its interaction with TAP/NXF1. The variable mRNA export phenotypes 
of the NS1 effector domain mutants provided a further opportunity to test the correlation 
between NXF1-binding and export activity. 293T cells were transfected with either GFP or 
GFP-NXF1 and 48h later mock infected or infected with the panel of NS1 effector domain 
mutant viruses at an M.O.I. of 5. At 6 h p.i., cells were harvested and lysed and GFP-Trap 
was performed on the supernatants. Protein analysis was carried out by western blotting 
which showed that both in the total and bound fractions, GFP and GFP-NXF1 were expressed 
and collected in comparable amounts as expected. (Figure 3.12).  
Cells transfected with GFP and infected with WT virus showed the presence of both 
GFP and NS1 proteins in the total fraction (lane 1). However, only GFP was found in the 
bound fraction (lanes 1 and 8) thus validating the specificity of the GFP-Trap procedure. In 
mock infected cells which were used as a further negative control, only NXF1 was detected in 
both the totals as well as in the bound fractions confirming the absence of infection in these 
cells (lanes 3 and 10). As expected from previous studies (Larsen et al., 2014; Satterly et al., 
2007) and data presented in this dissertation (Figure 3.5), WT NS1 co-precipitated with 
NXF1 (lane 9). Furthermore, all mutant NS1 polypeptides analysed in this experiment also 
co-precipitated with NXF1 (lanes 11-14). Based on the previous findings reported in this 
chapter indicating that NS1 mutant proteins that carried the function of viral mRNA export 
were capable of interacting with NXF1, this outcome was expected for the nuclear export 
competent dimerization mutant, NS1-W187R. However, the results obtained for the NS1-
Y89A, NS1-Y89F and NS1-E96/7A mutant viruses were more interesting since they 
suggested that although the interaction between NS1 and NXF1 was required for the efficient 
nuclear export of segment 7 mRNA, it was not sufficient. Therefore other factors and 




Figure 3.12 Interaction between NXF1 and NS1 effector domain mutant proteins. 293T cells were transfected 
with plasmids encoding GFP or GFP-NXF1 and 48 h later either mock infected or infected with the indicated 
NS1 mutant viruses at an M.O.I. of 5. Cells were harvested at 6 h p.i. and cell lysates were examined by western 
blotting for the indicated proteins before (Total) or after (Bound) being subjected to GFP-Trap pulldown assays. 
 
 
3.2.12 Effect of NS1 effector domain mutations on the interaction between NXF1 
and segment 7 mRNA 
The indication from the Y89 and E96/7 mutants that the interaction between NS1 and 
NXF1 was necessary but not sufficient to enable efficient export of segment 7 meant it was 
relevant to assess whether they still supported the binding of NXF1 to segment 7 mRNA, to 
understand if the block in the viral mRNA export pathway was due to the loss of that activity. 
To test this, 293T cells were transfected with either GFP or GFP-NXF1 and 48 h later mock 
infected or infected either with WT or NS1 effector domain mutant viruses at an M.O.I. of 10. 
At 6 h p.i., total RNA was extracted before or after the lysates had been subjected to GFP-
Trap pulldown, and primer extension reactions were carried out to examine segment 7RNA 
species.  
Viral RNAs were detected in the total fraction of every infected sample (Figure 3.13, 
lanes 1-2 and 4-7). Analysis of the bound fraction from WT virus infected cells showed that 
both segment 7 mRNA species co-precipitated with GFP-NXF1 (lane 9) but not with GFP 
alone (lane 8). The specificity of the interaction between NXF1 and segment 7 mRNAs was 
further confirmed as genomic vRNA did not co-precipitate with GFP-NXF1 (lane 9) or with 




Figure 3.13 Interaction between segment 7 mRNA and NXF1 in the presence of NS1 effector domain mutant 
proteins. 293T cells were transfected with GFP-NXF1 (GFP-NXF1 +) or with GFP alone (GFP-NXF1 -) and 48 
h later either mock infected or infected with the indicated viruses at an M.O.I. of 10, in duplicate sets. At 6 h p.i., 
cells were harvested and total cellular RNA was extracted from one set while the second set was subjected to 
GFP-Trap pulldown assays prior to total RNA extraction. RNA was analysed by radioactive reverse transcription 
followed by urea-PAGE and autoradiography with primers specific for segment 7 RNAs and 5S rRNA. 
 
These results are in line with and further validated the findings described earlier in this 
chapter (Figure 3.7) as well as a previous study (Wang et al., 2008). Analysis of the NS1-
W187R mutant showed that NXF1 was able to bind M1 mRNA and, to a lesser extent, M2 
mRNA (lane 14). These results were consistent with the ones obtained with the first set of 
NS1 mutants studied in this dissertation, supporting the hypothesis that NS1 promotes 
efficient nuclear export of segment 7 mRNA by facilitating the interaction between NXF1 and 
segment 7 mRNAs. In contrast, viral mRNAs were not detected in the GFP-NXF1 pulldowns 
from cells infected with either NS1-Y89A or NS1-Y89A mutant viruses (lanes 11 and 12), 
indicating that both these mutant NS1s failed to promote the interaction between NXF1 and 
segment 7. This is also in agreement with the findings reported above (Figure 3.7), which 
suggested that NS1 mutant proteins that could not promote nuclear export of segment 7 
mRNA were also unable to promote the interaction between NXF1 and segment 7 mRNAs. 
However, when analysing bound material from cells infected with the NS1-E96/7A virus, M1 
mRNA was clearly detected as well as a trace amount of M2 mRNA (lane 13). This latter 
finding indicated that, like the interaction between NS1 and NXF1, the interaction between 
NXF1 and segment 7 is necessary, but not sufficient for the successful nuclear export of 
segment 7 mRNA. 
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3.2.13 Analysis of NS1 interaction partners 
It was thus far observed that various NS1 mutations examined throughout this chapter 
disrupted the export mechanism for segment 7 mRNA at different steps. The RNA-binding 
domain mutations seemed to halt the nuclear export of segment 7 mRNA by making NS1 
unable to bind NXF1 and/or segment 7 mRNA. The NS1 effector domain mutants however, 
were all able to interact with NXF1. In this instance, the lack of interaction between NXF1 
and segment 7 mRNA in the presence of the mutants NS1-Y89A and NS1-Y89F could be 
what interrupted viral mRNA nuclear export. In the case of the NS1-E96/7A mutant virus 
however, it remained unclear what caused its loss of viral mRNA nuclear export function. The 
mutant NS1 protein was able to bind NXF1 and also to promote the interaction between 
NXF1 and segment 7 mRNA, suggesting the hypothesis that an as yet unidentified interaction 
with a further factor necessary for viral mRNA export was affected by the E96/7A mutation. 
Examination of the cellular interaction partners of the various WT and mutant NS1 
polypeptides might therefore be expected to show differences, in particular the E96/7A 
protein. Accordingly, 293T cells were transfected either with GFP or GFP-tagged NS1 mutant 
plasmids. At 48 h p.t., cells were collected, lysed and subjected to GFP-Trap. The bound 
fractions were loaded onto SDS-PAGE gels and stained with Coomassie Blue dye. GFP was 
the only protein detected from cells transfected with the GFP control plasmid, indicating no 
obvious contamination with cellular proteins that bound specifically to GFP (Figure 3.14, 
lane 1). Major polypeptide species of the expected size for GFP-NS1 were detected in all 
other samples, including the truncated form NS1-N81, confirming that cells were successfully 
transfected (lanes 2-9). Various other minor polypeptide species were also visible that were 
mostly common to all NS1-containing samples. Examination of this and replicate experiments 
(data not shown) generally found only minor differences in the polypeptide profiles that could 
not be correlated with the viral mRNA nuclear export activity of the particular NS1. However, 
one clear difference was consistently observed; a distinct novel polypeptide was detected in 
pulldowns from cells transfected with E96/7A (lane 8) that was absent from the other 
samples. Since NS1-E96/7A was precisely the mutant that posed most questions, being unable 
to promote nuclear export of segment 7 while being able to bind NXF1 and promote the 
interaction between NXF1 and segment 7 mRNA, the identification of this protein was 
pursued.  
Thus, a further aliquot of the NS1-E96/7A sample was run in another gel and sent to 
the Roslin Institute Proteomics Facility which unambiguously identified the mystery 
polypeptide as heat shock protein 70 (hsp70) through multiple peptide matches after liquid 




Figure 3.14 Analysis of NS1-GFP-interacting polypeptides. 293T cells were transfected with either GFP alone 
or with GFP-tagged NS1 mutant protein expressing plasmids as indicated and 48 h later cells were harvested and 
subjected to GFP-Trap pull down assays. Eluted samples were loaded onto SDS-PAGE gels and stained with 
Coomassie Blue dye. The red arrow indicates the unique polypeptide species that co-purified with NS1-E96/A 
(lane 8) that was sent to the Roslin Institute proteomics facility which identified it as hsp70. 
 
 
To confirm the interaction between NS1-E96/7A and hsp70, the GFP-trap pulldowns 
were repeated and analysed by western blotting for hsp70 as well as for the GFP-tagged “bait” 
proteins. In addition, because analysis of the overall protein-binding profiles of the various 
mutant NS1 proteins had not revealed any other striking differences that could unveil a crucial 
interaction for the viral mRNA export pathway, specific cellular proteins for which working 
antisera were available were also examined. Accordingly, 293T cells were transfected either 
with GFP or GFP-tagged NS1 mutant plasmids. At 48 h p.t., cells were collected, lysed and 
subjected to GFP-Trap followed by western blotting. Transfection was confirmed by the 
detection of GFP and GFP-tagged NS1 mutant proteins, while equivalent amounts of the 
cellular proteins hsp70, Nup62 and UAP56 in the total fractions of all samples confirmed that 
comparable amounts of cell lysates had been generated (Figure 3.15, lanes 1-9). However, in 
the bound fraction, hsp70 was detected only in the NS1-E96/7A sample (lane 17). These 
results confirmed that the interaction between NS1-E96/A and hsp70 existed and that it was 
specific to this particular NS1 mutant protein. In contrast, Nup62 was detected, albeit in trace 
amounts, in all samples apart from the one from cells transfected with GFP (lanes 10-18), 
suggesting a weak but NS1-specific interaction. UAP56 on the other hand, could not be 
detected in any of the bound fraction samples, suggesting that NS1 protein does not interact 
with it. Taken together, these results confirmed the specific gain-of-function interaction with 
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hsp70 for NS1 E96/7 and also suggested that NS1 was able to interact with a cellular 
component heavily implicated in the cellular mRNA export pathway Nup62 (Satterly et al., 
2007). However, since all NS1 mutants were able to support this latter interaction, no 




Figure 3.15 Analysis of NS1 interactions with cellular factors. 293T cells were transfected with GFP or with 
GFP-tagged NS1 mutant proteins expressing plasmids as indicated and 48 h p.t., cells were harvested and cell 
lysates examined by western blotting for the indicated proteins before (Total) or after (Bound) being subjected to 
GFP-Trap pulldown assays. 
 
3.3 Discussion 
The aim of the work presented in this chapter was to gather a deeper understanding of 
the mechanism by which segment 7 mRNA is exported from the nucleus to the cytoplasm 
following the identification of NS1 as a viral requirement for this process in Chapter 2. Since 
a panel of NS1 mutants (in the form of plasmid constructs as well as viruses) were already 
available in the Digard laboratory, these were used to tackle NS1 protein itself. The objective 
was to study the impact of mutations thought to inhibit specific roles attributed to NS1 and 
assess whether these mutations also affected the ability of NS1 to promote efficient nuclear 
export of segment 7 mRNA.  
 
Initially, the focus was on major mutations that would separately test the role of the 
two functional domains of NS1 (Qian et al., 1994; Qian et al., 1995) in order to identify which 
of them was associated with the mRNA nuclear export function. Positively-charged residues 
at positions 38 and 41 have been identified as required for the integrity of the RNA-binding 
domain and substitution of both the arginine at position 38 and the lysine at position 41 for 
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alanine was shown to disrupt the RNA-binding ability of NS1 (Hale et al., 2008b; Wang et al., 
1999). Hence, three NS1 mutants were used to test the impact of losing a functional RNA-
binding domain in the context of mRNA nuclear export: NS1-R38A, NS1-K41A and the 
double mutant NS1-(R+K). Abrogation of the entire effector domain required a more drastic 
change to be introduced onto NS1. A stop codon was introduced at position 82 resulting in a 
truncated NS1 protein comprising the first 81 amino acids of the full-length polypeptide 
(Zurcher et al., 2000). This mutant protein, NS1-N81, contained an intact RNA-binding 
domain but lacked the entire effector domain. Studying the cellular localisation of segment 
mRNA by FISH in the presence of these NS1 mutant proteins revealed that neither of them 
was able to support the export of the mRNA to the cytoplasm, resulting in a marked nuclear 
retention of the mRNA (Figure 3.1 and 3.3). This suggests that both the RNA-binding and the 
effector domains of NS1 are required for the function of viral mRNA nuclear export. 
Similarly, the splicing inhibition function attributed to NS1 has also been reported to require 
both functional domains of the protein (Lu et al., 1994).  
 
NS1 has previously been hypothesized to play a role in IAV mRNA nuclear export, 
although this had not been clearly demonstrated prior to the work described in this Chapter 
(Schneider and Wolff, 2009). The identification of interactions between NS1 and viral 
mRNAs (Burgui et al., 2003; Marion et al., 1997; Park and Katze, 1995; Wang et al., 2008) as 
well as between NS1 and NXF1 (Larsen et al., 2014; Satterly et al., 2007; Wang et al., 2008) 
provided strong indications that NS1 could facilitate the nuclear export of viral mRNAs via its 
interaction with NXF1 and other components of the cellular mRNA export machinery. Here, 
these interactions were corroborated and it was confirmed that WT NS1 interacts both with 
NXF1 and segment 7 mRNA in the experimental conditions described (Figures 3.5 and 3.8). 
Functional understanding of these interactions was further extended by showing that not only 
can NS1 bind segment 7 mRNA and NXF1, but that NS1 also promotes the interaction 
between NXF1 and segment 7 mRNA (Figures 3.6 and 3.7). As both functional domains of 
NS1 were demonstrated to be required for efficient segment 7 mRNA nuclear export to occur, 
it was plausible to consider that at least one but perhaps both would be also necessary for the 
interaction between NS1 and NXF1. Indeed, neither of the RNA-binding mutants nor the 
effector domain mutant could detectably interact with NXF1 (Figure 3.5) indicating that both 
functional domains are necessary for stable complex formation. Similarly, the three RNA-
binding mutants as well as the effector domain mutant were unable to interact with segment 7 
mRNA (Figure 3.8) and also failed to promote the interaction between segment 7 mRNA and 
NXF1 (Figures 3.7 and 3.8). These results suggested that, in order for segment 7 mRNA to be 
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efficiently exported to the nucleus via NS1, it was necessary to comply with at least three 
conditions: 1) NS1 must be able to interact with NXF1, 2) NS1 must be able to bind segment 
7 mRNA and 3) NS1 must be able to promote the interaction between segment 7 mRNA and 
NXF1. Failing to present any of these three features would result in segment 7 mRNA nuclear 
retention. Moreover, results suggest that both functional domains of NS1 must be active in 
order to fulfil the criteria. However, in a previous report, the interaction between NS1 and 
NXF1 was found to rely solely on the RNA-binding domain of NS1 (Satterly et al., 2007). 
Since the effector domain mutant used, NS1-N81, produced a truncated form of NS1 protein 
that was not easily detectable by western blotting with the antisera available in the laboratory, 
it is possible that an interaction between NXF1 and the first 81 amino acids of NS1 existed 
that could not be observed in the assays performed here. Nevertheless, even if NS1-N81 could 
bind NXF1, the latter failed to interact with segment 7 mRNA in the presence of NS1-N81. 
Therefore, the effector domain of NS1 does play a role in these interactions; if not directly in 
the interaction between NS1 and NXF1 or NS1 and segment 7 mRNA, then at least for the 
interaction between NXF1 and segment 7 mRNA. These findings were in favour of a model 
by which NS1 interacts with segment 7 mRNA and transfers it to NXF1 as a strategy to feed 
the viral transcript into the major cellular mRNA export pathway. It is however important to 
note that these interactions were not tested in vitro and thus, it was not possible to establish 
that they were direct. It is possible that these interactions could be mediated by yet another 
cellular (or viral, if present in the minimal IAV RNP set of genes) component. 
 
To date, the RNA-binding domain of NS1 has been shown to interact with multiple 
RNA species such as double-stranded RNAs (Chien et al., 1997; Hatada and Fukuda, 1992; 
Wang et al., 1999), small nuclear RNAs (Qiu et al., 1995; Wang and Krug, 1998), viral 
genomic RNAs (Hatada et al., 1997; Hatada et al., 1992) and viral mRNAs (Burgui et al., 
2003; Marion et al., 1997; Wang et al., 2008). However, the specific residues of NS1 involved 
in these interactions have not yet been identified. While it was previously thought that the 
RNA-binding domain of NS1 interacted with RNAs in a sequence independent fashion, a 
more recent study suggested that the interactions were specific, showed a very high affinity 
and were structure-dependent (Marc et al., 2013). Hence it is plausible to conjecture that NS1 
could bind segment 7 mRNA via its RNA-binding domain through the recognition of a 
specific sequence or structure within the mRNA, most likely in its 5’-UTR (Marc et al., 2013; 
Park and Katze, 1995). Another possibility is that NS1 binds segment 7 mRNA via its 
poly(A) tail. An interaction between NS1 and poly(A) sequences of cellular and viral mRNAs 
has been demonstrated and postulated to result in the inhibition of nuclear export of all 
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mRNAs containing a poly(A) tail, including viral mRNAs (Qiu and Krug, 1994). However, 
the results obtained in Chapter 2 point in a different direction, as the presence of NS1 could 
not rescue the nuclear export of segment 7 mRNA when it contained a poly(U) tail. This 
indicated that a poly(A) tail is in fact required for NS1 to be able to promote the nuclear 
export of segment 7 mRNA (Figure 2.7), either because NS1 binds to this mRNA sequence 
directly to promote rather than inhibit viral mRNA export or perhaps because NS1 needs to 
interact with a cellular factor that associates with a poly(A) tail. NS1 protein was later 
proposed to inhibit cellular, but not viral, mRNA formation by targeting CPSF30, a subunit of 
CPSF. Binding of NS1 to this subunit was shown to prevent CPSF from interacting with host 
pre-mRNAs, thereby inhibiting their 3’ cleavage and subsequent polyadenylation (Nemeroff 
et al., 1998). NS1 has also been shown to interfere with the cellular 3’ end processing 
machinery via targeting the poly (A) binding protein II (PABPII) resulting in the inhibition of 
the elongation of poly(A) tails catalysed by poly(A) polymerase (PAP) (Chen et al., 1999). 
Therefore although a positive function of an NS1-poly(A) tail during viral mRNA export 
cannot be ruled out, further work should probably prioritise the functional significance of the 
published interactions between NS1 and the 5’UTR of segment 7 mRNAs (Marc et al., 2013; 
Park and Katze, 1995) for nuclear export. 
 
The IAV strain used here was PR8, a strain that expresses an NS1 that lacks the ability 
to bind CPFS30 (Kochs et al., 2007). When selecting the panel of NS1 mutations to be 
examined in the context of segment 7 mRNA export, an NS1 mutant that would allow testing 
for an interplay between effects on cellular polyadenylation and viral mRNA export was 
included. This NS1 protein had two substitutions: phenylalanine was replaced by serine at 
position 103 and methionine was substituted by isoleucine at position 106 resulting in the 
NS1-(S+I) mutant protein. These mutations were previously demonstrated to restore the 
ability of PR8 NS1 to bind CPSF30 and thereby inhibit cellular mRNA polyadenylation 
(Kochs et al., 2007). Work carried out by other members of the Digard laboratory showed that 
these mutations did indeed confer the expected shut-off activity on the NS1 clone used here 
(personal communication, Dr Liliane Chung). The NS1-(S+I) mutant gave positive results for 
all tested activities regarding mRNA nuclear export. Segment 7 mRNA was found in the 
cytoplasm in the presence of NS1-(S+I) and the latter was able to interact with NXF1, 
segment 7 mRNA and to promote the interaction between NXF1 and segment 7 mRNA 
(Figures 3.1, 3.3, 3.5, 3.7 and 3.8). However, the restoration of NS1 binding ability to 
CPSF30 did seem to have an effect on NS1-mediated segment 7 mRNA cellular localisation; 
it appeared to actually improve the efficiency of mRNA nuclear export. Although segment 7 
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mRNA was clearly found in predominantly in the cytoplasm upon the presence of WT NS1 
and NS1-(S+I), less nuclear staining was found in cells either transfected or infected with 
NS1-(S+I) (Figures 3.1 and 3.3). Furthermore, the interaction between NS1-(S+I) and NXF1, 
as well as the interaction between NXF1 and segment 7 mRNA, appeared to be somewhat 
enhanced by NS1-(S+I) when compared to WT NS1 (Figures 3.5 and 3.7). However, the 
reasons behind this were not explored as the focus was more directed at understanding what 
caused NS1 mutants to fail to promote nuclear export of segment 7 mRNA rather than 
enhance it. In addition, the proposed phenotype of improved activity of the NS1-(S+I) mutant 
remained qualitative, as attempts to provide more quantitative data for the RNA pulldown 
assays (by densitometry of the various autoradiograms) were defeated by the technical 
difficulty of the assays and the consequent inherent variability of the data. Nonetheless, it is 
conceivable that NS1 binding CPSF30 favours the nuclear export of viral mRNAs by 
increasing the availability of components of the cellular mRNA export machinery. Since the 
interaction between NS1 and CPSF30 interferes with the 3’ end processing of cellular 
mRNAs, resulting in the inhibition of their export (Nemeroff et al., 1998), viral mRNAs 
might have less competition for cellular factors involved in mRNA nuclear export. 
 
 Given that the initial take on the requirement of the effector domain of NS1 was based 
on the introduction of a mutation that deleted the entire domain, a second set of NS1 mutants 
was used to study this function of the domain in connection with mRNA nuclear export in 
greater detail. Firstly, a preliminary panel of NS1 proteins carrying mutations in the effector 
domain that was already available in the Digard laboratory was screened. Based on the 
expression levels of these NS1 mutant proteins and their effect on segment 7 mRNA 
localisation, four NS1 mutants with the most stable protein expression and clearest export 
phenotype were selected for further examination. Two of the mutations inhibited the ability of 
NS1 to activate the PI3K pathway by blocking its interaction with the p85β regulatory subunit 
of PI3K (Shin et al., 2007): NS1-Y89A (Aramini et al., 2011; Lopes et al., 2017)  and NS1-
Y89F (Hale et al., 2006). The third, NS1-E96/7A, blocked the ability of NS1 to suppress 
TRIM25-mediated RIG-I signal transduction, resulting in the inhibition of host IFN response 
and attenuated virulence in mice (Gack et al., 2009). Finally, the fourth mutation, NS1-
W187R prevented NS1 dimerisation via its effector domain (Hale et al., 2008a). Cells 
containing an NS1-W187R mutant displayed segment 7 mRNA in the cytoplasm (Figures 3.9 
and 3.10), indicating that NS1 dimerisation via its effector domain is not required for this 
protein to mediate efficient mRNA nuclear export, although it is worth noting that NS1 
dimerization via the RNA-binding domain has also been reported (Kerry et al., 2011a). 
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Conversely, in the presence of both PI3K NS1 as well as the TRIM25 mutants, segment 7 
mRNA was found to be retained in the cell nucleus (Figures 3.9 and 3.10). These results 
could indicate that the activation of the PI3K signalling pathway and/or the inhibition of the 
interaction between NS1 and TRIM25 are somehow involved in facilitating viral mRNA 
nuclear export. An attempt was made to determine the effect of small-molecule inhibition of 
PI3K signalling on segment 7 mRNA localisation in cells infected with WT PR8. 
Unfortunately, results were inconsistent (data not shown) which prevented any conclusions 
being drawn. Alternatively, the mutated residues could in parallel disrupt a potential binding 
site for another cellular factor participating in the viral mRNA nuclear export pathway. This 
could be either because the residues are critical for this other interaction or perhaps due to 
conformational changes that would abolish the binding site of this other NS1 binding partner. 
 
Thus, the question of whether this second panel of NS1 mutants were able to support 
the interactions or lack thereof that had been previously established for the RNA-binding 
domain mutants and NS1-N81 was investigated. It was found that NS1-W187R behaved as 
expected for a protein capable of supporting segment 7 mRNA nuclear export. As with WT 
NS1, NS1-W187R was able to interact with NXF1 and to promote the interaction between 
NXF1 and segment 7 mRNA (Figures 3.12 and 3.13). More surprising however, was the 
observation that both the PI3K and the TRIM25 NS1 mutant proteins were able to interact 
with NXF1 (Figure 3.12) even though they failed to promote the efficient nuclear export of 
segment 7 mRNA. Curiously, export-incompetent TRIM25 mutant NS1-E96/7A, similarly to 
WT NS1 and NS1-W187R, was capable of promoting the interaction between NXF1 and 
segment 7 mRNA. Determination of whether these NS1 effector domain mutant proteins were 
capable of interacting with segment 7 mRNA was also attempted. However, results from 
those experiments showed substantial variability in their outcome and provided no confidence 
in determining the presence or absence of interactions (data not shown). Hence, these data 
were not included in this dissertation.  
 
The results that were obtained reproducibly, however, were unexpected but very 
interesting. On the one hand, they further confirmed and established that both functional 
domains of the NS1 protein are required for it to retain its mRNA export function. While it 
was not possible to pinpoint how many residues or regions needed to be kept intact within the 
effector domain, it was shown that at least substitutions at positions 89 and 96-97 resulted in 
segment 7 mRNA nuclear retention. It is worth noting that it was not possible to discern 
whether the mRNA nuclear retention observed in the presence of the mutant proteins was 
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residue substitution-specific or in any way connected with the other NS1 functions relying on 
the same residues. To date (to the best of my knowledge), no direct link has been 
demonstrated between either the activation of the PI3K signalling pathway activation or 
TRIM25 inhibition and IAV mRNA nuclear export.  
 
On the other hand, these results demonstrate that while the interactions between NS1 
and NXF1 and NXF1 and segment 7 mRNA are required for the efficient export of segment 7 
mRNA, they are not sufficient. Indeed, it is possible that a mutant NS1 protein can bind 
NXF1 and promote its interaction with segment 7 mRNA while still failing to perform its role 
in facilitating mRNA nuclear export. The realization that one or more other interactions 
would be necessary to complete the mRNA nuclear export mechanism as a whole was not 
surprising as the involvement and requirement of other cellular factors has been demonstrated 
or suggested before (Amorim et al., 2007; Bier et al., 2011; Mor et al., 2016; Read and 
Digard, 2010; Satterly et al., 2007; Wang et al., 2008). However, data presented in this 
chapter suggests that the role of NS1 itself in this mechanism is not limited to its interaction 
with NXF1 as perhaps indicated by the analysis of the first set of NS1 mutants. It is instead 
probable that NS1 mediates a further interaction or recruits an additional cellular component 
possibly, but not necessarily, downstream of its interaction with NXF1 in order to fulfil its 
function of promoting segment 7 RNA nuclear export.  
 
The findings presented in this chapter show that, in order to be export-competent, NS1 
is required to interact with NXF1, with segment 7 mRNA and to promote the interaction 
between NXF1 and segment 7 mRNA. However, these interactions were not sufficient and an 
attempt was made to identify another cellular factor that would be required to interact with 
NS1 and that could be correlated to its ability to promote mRNA nuclear export. When 
examining the protein profiles of cellular polypeptides that co-purified with one of the entire 
panel of NS1 mutants during GFP-trap pulldowns, it was found that they appeared to be 
generally the same and not much variation was seen in band intensity or presence/absence of 
minor polypeptide species when comparing all the mutants (Figure 3.14). However, the one 
notable, observable to the naked eye upon visualization of the Coomassie stained gel, 
difference was the appearance of one extra band in cells transfected with the TRIM25 NS1 
mutant, that was absent from all the other samples. Mass spectrometry analysis revealed that 
this band corresponded to hsp70. This could indicate that this protein is malfolded which 
could explain its lower expression levels (Figure 3.11A). One report has shown that hsp70 
induction is suppressed in cells infected with IAV, by inhibiting the cleavage of hsp70 pre-
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mRNAs at the polyadenylation site (Shimizu et al., 1999). Results from this study supported 
the argument that viral infection induced the shut off of host gene expression by interfering 
with the 3’ end processing of pre-mRNA, but no connection was made between hsp70 
suppression and viral mRNA export. However, in this same study a temperature sensitive 
Udorn NS1 mutant was found to not inhibit the hsp70 pre-mRNA cleavage at 40 ºC in MDCK 
cells. Interestingly, when the mutations responsible were examined, two base changes were 
identified, one at base 62 that did not cause a residue change and another at base 316 that 
caused an amino acid change at residue 96, one of the residues mutated in the PR8 NS1-
E96/7A that was found to interact with hsp70 in 293T cells. It is not clear if this is 
functionally relevant to the studies presented here, but the coincidence is intriguing. 
 
 The interaction observed between NS1-E96/7A and hsp70 could merely indicate that 
the protein is not properly folded, as hsp70 is associated with assisting with multiple protein 
folding processes (Mayer and Bukau, 2005). Recently, a report has shown that hsp70 can 
suppress protein aggregation by protecting partially folded and unfolded protein chains, affect 
late stages of protein folding and that it can both stabilise and destabilise folded structures in a 
nucleotide-dependent manner (Mashaghi et al., 2016). It is thus not clear what the 
implications of NS1 interaction with hsp70 could be and discerning if this interaction is 
significant would need more detailed studies in the future. Nevertheless, this interaction could 
be meaningful as it was present with the single mutant NS1 protein studied in this dissertation 
that could interact with NXF1 and promote the interaction between NXF1 and segment 7 
mRNA yet failed to promote the efficient export of segment 7 mRNA. It can be speculated 
that the interaction between NS1 and hsp70 results in a change in the conformation of NS1 
that while still allowing for its interaction with NXF1, perhaps interferes with its ability to 
interact with another factor necessary to complete the mRNA export mechanism. 
Alternatively, residues 96 and 97 of NS1 could be part of the binding site for another 
interacting partner playing a role in segment 7 mRNA export and mutation of these residues 
would result in hsp70 outcompeting this partner for the binding site. It would be interesting to 
test the effects of the growing numbers of small molecule inhibitors of hsp70 now available 
(Chatterjee and Burns, 2017) on the behaviour of the NS1-E96/7A mutant, though the 
likelihood of pleiotropic effects might be high. 
 
The analysis of the overall expression profiles of cells presenting the various NS1 
mutants did not point towards major differences that could be correlated to the ability or lack 
thereof of NS1 promoting the efficient nuclear export of segment 7 mRNA. Hence, an attempt 
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was made to analyse the ability of NS1 to interact with the most obvious suspects involved in 
cellular mRNA export. During mRNA synthesis and processing, IAV transcripts interact with 
multiple cellular proteins (York and Fodor, 2013) and many of them could play a role in the 
NS1-mediated viral mRNA export. Cellular proteins NXF1, Nxt1, Rae1 and E1B-AP5 have 
been reported to interact with NS1 (Satterly et al., 2007). Together with Nup98, these cellular 
factors were previously shown to be able to form a complex (Blevins et al., 2003). The same 
study proposed that Rae1 could deliver NXF1 to Nup98 representing the first of several 
interactions between an export complex and a nucleoporin that would ultimately result in the 
nuclear export of cellular mRNAs. Furthermore, reduction of UAP56 and NXF1 were shown 
to inhibit the mRNA nuclear export of several IAV segments (Read and Digard, 2010). 
Results indicated that neither of the NS1 mutant proteins studied in this Chapter were able to 
interact with UAP56 (Figure 3.15), even though the lack of this factor was shown to strongly 
inhibit nuclear export of both spliced and unspliced segment 7 mRNAs (Read and Digard, 
2010). Alternatively, the known interaction between NP and UAP56 (Momose et al., 2001) 
may be functionally relevant here. Furthermore, Nup 62 was detected, albeit in low amounts 
in cells transfected with all NS1-mutants, but not with GFP, indicating that NS1 can bind this 
nucleoporin, even if weakly (Figure 3.15). However, since all NS1 mutants could support this 
interaction, it does not seem to be correlated with the ability of NS1 to promote efficient 
nuclear export of segment 7 mRNA.  
 
 Despite the long list of candidate proteins, the spectrum of the analysis was very 
limited. One of the main reasons for this was that the work was restricted by available 
reagents. For instance, several attempts were made to study a potential interaction between 
NS1 and Nxt1, the co-factor of NXF1 (Herold et al., 2001; Suyama et al., 2000), both in IF as 
well as in western blotting. However, despite testing many different commercial antibodies, it 
was not possible to obtain specific detection of this cellular factor in multiple assays. Similar 
difficulties were encountered when attempts to test the interaction between NS1 and UIF, 
PABP1, Aly and Nup98. It was not possible to gather conclusive information as whether these 
proteins could interact with NS1 as antisera against them either failed to show specificity or 
failed to work reproducibly. It is also worth noting that a potential shortcoming of this assay 
and the overall expression profile of cells transfected with NS1 mutant proteins was that it 
was not done in the context of viral infection. Samples lacked all IAV components except 
NS1 and it is therefore possible, or perhaps even probable, that, potential differences in the 
expression profiles or interactions were missed. For instance, specific interactions of NS1 
associated with its role of promoting efficient segment 7 mRNA export may only be evident 
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in infected (or at least RNP-containing) cells, due to viral components being present that 
would trigger specific pathways/mechanism. One way to get around this would be to infect 
cells with the NS1-N81 mutant virus following the transfection of cells with the GFP-tagged 
NS1 mutant proteins. However, this mutant still produces a truncated form of NS1 containing 
the RNA-binding domain which could possibly maintain interactions and mask the phenotype 
of the other mutations under study. Alternatively, the minireplicon assay could be used 
although this assay would also not mimic a viral infection and again, important interactions 
that occur during infection could be missed. Hence, the list of possibilities for protein 
associated to the cellular mRNA export machinery that could intervene in IAV mRNA export 
via NS1 continues to be extensive. It would be interesting for studies to continue in order to 
identify NS1 partners in the mRNA nuclear export mechanism. Since it was shown in this 
Chapter that the participation of NXF1 in connection with NS1 is required but not sufficient, 
it can be speculated that a further unknown cellular (or even viral) component would act 
downstream of NS1 interacting with NXF1.  
 
Both in Chapter 2 and in this Chapter, NS1 was established as a viral requirement for 
the efficient nuclear export of segment 7 mRNA to occur. However, it was observed in both 
Chapters that, upon infection with NS1-N81, even though segment 7 mRNA was found 
markedly retained in the nucleus, significant levels of segment 7 gene products, M1 and M2 
were expressed (Figures 2.9, 3.2 and 3.4). Moreover, results described in this Chapter, 
showed that similarly, all NS1 point mutants that resulted in a clear nuclear retention of 
segment 7 mRNA were also able to produce both M1 and M2 proteins, although at lower 
levels when compared to export-competent NS1 mutants (Figures 3.2, 3.4, 3.11). This 
indicates that some mRNA is able to be exported to the cytoplasm for translation via a 
mechanism that does not rely on NS1. The shift in cellular localisation of segment 7 mRNA 
in the absence of NS1 when compared when WT NS1 protein is present is evident, suggesting 
that the mechanism involving NS1 in the mRNA nuclear export is more efficient and is 
favoured in a viral infection. Nonetheless, a different, NS1-independent mRNA, export 
mechanism must be used when NS1 is lacking or has not been produced at sufficient levels in 
early stages of infection. This is consistent with the fundamental observation that NS1 is a 
nonessential viral gene in cell culture whose loss nevertheless attenuates viral replication even 
in interferon-deficient systems (Garcia-Sastre et al., 1998). Moreover, the reduction in M1 
accumulation that we observed is in line with the decreases in late gene expression noted in 
many previous studies of NS1 mutants (Egorov et al., 1998; Enami and Enami, 2000; Falcon 
et al., 2004; Garaigorta et al., 2005; Hatada et al., 1990; Salvatore et al., 2002). The low-
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efficiency export of M1 mRNA in the absence of NS1 may be attributable to direct 
recruitment of the export apparatus through interactions with the nuclear cap-binding complex 
(Bier et al., 2011). Moreover, a degree of redundancy in cellular factors recruited for viral 
mRNA export has precedents from other viral systems (Jackson et al., 2011). Even though 
studying the mechanism of mRNA nuclear export in the absence of NS1 was not pursued in 




Figure 3.16 – Cartoon model synthesising results of Chapter 2. Demonstrated interactions are represented by a 
black arrow while hypothesised interactions are represented by grey arrows. A) Interactions shown to be 
required for efficient segment 7 mRNA nuclear export to occur. These interactions were identified between NS1 
and segment 7 mRNA, NS1 and NXF1 and NXF1 and segment 7 mRNA via NS1. An NS1 protein capable of 
promoting segment 7 mRNA efficient nuclear export must support all three interactions. B) It is however 
possible for an NS1 mutant protein to comply with the above mentioned requisites and still be unable to carry 
out its export function. Hence, it is likely that an additional and unknown factor is also required for this export 
mechanism to be successful. C) The identification of hsp70 as interacting solely with NS1-E96/7A could shed 
further light onto the mRNA export mechanism as it may be the reason for segment 7 mRNA export to be 
blocked despite being able to support the interactions indicated in A). The block could be due to a 
conformational change induced by hsp70 or by the interaction masking the interaction site for another factor 
playing a role in this mRNA export mechanism. 
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Overall, in this Chapter, the role of NS1 in promoting the efficient nuclear export of 
segment 7 mRNA was further validated. The main findings and proposed mechanisms are 
depicted and summarised in Figure 3.16. The interactions between NXF1 and NS1, NS1 and 
segment 7 mRNA and NXF1 and segment 7 mRNA in the presence of NS1 were shown to be  
required for the efficient export of segment 7 mRNA (Figure 3.16A). However, since despite 
being necessary, those interactions were shown not to be sufficient, suggesting that NS1 must 
partake in further interaction(s) or recruit a further component(s) to complete its function in 
viral mRNA nuclear export (Figure 3.16B). Finally, the identification of hsp70 as the unique 
interacting partner of an NS1 mutant protein that could support all the studied interactions and 
yet was unable to promote segment 7 mRNA nuclear export (Figure 3.16C) should not be 
dismissed. It is possible that this interaction either induces a conformational change of NS1 
preventing it from interacting with another factor required for export or that hsp70 
outcompetes other factors for the binding site that includes mutated residues 96 and 97 of 
NS1.  
In conclusion, we propose that NS1 acts as an adaptor protein through, but not only, 
its interaction with segment 7 mRNA and NXF1, the main component of the major cellular 




CHAPTER 4 – THE ROLE OF NS1 IN THE NUCLEAR 
EXPORT OF OTHER SEGMENT mRNAs 
_________________________________________________________________________ 
4.1 Introduction 
 The data described in the two previous chapters of this dissertation identified NS1 
protein of IAV as a viral requirement for the efficient nuclear export of segment 7 mRNA and 
that in order for NS1 to be an export-competent protein: 1) both functional domains of the 
protein must be present; 2) NS1 must be able to interact with NXF1; 3) NS1 must be able to 
bind segment 7 mRNA; and 4) NS1 must be able to promote the interaction between segment 
7 and NXF1. While these findings shed light on the mechanism used for the nuclear export of 
M1 mRNA, how the mRNAs of other IAV segments were exported remained unclear. Studies 
reporting that different IAV mRNAs present different requirements concerning cellular 
factors for their successful nuclear export suggested that segment-specific mechanisms might 
be in play (Amorim et al., 2007; Larsen et al., 2014; Read and Digard, 2010). For instance, 
when the ongoing activity of RNAP-II was identified as being required for IAV mRNA 
nuclear export, segment 7 transcripts were found to be more sensitive to RNAP-II inhibition 
than segment 5 mRNA (Amorim et al., 2007). Later, a strong dependence on NXF1 was 
found for the mRNAs of segments 7 and 4 while intronless, early gene mRNAs, especially 
segment 5, showed the least degree of dependence (Read and Digard, 2010). In addition, cell 
type has also been proposed to affect the extent to which NXF1 activity is required (Larsen et 
al., 2014). Taking these studies into consideration, it seemed unwise to generalise the data 
obtained in the two previous chapters across all IAV mRNAs and all cell types. These aspects 
were therefore addressed in this chapter; in particular the role of NXF1 in the context of 




4.2.1 Analysis of viral replication and protein expression in cells infected with 
WT PR8 or NS1-N81  
 In chapters 2 and 3, reduced levels of M1 and M2 protein expression in the absence of 
intact NS1 were associated with less efficient nuclear export of segment 7 mRNA. 
Examination of HA accumulation in cells infected with the NS1-N81 virus (using control 
untreated material from a previous experiment that examined the effect of spliceostatin on 
segment 7 expression; Figure 2.9) also showed a decreased accumulation of HA but not NP 
(Figure 4.1A). Furthermore, examination of HA mRNA levels from the corresponding 
experiment by radioactive primer extension indicated that this was not due to lower levels of 
segment 4 transcription (Figure 4.1B). These data were therefore suggestive of a role for NS1 





Figure 4.1 Accumulation of segment 4 gene product and mRNA in infected cells. 293T cells were mock infected 
or infected with WT or NS1-N81 viruses at an M.O.I. of 5. A) At 6 h p.i., cell lysates were harvested in 
Laemmli’s sample buffer and subsequently analysed by SDS-PAGE and western blotting for the indicated 
proteins. B) At 6 h p.i., cells were collected and total RNA was isolated and analysed by radioactive reverse 
transcriptase using primers specific for segment 4 mRNA and cellular 5S rRNA, followed by urea-PAGE and 
autoradiography. Please note that NS1, NP and tubulin levels shown in panel A correspond to the same 
experiment and data presented in panel B of Figure 2.9.  
 
 
However, lower levels of any or all viral proteins produced by NS1-N81 could be due 
to the virus replication being delayed as opposed to being completely unable to promote the 
efficient nuclear export of selected viral mRNAs. Since the cellular localisation of segment 7 
mRNA in the context of viral infection was typically determined at 6 h p.i., it was important 
to compare WT and NS1-N81 growth kinetics and protein synthesis over time, beyond the 6 h 
p.i. time point for both WT PR8 and NS1-N81. For this purpose, single cycle growth curve 
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assays were performed. MDCK cells were either infected with WT PR8 or NS1-N81 at an 
M.O.I. of 3 and samples were collected after 1 h of adsorption (defined as 0 h p.i.) and then at 
various times p.i.. The titres of both viruses were determined for each time point by plaque 
assays. At 0 h p.i. the titre for both WT PR8 and NS1-N81 were the same, confirming that the 
same inoculum was used for both viruses (Figure 4.2A) and at 4 h p.i., the titre of both 
viruses were also very similar. At 6 h p.i. however, the titre determined for NS1-N81 was 10-
fold lower than the one obtained for WT PR8 (Figure 4.2, compare red and black lines) 
indicating that NS1-N81 replicated more slowly compared to WT PR8. This lag increased 
over time and was largest at 12 h p.i. when the titre of NS1-N81 was 100-fold lower than the 
titre of WT PR8. While WT PR8 titres peaked at 12 h p.i., NS1-N81 virus peaked at 24 h p.i. 
when it registered a titre similar to WT PR8. The ability of NS1-N81 to (slowly) reach WT 
levels of titre could mean that the mutant virus was merely delayed in its replication kinetics 
and was nevertheless able to catch up over time. Alternatively, the NS1-N81 protein could 
have reverted to WT NS1 over time during infection, which (as explained in the Materials and 
Methods section) was (a) an occasional problem and (b) not surprising as only one nucleotide 
was changed to introduce a stop codon and produce the truncated NS1-N81 protein. However, 
protein analysis over time would verify if NS1-N81 was indeed delayed or if there was a 
reversion of the NS1 mutation, or possibly, a combination of both effects. 
To this end, 293 T cells were either mock infected or infected with WT PR8 or NS1-
N81 viruses at an M.O.I. of 5. Cells were harvested at 3, 4.5, 6, 8 and 10 h p.i., to cover an 
entire IAV replication cycle that typically takes 8 h, and analysed by western blotting.  
 In mock infected cells collected at 10 h p.i., only the cellular protein tubulin could be 
detected, confirming the lack of a viral infection throughout the entire course of the 
experiment (Figure 4.2B, lane 1). Tubulin levels were reasonably similar for both viruses at 
the same time points, with the exception of lower levels detected at 3 h p.i. for both viruses, 
most likely because of a technical error. Overall, in both viruses, it was possible to observe an 
increase of viral protein levels over time as would be expected during the course of an 
infection. NP accumulation kinetics were similar between the two viruses, while NS2 levels 
were higher in the NS1 mutant than in the WT virus; otherwise viral proteins were generally 
lower in cell infected with NS1-N81 especially at earlier times post infection before 8 h p.i.. 
Consistent with previous data in this thesis, M1 and M2 accumulation remained lower than in 
WT infection even at 10h p.i.. In contrast, expression of a polymerase protein, PB1, reached 
apparently normal levels by the end of the time course. HA accumulation followed a more 
complicated pattern, with readily detectable amounts visible at 3 h p.i., presumably reflecting 
detection of input material from the high MOI inoculum, as levels then declined at 4.5 h p.i.. 
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In WT virus, amounts then increased again with a maximum at 6 h p.i., whereas the NS1-N81 
virus showed more gradual accumulation kinetics in which levels slowly increased to 10 h 




Figure 4.2 Viral kinetics and viral protein expression analysis over time. A) Growth curves of WT and NS1 
mutant virus NS1-N81. MDCK cells were infected with WT PR8 or NS1-N81 viruses at an M.O.I. of 3. 
Supernatants were collected after 1 h of adsorption (0 h p.i.) and at 4, 6, 8, 12, 24 and 48 h p.i.. Viral titres were 
determined by plaque assays. Data plotted are the mean ± range of two independent experiments. B) 293T cells 
were mock infected or infected with WT or NS1-N81 viruses at an M.O.I. of 5. Samples were harvested at 3, 4.5, 




even at low levels at 3 h p.i. and from 4.5 h p.i. onwards, at steady high levels, consistent with 
it being considered an early protein (Inglis and Mahy, 1979; Skehel, 1972). However, it was 
also possible to detect full-length NS1 protein in cells infected with NS1-N81, although at 
noticeably lower levels than WT PR8 at all time points examined. NS1-N81 mutant virus 
should produce a truncated and thus faster-migrating NS1 protein that lacks the effector 
domain. This indicated that the mutation introducing a stop codon at position 82 of NS1 was 
reverting during infection in this experiment. Although this reversion of the NS1-N81 
mutation was not intended nor desired, the levels of NS1 were still remarkably lower when 
compared to WT PR8, indicating that the differences in accumulation kinetics of the various 
viral polypeptides could still be considered to reflect a lack of normal NS1 expression. 
Overall, the data suggested that a more detailed time course analysis of viral mRNA 
localisation was worthwhile. 
 
 
4.2.2 Cellular localization of segments 7 and 5 in the presence and absence of 
intact NS1 
Thus far in this dissertation, the cellular localisation of segment 7 mRNA was 
determined typically at 6 h p.i. using FISH as described previously (Amorim et al., 2007). 
This time point was useful and sufficient to observe shifts in the localization of segment 7 
mRNA from the nucleus to the cytoplasm depending on the nature of the NS1 protein present, 
but nonetheless, observing the cellular localisation of viral mRNAs over time could provide 
further information on the timing of mRNA export and how it differed depending on whether 
intact NS1 was present or absent. In addition, studying the mRNA nuclear export of other 
IAV segments was another aim of this dissertation and, particularly, the present chapter.  
To address these questions, 293T cells were mock infected or infected with WT PR8 
or NS1-N81 at an M.O.I. of 5 in multiple sets. Cells were fixed at 3, 4.5, 6, 8 and 10 h p.i. 
before being processed for FISH using a fluorescently labelled RNA probe to detect either 
segment 7 or segment 5 positive sense RNA molecules. In mock infected cells, no signal was 
detected for segment 7 (Figure 4.3, red) or segment 5 (Figure 4.3, green) mRNAs, 
confirming probe specificity. As with data in the previous chapters, segment 7 mRNA was 
cytoplasmic in WT PR8 infection but retained in the cell nucleus in the presence of NS1-N81 
at 6 h p.i.. The time course data new to this experiment showed that at 3 h p.i., segment 7 
mRNA was already detectable mostly in the nucleus, both with WT PR8 and NS1-N81 
viruses. However, at 4.5h the shift from nuclear to cytoplasmic localisation was evident, but 
not complete, in cells infected with WT PR8 while the mRNA was still markedly retained in 
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the nucleus in cells infected with NS1-N81. This scenario was maintained up to 8 h p.i. and 
was clearest at 6 h p.i.. At 10 h p.i., segment 7 mRNA was detectable in the cytoplasm of 
some cells infected with NS1-N81, which could be due to reversion of this mutant virus 
and/or slow non-NS1 dependent mRNA export. Curiously, the opposite appeared to happen in 
cells infected with WT PR8 at 10 h p.i., where more nuclear staining was observed, possibly 
due to a decreased intensity of cytoplasmic signal reflecting cytoplasmic mRNA degradation.  
 
 
Figure 4.3 Time course of segment 5 and 7 mRNA localisation during infection. 293T cells were mock infected 
or infected with WT or NS1-N81 mutant virus at an M.O.I. of 5. At the specified time points, cells were fixed 
and processed for FISH using fluorescently labelled RNA probes for positive sense viral RNAs of segment 7 
(red) or segment 5 (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS 




These results further confirmed that the absence of NS1 had an impact of the mRNA 
localisation of segment 7 and that this effect started early in infection and was maintained 
throughout the majority of a full replication cycle. Analysis of segment 5 mRNA localisation 
showed a strikingly different outcome however. Cells infected with WT PR8 presented 
segment 5 mRNA clearly in the cytoplasm, from an early infection stage at 3 h p.i. up until 
later stages at 10 h p.i. (Figure 4.3 green). This was expected and had been reported 
previously (Amorim et al., 2007; Read and Digard, 2010). However, in the presence of NS1-
N81, the mRNA of segment 5 was likewise found to localise clearly in the cell cytoplasm 
throughout the entire course of infection suggesting that the mechanism used for the nuclear 
export of segment 5 mRNA was independent of the NS1 effector domain. It could thus be 
concluded that in line with previous studies (Amorim et al., 2007; Larsen et al., 2014; Read 




4.2.3 Cellular localization of segments 2 and 4 in the presence and absence of 
intact NS1 
 Next, segment 2 and 4 mRNA localization were examined as above. Neither segment 
could be detected in mock infected cells confirming probe specificity (Figure 4.4). Early in 
infection, segment 2 mRNA signal was not detected at levels above background until 4.5 h 
p.i. both in cells infected with WT PR8 as well as with NS1-N81 (Figure 4.4, red). This was 
not surprising even though the gene product of segment 2, PB1, is considered an early protein, 
given the lower levels of mRNA produced by the P gene segments (Dalton et al., 2006; Robb 
et al., 2009; Smith et al., 1987). Thereafter, throughout the course of infection the signal from 
segment 2 mRNA became more intense but remained localised mostly to the cell nucleus both 
in cells infected with WT PR8 as well as with NS1-N81. This could indicate that the nuclear 
export of segment 2 mRNA was, similarly to segment 5, independent of the presence of the 
NS1 effector domain. However, the apparent localisation of segment 2 RNA mostly to the cell 
nucleus could also be a consequence of a proportionally greater detection of cRNA, as 
segment 2 mRNA and cRNA were previously reported to accumulate in similar amounts 
(Dalton et al., 2006; Robb et al., 2009). Analysis of segment 4 cellular localisation however 
showed a different outcome. Segment 4 mRNA could be easily detected as early as at 3 h p.i. 
in cells infected with both viruses and already at that time point dissimilarities in the mRNA 
localisation were evident (Figure 4.4, green). In cells infected with WT PR8, HA mRNA was 
found in the cell cytoplasm and this phenotype was maintained over time. Conversely, cells 
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infected with NS1-N81 displayed segment 4 mRNA in the nucleus up until 6 h p.i.. Later in 
infection, at 10 h p.i., more cytoplasmic staining was detected in cells infected with NS1-N81 
which again, could be due to reversion of the mutant virus occurring during the course of 
infection, and/or to slowed mRNA export kinetics. Even if that was the case, more nuclear 
staining was found in cells infected with NS1-N81 when compared with WT, indicating that 
an intact NS1 was required for the efficient nuclear export of segment 4 mRNA. It could 
therefore be concluded that not all IAV mRNAs share the same mechanism to achieve nuclear 
export. While segment 5 and possibly segment 2 mRNA nuclear export appeared to happen in 
an NS1-independent fashion, the requirement of NS1 for the efficient nuclear export of 
segments 4 and 7 was evident. Consequently, it was proposed that NS1 was necessary for the 





Figure 4.4 Time course of segment 2 and 4 mRNA localisation during infection.. 293T cells were mock infected 
or infected with WT or NS1-N81 mutant virus at an M.O.I. of 5. At the specified time points, cells were fixed 
and processed for FISH using fluorescently labelled RNA probes for positive sense viral RNAs of segment 2 
(red) or segment 4 (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS 
analysis software. Scale-bar indicates 10 µm. 
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4.2.4 Effect of cell type on the IAV mRNA nuclear export and its dependence on 
NS1  
The confirmation that particular IAV mRNAs utilised different mechanisms to 
accomplish nuclear export was broadly in line with previous studies where IAV mRNAs were 
found to behave dissimilarly in this respect (Amorim et al., 2007; Larsen et al., 2014; Read 
and Digard, 2010). Another variable that could provide more insights onto the IAV mRNA 
nuclear export mechanisms was the cell type. Indeed, thus far in this dissertation, the study of 
mRNA cellular localization was done using 293T cells. This was due to transfection-based 
assays being more effective in these cells and all experiments involving the minireplicon 
system were based on this technique. Subsequent validation of phenotypes in the context of 
viral infection required using the same cell type in order to avoid introducing new variables. 
However, cell type has been shown to affect various processes of the IAV replication 
cycle, including mRNA nuclear export (Larsen et al., 2014; Lee et al., 2008). It was thus 
desirable to examine whether the NS1-(in)dependent localisation phenotypes of viral mRNAs 
seen in 293T cells would be reproducible in a different cell type. Accordingly, chicken 
embryo fibroblast DF-1 cells were mock infected or infected with WT PR8 or NS1-N81 
viruses at an M.O.I. of 5. Cells were fixed at 6 h p.i. and processed for FISH using 
fluorescently labelled RNA to target mRNAs of segments 2, 4, 5 and 7. None of the viral 
mRNAs could be detected in the mock samples confirming probe specificity in this cell type 
and determining background levels of staining (Figure 4.5). Analysis of segment 2 cellular 
localisation showed the viral RNA to localise both in the nucleus as well as in the cytoplasm 
in the presence of WT PR8 and NS1-N81, indicating that the absence of a WT NS1 protein 
did not obviously alter the localisation of mRNA and/or cRNA. Equally, segment 5 mRNA 
displayed the same localisation irrespective of which virus the cell had been infected with. 
However, instead of presenting a mixed phenotype as was the case for segment 2, segment 5 
mRNA was clearly located most predominantly in the cell cytoplasm, to the extent that the 
outlines of cell nuclei could be estimated by a void of staining in the centre of cells (Figure 
4.5). These results were in line with the phenotypes observed for segment 5 using 293T cells 
(Figure 4.3, green) which indicated that segment 5 nuclear export occurred independently of 
NS1. In contrast, the cellular localisation of segment 7 mRNA further validated the results 
that had been thus far obtained in 293T cells, with mRNA found mainly in the cytoplasm in 
cells infected with WT PR8 and markedly retained in the nucleus in cells infected with NS1-
N81. When examining the cellular localisation of segment 4 mRNA, a different phenotype 
was similarly seen depending on which virus was used for the infection assay. In cells 
infected with WT PR8, segment 4 mRNA was found mainly in the cytoplasm. Conversely, 
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cells infected with NS1-N81 displayed segment 4 mRNA mostly in the nucleus although 
some cytoplasmic staining could nonetheless be detected (Figure 4.5). In addition, the 
intensity of the signal was noticeably weaker in cells infected with NS1-N81, contributing to 
a striking difference in segment 4 localisation when compared to WT PR8 infected cells.  
Taken together, these findings validated the data obtained before in 293T cells. The 
mRNA of both segments 2 and 5 was found to be insensitive to the lack of an export-
competent NS1 protein. Moreover, and arguably more importantly, the role of NS1 in 
promoting the efficient nuclear export of segments 4 and 7 was demonstrated in another cell 




Figure 4.5 Localisation of IAV mRNAs in DF-1 cells in the presence or absence of a full-length NS1 protein. 
DF-1 cells were mock infected or infected with WT or NS1-N81 mutant virus at an M.O.I. of 5. At 6 h p.i., cells 
were processed for FISH using fluorescently labelled RNA probes for positive sense viral RNAs of the indicated 
segments. Images were captured using a Leica-TCS confocal microscope and Leica TCS analysis software. 




Since the cellular localisation phenotypes for segments 4 and 7 were similar in regards 
to their dependence on an export-competent NS1 protein, it was plausible to hypothesise that 
these two segments used the same export mechanism. Hence it was decided to focus on 
segment 4 mRNA nuclear export in greater detail in an attempt to better understand its nuclear 
export requirements. Firstly, to further test the effect of cell type on mRNA localisation, A549 
cells were mock infected or infected with WT PR8 or NS1-N81. Cells were fixed at 6 h p.i. 
and processed for FISH using fluorescently labelled RNA probes targeting either IAV 
segment 4 or 7 (Figure 4.6). As expected, segment 7 mRNA was found clearly to localize in 
the cytoplasm upon infection with WT PR8 and in the nucleus when cells were infected with 
PR8 NS1-N81 (Figure 4.6, purple). Segment 4 mRNA localisation phenotype was also as 
expected for the PR8 pair of viruses as it was cytoplasmic in the presence of a WT NS1 
protein but nuclear in the presence of the export-incompetent truncated version of NS1 
(Figure 4.6, red).  
Overall, these results allowed validating the role of NS1 in promoting the efficient 




Figure 4.6 Cellular localisation of mRNAs from segments 4 and 7 in A549 infected cells in the presence or 
absence of a full-length NS1 protein. A549 cells were mock infected or infected with WT or NS1-N81 mutant 
PR8 viruses at an M.O.I. of 5. At 6 h p.i., cells were processed for FISH using fluorescently labelled RNA 
probes for positive sense viral RNAs of segment 4 (red) and 7 (purple) Images were captured using a Leica-TCS 
confocal microscope and Leica TCS analysis software. Scale-bar indicates 10 µm. 
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4.2.5 Cellular localisation of minireplicon-generated segment 4 mRNA in the 
absence and presence of NS1 
 The data above suggested that both segment 4 and 7 mRNAs required NS1 for their 
successful nuclear export. In order to further examine if the requirements for segment 4 
mRNA nuclear export matched those established for segment 7 mRNA, the minireplicon 
assay was used with the objective of determining the cellular localisation of segment 4 mRNA 
in the complete absence of NS1, as well as testing the effect of the sole addition of NS1.  
To this effect, 293T cells were transfected with plasmids encoding for the three 
polymerase subunits, NP, a viral template for segment 4 and either EGFP, NS1-EGFP or 
NS2-EGFP. Cells were fixed at 24 h p.i. and processed for FISH using a fluorescently 
labelled RNA probe targeting segment 4 mRNA. Since the negative control lacking the PB2 
polymerase subunit used in this experiment did not include EGFP, this sample was further 
subjected to IF targeting NP protein. The cellular localisation of the various fluorophores was 
then observed via confocal microscopy (Figure 4.7A) and cells were scored according to  
where segment 4 mRNA was predominantly found (Figure 4.7B). The 2PNP negative control 
sample displayed NP protein in the cell cytoplasm confirming cell transfection while segment 
4 mRNA signal could not be detected (Figure 4.7A). In the presence of EGFP alone, segment 
4 mRNA could be found retained in the cell nucleus (~50% of cells), in the cytoplasm (~30%) 
or both (~20%) (Figure 4.7A and B). Thus while the mRNA was still found to be nuclear in a 
substantial percentage of cells, the nuclear retention phenotype of segment 4 in the absence of 
NS1 was not as strong as the one observed for segment 7 (compare with Figure 2.3). A 
similar outcome was obtained when assessing the localisation of segment 4 mRNA in the 
presence of NS2-EGFP. In this case, a lower percentage (~20%) of cells was found to present 
segment 4 mRNA in the cell cytoplasm. The majority of the cells scored displayed segment 4 
mRNA either in the nucleus (~50%) or both in the nucleus and the cytoplasm (~20%) (Figure 
4.7A and B). As before, the nuclear retention of segment 4 in the presence of NS2 was not as 
strong or clear as the one observed with segment 7 in the presence of NS2 (Figure 2.3). In the 
presence of NS1-EFGP however, segment 4 mRNA could be found almost entirely (~95%) in 
the cytoplasm of individual cells, with only a small percentage of cells displaying the mRNA 
both in the cytoplasm as well as inside the nucleus (5%). No cells displaying segment 4 
mRNA retained in the nucleus were found upon the addition of NS1-EGFP in the 
minireplicon setting (Figure 4.7A and B). Overall, even though segment 4 mRNA was found 
to be more cytoplasmic without the addition of NS1 than segment 7, and despite a greater 
variability between individual cells, a very clear shift toward cytoplasmic localisation of HA 




Figure 4.7 Cellular localisation of segment 4 mRNA in the presence or absence of NS1 protein in transfected 
cells. A) 293T cells were co-transfected with plasmids to recreate segment 7 RNPs or, as a negative control with 
a combination that excluded a plasmid expressing PB2 (2PNP), together with either GFP alone or GFP-tagged 
plasmids expressing NS1 or NS2, as indicated. Cells were incubated at 37 ºC and processed for FISH analysis at 
24 h p.t. using a fluorescently labelled RNA probe for the detection of positive sense viral RNAs of segment 4 
(red) and GFP expression was detected by confocal microscopy (green). 2PNP transfected cells lacking GFP 
were stained by IF for NP (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS 
analysis software. Scale-bar indicates 10 µm. B) Individual cells were scored according to the predominant 
cellular localisation of segment 7 mRNA considering three phenotypes, nuclear, cytoplasmic or mixed. Values 
are the mean ± SEM from three independent experiments. 
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These results confirm that segment 4 mRNA required NS1 for efficient nuclear export, 
although perhaps with a lower degree of NS1 dependence when compared to segment 7 
mRNA.   
 
 
4.2.6 Analysis of the effect of NS1 on NXF1 interaction with segment 4 mRNA  
Previously in this dissertation, it was found that NS1 promoted the interaction between 
NXF1 and segment 7 mRNA (Figure 3.6). Hypothesising that both segments 7 and 4 
preferentially use the same mechanism of nuclear export involving the participation of NS1, 
the next question to ask was whether NS1 could also facilitate an interaction between NXF1 
and segment 4 mRNA.  
To test this, 293T cells were transfected with GFP-NXF1 along with the minireplicon 
basic set of plasmids encoding PB1, PB2, PA, NP and a viral RNA template for segment 4, 
with or without NS1. Cells were harvested and lysed at 48 h p.t. before being subjected to 
GFP-Trap pull down after saving aliquots of supernatant for total RNA and western blot 
analysis. RNA isolation was performed and examined by primer extension. The loading 
control 5S rRNA was found in similar amounts in material from total cell lysates, indicating 
that equivalent amounts of RNA were extracted from equal numbers of cells and was not 
detected in the bound fractions, as expected (Figure 4.8A, lanes 1-6). Likewise, segment 4 
vRNA could also only be detected in the total fractions, suggesting that NXF1 did not interact  
with this RNA species. Examination of segment 4 mRNA showed that it could not be detected 
in the negative control samples, confirming that the minireplicon assay was successful. While 
the mRNA was found in the totals fraction with or without NS1 as expected (Figure 4.8A, 
lanes 2-3), it was also clearly detected in the bound fraction, also both in the absence or 
presence of NS1 (lanes 5-6). More HA mRNA was precipitated in the presence of NS1 
(Figure 4.8, lane 6). However, more segment 4 mRNA was present in the total fraction in the 
presence of NS1 and the difference in band intensities in the two bound fractions was not such 
that it would allow a clear conclusion that NS1 promoted the interaction between NXF1 and 
segment 4 mRNA to be made.  
To complement this experiment, protein analysis of samples from the total fractions 
was also carried out (Figure 4.8B). The loading of comparable amounts of cell lysate was 
confirmed by the detection of equivalent amounts of tubulin. NP and GFP-NXF1 levels were 
also similar, indicating that transfection efficiency was equivalent in all samples. NS1 protein 
was detected in samples where the NS1 plasmid was included (lanes 1 and 3) but not in the 
sample where it was left out (lane 2). HA protein could not be detected in the 2PNP negative 
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control as expected (lane 1) and while it was present in cells transfected with GFP-NXF1 and 
the minireplicon set of proteins without NS1 (lane 2), the levels of its expression were 
noticeably higher in the presence of NS1 (lane 3). These results were in line with a role of 
NS1 in promoting the nuclear export of segment 4 mRNA as more mRNA being exported to 
the cytoplasm would normally result in higher amounts of protein being produced. Taken 
together, these data indicated that NS1 promotes the expression of HA without necessarily 
having a major effect on NXF1-segment 4 mRNA interactions. 
 
 
Figure 4.8 Analysis of the effect of NS1 on the interaction between NXF1 and segment 4 mRNA. 293T cells 
were transfected with plasmids to recreate segment 7 RNPs (3PNP+) or, as a negative control, with a 2PNP 
combination lacking a plasmid expressing PB2 (3PNP-) along with GFP-NXF1 and with or without NS1 as 
indicated. At 48 h p.t, cells were harvested and GFP-Trap pulldown assays were carried out. A) RNA was 
extracted from total cell lysate and GFP-Trap pulldowns (bound) and analysed by radioactive reverse 
transcriptase with primers specific for segment 4 mRNAs and cellular 5S rRNA followed by urea-PAGE and 
autoradiography. B) Aliquots of supernatant were collected prior to RNA extraction in Laemmli’s sample buffer 
for protein analysis by western blotting for the indicated polypeptides. 
 
 
4.2.7 Analysis of segment 4 mRNA localisation in the presence of NS1 mutant 
proteins in the context of viral infection 
 The realization that segment 4 mRNA efficient nuclear export involved the 
participation of NS1 even if the requirement was less stringent than that of segment 7 mRNA 
was intriguing. Earlier in this chapter it was observed that segment 4 mRNA was partially 
retained in the nucleus upon infection with the NS1-N81 mutant virus. This effect was shown 
in 293T, DF-1 and A549 cells, indicating that it was not a random phenomenon that could 
only be attributed to one particular cell type. Hence, the next question that was asked was 
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whether segment 4 mRNA nuclear export would respond in the same way as segment 7 upon 
infection with NS1 mutant viruses. To answer this, 293T cells were mock infected or infected 
with either WT PR8 or NS1 mutant viruses at an M.O.I. of 5. Cells were fixed at 6 h p.i. and 
processed for FISH using an RNA probe targeting segment 4 mRNA. Subsequently, cells 
were subjected to IF targeting the NS1 protein.  
The low signal detection both for segment 4 mRNA (green) and NS1 protein (red) in 
the mock sample confirmed the lack of infection and set background levels (Figure 4.9). 
Conversely, strong signals from both fluorophores localised predominantly in the cell 
cytoplasm could clearly be detected in cells infected with WT PR8, as expected. The mutant 
NS1 proteins were also detected in the cell cytoplasm in all samples apart from NS1-N81, 
where little staining above background could be detected (Figure 4.9). Since the antibody 
used to detect NS1 was raised against the effector domain which was lacking in this mutant, 
this was not unexpected. After infection with NS1-N81, segment 4 mRNA was markedly 
retained in the host cell nuclei, confirming that nuclear export of the mRNA was not as 
efficient in the presence of a truncated form of NS1 protein. In cells infected with the RNA-
binding domain mutants, NS1-R38A, NS1-K41A and the double mutant NS1-(R+K), mixed 
phenotypes were observed (Figure 4.9). The mRNA localisation patterns were noticeably 
different than that observed in WT PR8 infected cells, where all cells presented segment 4 
mRNA clearly in the cytoplasm. This was not the case in cells infected with any of the RNA-
binding mutants. However, there was also not such a clear nuclear retention in cells infected 
with these mutants as seen in cells infected with NS1-N81. Nevertheless, NS1-R38A and 
NS1-(R+K) showed a greater tendency to result in HA mRNA nuclear retention while a 
weaker effect was observed in cells infected with NS1-K41A (Figure 4.9). In the presence of 
the NS1-(S+I) mutant virus that was used as a positive control, segment 4 mRNA was 
displayed in the cell cytoplasm as had been observed before when studying segment 7 mRNA 
localisation (Figure 3.4). Taken together, these results were in line with the data obtained for 
segment 7 mRNA, where similar cellular localization phenotypes were observed when cells 
were infected with this same panel of NS1 mutant viruses (Figure 3.4). These findings 
support the hypothesis that NS1 is required for the efficient nuclear export of segment 4 and 





Figure 4.9 Analysis of segment 4 mRNA localisation in cells infected with NS1 mutant viruses. 293T cells were 
mock infected or infected with the indicated viruses at an M.O.I. of 5. At 6 h p.i., cells were processed for FISH 
and stained for segment 4 mRNA using a specific fluorescent RNA probe (green), then for DNA using DAPI and 
NS1 protein by IF (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS 
analysis software. Scale-bar indicates 10 µm. 
 
 
4.2.8 Analysis of the interactions between segment 4 mRNA with NXF1 and NS1  
 In this dissertation, the study of segment 7 mRNA nuclear export showed not only that 
it required NS1 for its efficient export to the cytoplasm to occur, but also that NXF1 
participation was necessary. It was found that if NS1 failed to: 1) interact with NXF1; 2) 
interact with segment 7; or 3) promote the interaction between NXF1 and segment 7 mRNA, 
then the nuclear export of this mRNA was inhibited (Figures 3.5, 3.7 and 3.8). These data 
lead to the hypothesis that NS1 acted as an adaptor protein between the viral mRNA and 
NXF1 as a way to feed the mRNA into the major cellular mRNA export pathway. The 
response of segment 4 mRNA to the absence of an export-competent NS1 protein was similar 
to segment 7, suggesting that both mRNAs utilised the same nuclear export mechanism. 
However, HA mRNA bound to NXF1 in the absence of NS1 and the interaction was not 
obviously stimulated by NS1 (Figure 4.8). Hence, a further attempt to understand whether 
successful segment 4 nuclear export could be correlated with an NS1-dependent interaction 
with NXF1 was made in the context of virus infection. Furthermore, the ability of mutant NS1 
proteins to interact with segment 4 mRNA was also studied.  
To test the effect of NS1 mutations on the interaction between NXF1 and segment 4 
mRNA, 293T cells were transfected with either GFP or GFP-NXF1 and 48 h later either mock 
infected or infected with WT PR8 or one of the NS1 mutant viruses at an M.O.I. of 10. Cells 
were harvested, lysed and subjected to GFP-Trap pull down at 6 h p.i.. The RNA was isolated 
and examined via primer extension. Detection of 5S rRNA from aliquots of total cell lysate 
was similar in all samples, confirming that equivalent amounts of RNA had been extracted 
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and thus that samples were comparable (Figure 4.10A, lanes 1-8). Segment 4 mRNA was 
also detected in total samples except from mock infected cells, confirming that the infections 
were successful. Examining the bound fractions, it was found that segment 4 mRNA could be 
clearly detected in samples that had been infected with WT and NS1-(S+I) viruses (lanes 10 
and 15, respectively) while only trace amounts were observed from cells infected with NS1-
N81, NS1-R38A and NS1-K41A viruses (lanes 11-13). However, segment 4 mRNA could not 
be detected in the presence of the RNA-binding double mutant NS1-(R+K) (lane 14). 
Additionally, segment 4 mRNA was absent from a cell sample that had been transfected with 
GFP and infected with WT PR8 (lane 9) indicating that GFP could not precipitate segment 4 
mRNA, as expected. Segment 4 mRNA could also not be detected in cells that had been 
transfected with GFP-NXF1 and mock infected (lane 16), confirming the specificity of the 
interaction observed between NXF1 and segment 4 mRNA in other samples. These results 
confirmed that NXF1 interacted with segment 4 mRNA as had been previously reported 
(Wang et al., 2008) and in contrast to the previous minireplicon-based experiment (Figure 
4.8), suggested that the interaction between NXF1 and segment 4 is influenced by the 
presence of NS1, as only trace amounts of segment 4 mRNA were found to interact with 
NXF1 in the presence of mutant forms of NS1 unable to promote consistent cytoplasmic 
accumulation of the transcript. These findings are in line with what was observed for segment 
7 and strengthened the adaptor hypothesis. 
In order to determine whether an interaction between NS1 protein and segment 4 
mRNA could be detected, 293T cells were transfected with GFP, NS1-GFP or one of the 
GFP-tagged NS1 mutants. At 48 h p.t., cells were infected with the NS1-N81 mutant virus at 
an M.O.I. of 10 to supply segment 4 mRNA and an export-incompetent NS1 in all samples so 
as not to mask activity of the exogenous GFP-NS1 polypeptides. Subsequently, samples were 
processed as described above. Equivalent amounts of total RNA were analysed for each 
sample as indicated by similar amounts of 5S rRNA (Figure 4.10B, lanes 1-8) and even 
though the radiograph was over-exposed on the left hand end due to leakage of the X-ray film 
cassette, the absence (in mock infected cells) or presence of segment 4 mRNA in similar 
amounts in infected with NS1-N81 mutant virus could be seen. Analysis of the bound 
fractions showed that segment 4 mRNA could clearly interact with WT NS1-GFP and with 
NS1(S+I)-GFP, both nuclear export competent proteins (lanes 11 and 16). However, in cells 
transfected with N81-GFP or any of the RNA-binding mutants, only trace to no detectable 
amounts of segment 4 mRNA were precipitated indicating that these NS1 mutant proteins 




Figure 4.10 Figure 4.10 Analysis of segment 4 mRNA interactions with NXF1 and NS1. A) 293T cells were 
transfected with GFP-NXF1 (+) or with GFP alone (-) and 48 h later either mock infected or infected with the 
indicated viruses at an M.O.I. of 10, in duplicate sets. At 6 h p.i., cells were harvested and total cellular RNA 
was extracted from one set while the second set was subjected to GFP-Trap pulldown assays prior to total RNA 
extraction. RNA was analysed by radioactive reverse transcriptase with primers specific for segment 4 mRNAs 
and cellular 5S rRNA, followed by urea-PAGE and autoradiography. B) 293T cells were transfected with GFP-
tagged plasmids expressing either GFP alone or GFP-NS1 mutant proteins, as indicated. At 48 h p.t., cells were 
mock infected or infected with WT or NS1-N81 as specified, at an M.O.I. of 10. At 6 h p.i., cells were harvested 
and total cellular RNA was extracted from one set while the second set was subjected to GFP-Trap pulldown 
assays prior to total RNA extraction. RNA analysis was done as described for panel A. 
 
 
segment 7, segment 4 mRNA was only able to interact with NS1 proteins that were also 
capable of mediating efficient export of the transcript. Furthermore, it was demonstrated that 
both functional domains of NS1 protein were necessary as the lack of either of them resulted 
in the loss of the interaction. Taken together, these data indicated that indeed, the mRNA 
nuclear export mechanisms used by segments 4 and 7 overlap substantially and for both 
mRNAs, NS1 participation is required for the interaction between the viral transcripts and the 
cellular mRNA export machinery. 
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In conclusion, the findings presented in this dissertation strongly suggest that NS1 





 The aim of the work presented in this chapter was to study the role of NS1 in the 
nuclear export of mRNAs from IAV segments, other than segment 7. NS1 was identified as a 
viral requirement for the efficient nuclear export of segment 7 in Chapter 2 and parts of the 
mechanism used for this were unveiled in Chapter 3. However, the immediate extrapolation 
and generalisation that the requirements for nuclear export would be the same for all IAV 
transcripts would not be sensible. For instance, the ongoing activity of RNAP-II was shown to 
be required for the nuclear export of segment 7 but not for segment 5 as cell treatment with 
DRB resulted in the nuclear retention of segment 7 while segment 5 was still found in the 
cytoplasm (Amorim et al., 2007). This study suggested that segment 5 mRNA used a different 
nuclear export mechanism than segment 7 and this was supported by further reports where 
nuclear export of individual IAV mRNAs presented different degrees of sensitivity to the 
inhibition of cellular factors involved mRNA export (Larsen et al., 2014; Read and Digard, 
2010). The Read & Digard study revealed that while intronless segment 4, unspliced M1 and 
spliced M2 mRNAs were strongly dependent on the presence of NXF1 for nuclear export, 
segment 5 mRNA showed the least degree of dependency on NXF1. Similarly, reduced levels 
of UAP56 resulted in the inhibition of M1, M2 and NS1 trafficking and/or translation while 
NS2 synthesis remained unaffected. Depletion of Aly, on the other hand, showed that this 
cellular factor had little effect on the nuclear export of the mRNAs examined. This work 
concluded that not all IAV mRNAs have the same cellular requirements for their nuclear 
export. Furthermore, the authors proposed that a subset of mRNAs used the main cellular 
mRNA export pathway including most, but not all, late gene mRNAs. These findings were 
further supported by a later report showing that nuclear export of intronless segments 4 and 6 
was reduced upon the inhibition of NXF1 while segments 1, 2, 3 and 5 remained unaffected 
(Larsen et al., 2014). Hence, determining whether NS1 participated in the nuclear export of all 
or only selected gene transcripts would contribute to increasing knowledge of the overall 
mechanism used by IAV to transport its mRNAs to the cytoplasm.  
 
Since segments 1, 2, 3, and 5 are an inherent part of the minireplicon system, this 
approach could not readily be used to study the nuclear export of these segments. Technical 
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limitations were also encountered in the viral side of things, with respect to NS1 itself and the 
possibility of making a truly NS1-minus system. Attempts were made to rescue mutant 
viruses where NS1 would be completely absent or only present as a very short truncated form 
containing only the first 13 amino acids (ΔNS1 and NS1-N13, respectively). However, 
although viable viruses could be generated, it was not possible to obtain titres that would 
allow the use of a sufficiently high M.O.I. to successfully carry out FISH assays. Thus, the 
role of NS1 in the export of other IAV mRNAs was carried out using the NS1-N81 virus. This 
strategy had the shortcoming that the effect of the total absence of NS1 would not be possible 
to study. For this reason, it was relevant to determine if this mutant virus showed similar 
growth rates as WT or if the impaired nuclear export of segment 7 mRNA export in the 
presence of this mutant virus could be due to a growth defect of NS1-N81. Single cycle 
growth curves of WT PR8 and NS1-N81 showed that, indeed, the latter was delayed when 
compared to WT (Figure 4.2A); a result consistent with previous studies (Egorov et al., 1998; 
Garcia-Sastre et al., 1998; Solorzano et al., 2005). The delay was visible until 24 h p.i. at 
which point NS1-N81 seemed to “catch up” with WT, presenting similar titres both at 24 h 
p.i. and 48 h p.i.. Several of the other IAV polypeptides have functions in antagonising 
cellular responses to viral infection in addition to those encompassed in the NS1 RNA-
binding domain, so slower rather than lower replication kinetics for the NS1-N81 mutant are 
not unexpected. Another possible reason for the behaviour of this virus is that on occasions, 
NS1-N81 was able to revert the mutation that inserted a stop codon at position 82 of the gene. 
Reversion of NS1-N81 was confirmed in some experiments (e.g. Figure 4.2B) by the 
detection of a full-length NS1 protein in western blotting analysis. This was not seen in every 
experiment (data not shown) and the virus was regenerated from plasmid rather than by 
passage of existing stocks. However, reversion of NS1-N81 could be detected as early as at 3 
h p.i. when it did occur, indicating that perhaps the virus stock used in the infection already 
contained trace amounts of revertants which had occurred during the minimum passaging 
required to produce it. Nevertheless, even in this scenario, the amounts of NS1 protein 
produced by NS1-81 at 10 h p.i. were markedly reduced when compared to WT levels. 
Analysis of other viral protein expression showed that the NS1-N81 mutation changed the 
accumulation kinetics of most other viral polypeptides. Interestingly, NS2 protein expression 
increased at 8 h p.i. surpassing the levels detected for this protein in cells infected with WT 
virus. This is consistent with a previous report showing that inactivation of the NS1 gene 
increased the efficiency of segment 8 splicing, yielding increased levels of NS2 transcripts 
(Fortes et al., 1994). Conversely, NP, PB1, HA, M1 and M2 levels all decreased, but with the 
early NP and PB1 genes being least affected and the segment 7 products the most. It was 
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possible that decreased levels of viral proteins could be attributed to NS1-N81 being 
transcriptionally attenuated. Alternatively, it was also plausible that reduced viral protein 
expression could be the result of a defect at a post-transcriptional level. This hypothesis was 
supported by another experiment where more segment 4 mRNA was detected in cells infected 
with NS1-N81 than WT, but less HA protein was produced (Figure 4.1A and 4.1B). These 
results indicated that HA expression was indeed attenuated at a post-transcriptional level – 
bearing in mind identified roles for NS1 in viral gene expression, either at the level of mRNA 
translation (de la Luna et al., 1995; Nordholm et al., 2017; Panthu et al., 2017; Schierhorn et 
al., 2017) and/or at the level of mRNA export (this thesis; (Pereira et al., 2017).  
  
Following on from biochemical observations, the cellular localisation of mRNAs from 
segments 2, 5, 4 and 7 were examined over time in WT and NS1-deficient infections. As 
observed before, segment 7 mRNA was found in the cytoplasm of cells infected with WT 
PR8 and retained in the nucleus upon infection with NS1-N81 (Figure 4.3). Segment 7 
mRNA was detected in the cytoplasm of cells infected with WT PR8 from as early as 4.5 h 
p.i. and was increasingly visible there until 8 h p.i. Conversely, segment 7 mRNA was 
retained in the nucleus during the course of NS1-N81 infection and this differential only 
became less pronounced at 10 h.i. by which time at least some cells contained WT NS1 due to 
reversion (Figure 4.2A). In contrast, segment 5 mRNA was readily found in the cell 
cytoplasm during infection with either virus, indicating that the mechanism used to export this 
mRNA occurred in an NS1 effector domain-independent manner. This was consistent with 
NP synthesis being less affected than other viral proteins in cells infected with NS1-N81 
(Figure 4.2B). These results were also consistent with previous reports demonstrating the 
difference in mRNA nuclear export requirements for NP and M1 mRNAs (Amorim et al., 
2007; Larsen et al., 2014; Read and Digard, 2010). Similarly, segment 2 mRNA nuclear 
export also did not show an obvious effect from mutating NS1 as the localisation of plus-
sense RNA did not differ between cells infected with WT PR8 or NS1-N81 (Figure 4.4). 
However, since the RNA signal was found more predominantly in cell nuclei in both 
instances, it is possible that these results reflect a proportionally greater detection of cRNA 
from a segment where the two classes of positive-sense RNA are present in similar amounts 
(Dalton et al., 2006; Robb et al., 2009). A higher detection of nuclear cRNA could mask a 
potential effect of NS1-N81 on mRNA localisation, so the possibility that NS1 plays a role in 
segment 2 efficient mRNA export cannot be excluded. However, the levels of cytoplasmic 
staining seen in WT PR8 infected cells were not noticeably diminished in cells infected with 
NS1-N81 which suggests that the mRNA export of segment 2 mRNA is indeed independent 
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of the NS1 effector domain. In contrast, the absence of WT NS1 had a clear impact on the 
localisation of segment 4 mRNA (Figure 4.4). While cells infected with WT PR8 displayed 
segment 4 mRNA in the cytoplasm throughout the course of the infection, a clear mRNA 
retention phenotype could be observed in cells infected with NS1-N81, at least at earlier times 
p.i.. These findings indicated that NS1 played a role and was required for the rapid 
cytoplasmic accumulation of segment 4 mRNA. The mRNA localisation phenotypes for all 
these segments were further validated as they were maintained in a different cell type, DF-1 
cells upon infection with either WT PR8 or NS1-N81 (Figure 4.5). In these cells the nuclear 
retention of segments 4 and 7 in the absence of a full-length NS1 protein was evident as was 
the insensitivity of segment 5 mRNA. Segment 2 mRNA on the other had seemed to be more 
nuclear in cells infected with NS1-N81. This could indicate that NS1 is potentially more 
important for nuclear export of this mRNA in some cell types. Indeed, it has been suggested 
that cell variability influences the mRNA export requirements of IAV mRNAs (Larsen et al., 
2014). In this report, segment 5 mRNA export was shown to be sensitive to inhibition of 
NXF1 in 293T cells but not in A549 cells. A549 cells were used in this Chapter, but only to 
study segment 4 and 7 mRNAs. Since the Larsen et al. report was published after the end of 
the experimental work presented in this dissertation the nuclear export of segment 5 in A549 
cells was not examined, as its independence from NS1 had been clearly shown both in 293T 
and DF-1 cells. However, it would be interesting to test whether segment 5 mRNA could be 
affected by the absence of WT NS1 in A549 cells in future studies. 
 
 Even though the minireplicon system was not suitable for studying nuclear export of 
segments 2 and 5 mRNAs, it could be used to study segment 4 as the latter gene is not a 
required component of the system. Additionally, using the minireplicon assay to study 
segment 4 mRNA nuclear export allowed a test of the effect of the total absence of NS1. 
Addition of NS1 to the segment 4 minigenome system resulted in a clear increase in 
cytoplasmic detection of segment 4 mRNA (Figure 4.7), in agreement with the results 
obtained for segment 7 mRNA in chapter 2. However, nuclear retention of segment 4 mRNA 
in the total absence of NS1 was not as pronounced as the one observed for segment 7. This 
was visible as an increased percentage of cells displaying a mixed phenotype of segment 4 
mRNA both in the nucleus and cytoplasm. The reasons for this difference are not clear since 
in Chapter 2, results obtained in the context of viral infection were corroborated by assays 
performed using the minireplicon system. Nevertheless, the addition of NS1 resulted in a clear 
shift of segment 4 mRNA towards cytoplasmic localisation, further establishing NS1 as a 
viral requirement for the efficient nuclear export of segment 4 mRNA. The similarities in 
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behaviour of segments 4 and 7 mRNA to perturbations of nuclear export have been noted 
previously (Amorim et al., 2007; Read and Digard, 2010). Both transcripts were previously 
shown to strongly depend on the presence of NXF1 for cytoplasmic accumulation (Read and 
Digard, 2010). This dependence was also observed in Chapter 2 and was attributed to the 
ability of NXF1 to interact with export-competent NS1 proteins and to segment 7 mRNA via 
NS1. Hence it was plausible to conjecture that the NS1 interaction with NXF1 and segment 4 
mRNAs were also required for the efficient nuclear export of segment 4 mRNA. However, 
using the minireplicon system, it was found that the interaction between NXF1 and segment 4 
mRNA was readily detectable even in the absence of NS1 (Figure 4.8A). Nevertheless, HA 
protein expression was strikingly higher when NS1 was present, which is in line with NS1 
facilitating the nuclear export of segment 4 mRNA (Figure 4.8B). Since the results obtained 
using the minireplicon assays seemed to be less clear for the study of segment 4, the panel of 
NS1 mutants was used instead in order to better evaluate the overlaps between segments and 7 
and 4 mRNA nuclear export mechanisms.  
 
 Upon infection with the various NS1 mutant viruses, segment 4 mRNA exhibited 
similar phenotypes to M1 mRNA. HA mRNA was found in the cytoplasm of cells infected 
with WT PR8 and NS1-(S+I) and retained (to greater or lesser extents) in the nuclei of cells 
infected with NS1-N81 and the RNA-binding domain mutants NS1-R38A, NS1-K41A and 
NS1-(R+K) (Figure 4.9). This indicated that, as with segment 7, both functional domains of 
NS1 were required to promote efficient cytoplasmic residency of segment 4 mRNA. The 
interactions between NXF1 and segment 4 mRNA in the presence of NS1 mutants were also 
much like the behaviours seen with segment 7. In the context of virus infection, NXF1 
binding to segment 4 mRNA was notably stronger in the presence of export-competent NS1 
proteins (Figure 4.10A). Likewise, the interaction between NS1 and segment 4 mRNA was 
found to only be supported by NS1 proteins also capable of promoting the efficient nuclear 
export of segment 4 mRNA (Figure 4.10B). These findings indicate that only NS1 mutants 
able to promote the interaction between NXF1 and segment 4 mRNA can retain their viral 
mRNA nuclear export function. Additionally, the participation of NS1 in the efficient nuclear 
export of intronless segment 4 mRNA further strengthens the results obtained in Chapter 2 
concerning the splicing independence of the mechanism. Indeed, since segment 4 mRNA is 
not spliced, NS1-mediated mRNA export does not necessitate mRNAs undergoing splicing 
events, contrary to what was proposed in a recent report (Mor et al., 2016). 
Taken together, the results presented and discussed in this Chapter make a strong case 
for segments 4 and 7 utilising the same mRNA nuclear export mechanism; one involving NS1 
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participation in order to introduce them into the major cellular mRNA export pathway. The 
suggestion that different export mechanisms are used according to IAV mRNA categorisation 
into classes such as intronless, spliced, unspliced, early or late is not novel (Amorim et al., 
2007; Larsen et al., 2014; Read and Digard, 2010; Wang et al., 2008). However, the data from 
this Chapter further support this separation in that NS1 is required for the nuclear export of 
HA and M1 mRNAs, which are considered late class and unspliced mRNAs.  
 
While it would have been very useful to include data on segment 6 mRNA export, 
since this is also a late and intronless segment, attempts to obtain a working FISH probe to 
determine its cellular localisation were unsuccessful. Additionally, the lab’s lack of a specific 
antibody against this protein also prevented inferences to be made by protein expression 
analysis. Nevertheless, previous studies have provided evidence that does point towards 
segment 6 using the same mRNA nuclear export mechanism as segments 4 and 7. 
Specifically, segment 6 mRNA was found to colocalise with NS1 in the cell nucleus in 
addition to be shown to interact with both NS1 and NXF1 (Wang et al., 2008). Furthermore, 
segment 6 mRNA nuclear export was found to be reduced upon inhibition of RNA Pol II 
(Vogel et al., 1994) or NXF1 (Larsen et al., 2014).  
 
Thus, we conclude by proposing a model for a sub-set of IAV mRNAs nuclear export 
in which NS1 acts as an adaptor protein between viral late gene intronless/unspliced mRNAs 
and NXF1 as a strategy to incorporate viral mRNAs into the major cellular mRNA export 
pathway. We further speculate that this mechanism could be used as a kinetic regulator in the 




CHAPTER 5 – CONCLUDING REMARKS 
_________________________________________________________________________ 
 This dissertation focused on the study of IAV mRNA nuclear export in an attempt to 
identify and determine the requirements needed for this important step of the virus life cycle 
to occur.  
 
 In previous work carried out in the Digard laboratory, Dr. Eliot Read remarked that, 
while segment 7 mRNA could be found in the cell cytoplasm during viral infection using 
FISH, this mRNA was retained in the nucleus in a minireplicon assay. This observation was 
the basis for the work described in this dissertation, starting from the postulation that a viral 
component absent from the minireplicon system could play a role in the mRNA export of 
segment 7 mRNA. Thus, Chapter 2 reports on the study of viral requirements for an efficient 
nuclear export of segment 7 mRNA. Using FISH as the technique to observe the mRNA 
cellular localisation allowed the identification of NS1 as the viral component in the absence of 
which, most segment 7 mRNA was found to be markedly retained in the cell nucleus. 
Furthermore, it was demonstrated that the presence of a poly(A) tail in the mRNA was 
another requirement for nuclear export and NS1 presence could not override the lack of this 
signal. Lastly, the potential link between mRNA export and splicing was explored and it was 
demonstrated that mRNA nuclear export enabled by NS1 ensued independently of splicing 
events. 
 
 The work presented in Chapter 3 examined in more detail the role of NS1 in 
promoting the efficient export of segment 7 mRNA focusing on NS1 protein itself and its 
connection with the major cellular mRNA export pathway, NXF1/Nxt1. This study was 
carried out using a set of NS1 proteins carrying mutations in several sites previously 
associated with many of the function attributed to NS1. Both functional domains of NS1, the 
RNA-binding domain and the effector domain, revealed to be necessary for the protein to 
retain its nuclear export function. Moreover, in order for nuclear export to be successful, NS1 
further needs to interact with NXF1 protein and segment 7 mRNA. Importantly, NS1 must 
also be capable of promoting the interaction between NXF1 and segment 7 mRNA. Any NS1 
mutant protein examined that failed to support either one of these interactions also failed to 
promote efficient export of segment 7 mRNA.  
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However, and surprisingly, even while these requirements were established as 
necessary, they were found to be insufficient. Indeed, analysis of NS1 protein with mutations 
inserted in the effector domain showed that even though these proteins could interact with 
NXF1 and promote the interaction between NXF1 and segment 7 mRNA, the nuclear export 
of the latter was nevertheless impaired. This suggests that the role of NS1 in the mechanism 
of mRNA nuclear export is not limited to its interaction with segment 7 mRNA and NXF1 
and that it is required for a further step in the export pathway, upstream of the participation of 
NXF1. Based on the findings presented in this Chapter it is possible to conjecture a model for 
segment 7 mRNA nuclear export where NS1 would bind the mRNA and recruit an unknown 
cellular factor which would in turn recruit NXF1. NS1 would then interact with NXF1 and 
transfer segment 7 mRNA to NXF1 as a mechanism to feed the viral mRNA onto the main 
cellular mRNA export pathway leading to its successful export to the cell cytoplasm.  
 
Chapter 4 focused on studying the mRNA nuclear export of IAV segments other than 
7 and the potential involvement of NS1 in this process. The nuclear export of mRNAs from 
segments 2 and 5 is insensitive to the lack of NS1 and suggests that the transcripts utilise a 
different mechanism to achieve nuclear export. However, segment 4 mRNA presents 
essentially the same requirements as segment 7 mRNA. Efficient nuclear export of segment 4 
mRNA occurs only when NS1 is present and capable of interacting with NXF1 and the 
mRNA while also having to be able to promote the interaction between segment 4 mRNA and 
NXF1. Since the common features shared by segments 4 and unspliced segment 7 are their 
classification as late mRNAs that evade splicing, it is proposed that the role of NS1 is 
restricted to this class of viral transcripts. It is reasonable to hypothesise that the participation 
of NS1 in the nuclear export of late transcripts could act as a time regulation ensuring these 
mRNAs are  more efficiently exported later in infection, when higher levels of NS1 would 
have been produced.  
 
Nevertheless, the results presented in this dissertation raise several important 
questions. Since NS1 is suggested to play another role in the export mechanism other than its 
interaction with NXF1 and viral mRNAs, it is plausible that NS1 could recruit another 
cellular factor involved in the NXF1/Nxt1 pathway, but which one? The most likely 
candidates would be components of the hTREX complex as they have a similar role of 
interacting with cellular mRNAs and recruiting NXF1. Another key question raised by results 
described in Chapter 4 concerns the nuclear export of early and intronless mRNAS. What is 
the mechanism used by these transcripts to reach the cytoplasm? There is mounting evidence 
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that not all IAV mRNAs have the same requirements for nuclear export (Amorim et al., 2007; 
Larsen et al., 2014; Read and Digard, 2010). While the mechanism for late intronless mRNAs 
appears to be getting clearer with the previous identification of NXF1 pathway, and now NS1, 
being required, the question of how early intronless transcripts are exported remains largely 
unknown. 
 
Given the nonessential nature of NS1 in the life cycle of IAV, how do late intronless 
mRNAs get exported to the cytoplasm in the absence of NS1? This is perhaps the most 
intriguing question raised by the results presented in this dissertation. It is important to note 
that even when mRNA nuclear retention was noticeable, gene product synthesis from the 
mRNA was reduced, but not totally inhibited. Nuclear translation is one possibility (Dolan et 
al., 2010). However, it is also possible that a redundant, and less efficient (or slower), 
mechanism exists that is independent of NS1. Such mechanism would ensure that sufficient 
amounts of mRNA are exported to allow protein synthesis in levels that would permit the 
replication of the virus.  
 
Overall, the findings presented in this dissertation provide new insights into how late 
and intronless IAV transcripts are efficiently exported from the cell nucleus to the cytoplasm. 
Specifically, while a role for NS1 in viral nuclear export had been suggested, hinted at and 
hypothesised before, the data here provided the most concrete and direct evidence up to date 
in support of this hypothesis. The data provided a deeper understanding and characterized the 
role of NS1 in mRNA nuclear export mechanisms in greater detail. We showed that, in order 
to promote mRNA export, NS1 needed to be able to interact with NXF1 and the viral mRNA. 
Moreover, it was demonstrated that NS1 promoted the interaction between NXF1 and viral 
mRNAs. These results support and strengthen the hypothesis that NS1 acts as an adaptor 
protein between the viral mRNA and the nuclear export cellular machinery. Finally, this study 
reinforces the argument that different segments vary in their strategy to achieve mRNA 
nuclear export raising the intriguing question of what mechanism is used for the export of 




CHAPTER 6 – MATERIALS & METHODS 
_________________________________________________________________________ 
6.1 Materials 
6.1.1 General reagents 
 
General purpose reagents (analytical grade if available) were supplied variously by 
Bethesda Research Laboratories (BRL), BDH Chemicals Ltd., VWR, Fisons and Sigma. The 
following reagents were obtained from the indicated companies:  
Acrylamide/bis-acrylamide (37:5:1)   GeneFlow 
Agarose       Boehringer Mannheim 
Blocking reagent (for FISH)    Roche 
Dimethyl sulphoxide (DMSO)   Aldrich Chemical Company Ltd. 
Lipofectamine 2000     Invitrogen 
Nucleobond Xtra Midi kit    Machery Nagel 
Nitrocellulose      Schleicher and Schuell Co. 
Opti-MEM      Invitrogen 
Protein molecular weight markers   New England Biolabs 
QIAquick PCR purification kit   Qiagen 
SV Miniprep kit     Promega 
Trizol reagent      Invitrogen 






[32P] ATP (3000 Ci/mmol)    Perkin Elmer 
 
6.1.3 Enzymes 
DNA restriction endonucleases were supplied by Boehringer Mannheim, Invitrogen 
and New England Biolabs. Alternatively, the following enzymes were obtained from the 
companies indicated: 
AMV Reverse Transcriptase     Promega 
Pfu native DNA polymerase     Stratagene 
PNK (T4 Polynucleotide Kinase)    Fermentas  
RNaseOUT™ Recombinant Ribonuclease Inhibitor  Invitrogen 
SP6 RNA polymerase      Roche 
Superscript III Reverse Transcriptase   Invitrogen 




Oligonucleotides were ordered from Sigma-Genosys unless otherwise indicated.  
 
Table 6.1 Primers used for primer extension 
Primer Purpose Sequence 
PD62 Segment 5 mRNA detection 5’ CGT CCA ATT CCA CCA ATC 3’ 
PD64 Segment 5 vRNA detection 5’ GTC TTC GAG CTC TCG GAC G 3’ 
PD376 Segment 2 mRNA detection 5’ GTA TCC TGT TCC TGT CCC 3’ 
PD378 Segment 8 mRNA detection 5’ TTA GGG ATT TCT GAT CTC GGC 3’ 
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PD380 Segment 4 mRNA detection 5’ TCA CTG TCA CAT TCT TCT GCA GC 3’ 
PD381 Segment 4 vRNA detection 5’ CCC TGG GGG CAA TCA GTT TCT 3’ 
PD1156 Segment 7 mRNA detection 5’ GAA GGC CCT CCT TTC AGT CC 3’ 
PD1157 Segment 7 vRNA detection 5’ GAA AAG AGG GCC TTC TAC GG 3’ 
PD1158 5S rRNA detection 5’ TCC CAG GCG GTC TCC CAT CC 3’ 
PD1162 Segment 6 vRNA detection 5’ TGG ACT AGT GCG AGC AGC AT 3’ 
PD1163 Segment 6 mRNA detection 5’ TCC AGT ATG GTT TTG ACT TCC 3’ 
 
 
Table 6.2 Primers used for the addition of restriction sites to allow subcloning of NS1 and 
NS2 genes into pEGFPN1 vector 
Primer Purpose Sequence 
PD1081 
Reverse transcription reaction to 
have cDNA from segment 8 in 
order to clone NS2 into the 
vector 
5’TTT TTT TTT TTT TTT AGT ACT A 3’ 
PD1082 
Addition of KpnI restriction site 
to 5’end of segment 8 
5’ GCA ACC GGT ACC ATG GAT CCA 
AAC ACT GTG TC  3’ 
PD1083 
Addition of AgeI restriction site 
to 3’ end of NS1 coding region 
5’ GGT TGC ACC GGT ACT TCT GAC 
CTA ATT GTT CC 3’ 
PD1084 
Addition of AgeI restriction site 
to 3’ end of NS2 coding region 
5’ GGT TGC ACC GGT ATA AGC TGA 







Table 6.3 Primers used for the subcloning of segment 7 intron sequence into a pcDNA3 
vector to make an M1 specific RNA probe for FISH 
Primer Purpose Sequence 
PD1088 
Addition of HindIII restriction 
site to 5’ end of segment 7 intron 
sequence 
5’ GCA ACC AAG CTT GTA CGT ACT 
CTC TAT CAT CCC GTC 3’ 
PD1089 
Addition of EcoRI restriction site 
to 3’ end of segment 7 intron 
sequence 
5’ GGT TGC GAA TTC CTG CAA ATT TTC 
AAG AAG ATC AT 3’ 
 
 
6.1.5 Immunological reagents 
Table 6.4 Antibodies against influenza A proteins 
Antibody target Source/Reference Application (dilution) 
Rabbit polyclonal anti-PB2 (Amorim et al., 2007) WB (1:500) 
Rabbit polyclonal anti-PB1 (V19-7) (Digard et al., 1989) WB (1:500) 
Rabbit polyclonal anti-NP (A2915) (Noton et al., 2007) 
WB (1:500), IF 
(1:500) 
Rabbit polyclonal anti-M1 (Amorim et al., 2007) WB (1:500) 
Mouse monoclonal anti-M2  Clone 14C2, Abcam WB (1:1000) 
Rabbit polyclonal anti-NS1 (V29) (Carrasco et al., 2004) WB (1:500) 
Rabbit polyclonal anti-NS2 
Kind gift of Dr Augustin 
Portela 
WB (1:500) 
Rabbit polyclonal anti-PR8 (Amorim et al., 2007) WB (1:500) 
Anti-NS1 






Table 6.5 Antibodies against cellular proteins 
Antibody target Source Application (dilution) 




Mouse monoclonal anti-Aly Clone 11G5 from Abcam WB (1:500) 
Mouse monoclonal anti-UAP56 Ab47955 from Abcam WB (1:500) 
Mouse monoclonal anti-TAP/NXF1 Clone 53H8 Abcam WB (1:200) 
Mouse monoclonal anti-Hur/ELAV1 Clone 19F12 from Abcam WB (1:200) 
Mouse monoclonal anti-Nup62 BD Biosciences 610497 WB (1:500) 
Mouse monoclonal anti-Hsp70 BD Biosciences 610607 




Table 6.6 Other primary antibodies 
Antibody target Source Application (dilution) 
Mouse monoclonal anti-GFP (Jl-8) Clontech 632380 WB (1:5000) 
Mouse monoclonal anti-V5 tag Clone  V5.E10 from abm WB (1:500) 
 
 
Table 6.7 Secondary antibodies 
Antibody  Source Application (dilution) 
IRD800 conjugated goat anti-mouse Licor 926-32210 WB (1:10000) 
IRD800 conjugated donkey anti-
rabbit 
Licor 926-32213 WB (1:10000) 
IRD680 conjugated goat anti-rabbit  Licor 926-32221 WB (1:10000) 
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IRD680 conjugated donkey anti-
mouse  
Licor 926-32222 WB (1:10000) 
Alexa 680 conjugated goat anti-rat Invitrogen A-21096 WB (1:10000) 
Alexa 633 conjugated goat anti-
rabbit  
Invitrogen A-11034 IF (1:1000) 
 
Additionally, the DNA-binding fluorescent dye DAPI (4’,6’-diamidino-2-phenylindole 




Table 6.8 List of plasmids used 
Plasmid Details 
pPolIHA Plasmid expressing PR8 segment 4 vRNA sense sequence from a polI 
promoter (de Wit et al., 2004)  
pPolINP Plasmid expressing PR8 segment 5 vRNA sense sequence from a polI 
promoter (de Wit et al., 2004)  
pPolIM Plasmid expressing PR8 segment 7 vRNA sense sequence from a polI 
promoter (de Wit et al., 2004)  
pPolINS Plasmid expressing PR8 segment 8 vRNA sense sequence from a polI 
promoter (de Wit et al., 2004)  
pPolIMU Plasmid expressing PR8 segment 7 vRNA sense sequence from a polI 
promoter with the wildtype oligoU stretch at the 5’ end mutated into a 
oligoA stretch (Read, 2010) 
pcDNA:PB2 Mt. Sinai PR8 segment 1 in a pcDNA3 backbone (Invitrogen); (Mullin et 
al., 2004) 
pcDNA:PB1 Mt. Sinai PR8 segment 2 in a pcDNA3 backbone (Invitrogen); (Mullin et 
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al., 2004) 
pcDNA:PA Mt. Sinai PR8 segment 3 in a pcDNA3 backbone (Invitrogen); (Mullin et 
al., 2004) 
pcDNA:HA Mt. Sinai PR8 segment 4 in a pcDNA3 backbone (Invitrogen); (Mullin et 
al., 2004) 
pcDNA:NP Mt. Sinai PR8 segment 5 in a pcDNA3 backbone (Invitrogen); (Mullin et 
al., 2004) 
pcDNA:M1 Mt. Sinai PR8 segment 7 in a pcDNA3 backbone (Invitrogen); (Amorim et 
al., 2007); a kind gift of Dr D. Elton 
pCB8+ A cDNA copy of segment 8 from the Mt. Sinai strain of PR8 cloned into 
plasmid pSP65 (Promega). A kind gift of S. Inglis 
pCB8- A cDNA copy of segment 8 from the Mt. Sinai strain of PR8 cloned into 
plasmid pSP65 (Promega). A kind gift of S. Inglis 
pCAGSNS2 Influenza A NS2 expression vector in a pCAGGS backbone; a gift from 
W. Barclay 
pCAGSNS1A Influenza A NS1 expression vector in a pCAGGS backbone; a gift from 
W. Barclay 
pCAGSNS1B Influenza B expression vector in a pCAGGS backbone; a gift from W. 
Barclay 
pGFP-NXF1 GFP tagged NXF1 expression vector; a gift from A. Whitehouse (Williams 








6.1.7 Bacterial strains 
DH5α 
 
6.1.8 Virus strains 
H1N1 A/PR/8/34  An MDCK cell adapted version of the National Institute for Biological 
Standards and Control strain of PR8 rescued from plasmids (de Wit et 
al., 2004) 
 
6.1.9 Mutant viruses 
The following mutant viruses were made by Dr. Helen Wise, using the H1N1 
A/PR/8/34 background. 
 
Table 6.9 List of mutant viruses used 
Mutant virus Mutation Expected effect of the mutation 
NS1-N81 Stop codon at 
position 81 
Stop codon introduced at position 82. The mutant 
virus produced a truncated form of NS1 comprising 
the N-terminal 81 a.a. and most of the effector 
domain is eliminated (Zurcher et al., 2000) 
NS1-R38A R38A Inhibition of the RNA-binding domain by residue 
substitution at position 38 (Wang et al., 1999) 
NS1-K41A K41A Inhibition of the RNA-binding domain by residue 
substitution at position 41 (Wang et al., 1999) 
NS1-(R+K) R38A, K41A Inhibition of the RNA-binding domain by residue 
substitution at positions 38 and 41 resulting in a 
double mutant (Wang et al., 1999) 
NS1-(S+I) F103S, M106I Restoration of the CPSF binding ability that the 
PR8 strain does not possess (Kochs et al., 2007) 
NS1-E96/7A E96A, E97A Blocks the ability of NS1 to supress TRIM25-
mediated RIG-I signal transduction resulting in the 
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inhibition of host IFN response (Gack et al., 2009) 
NS1-Y89A Y89A Inhibits the ability of NS1 to activate the PI3K 
pathway (Aramini et al., 2011) 
NS1-Y89F Y89F Inhibits the ability of NS1 to activate the PI3K 
pathway (Hale et al., 2006) 
NS1-W187R W187R Prevents NS1 dimerization via its effector domain 
(Hale et al., 2008a)  
 
6.1.10 Drugs 
Spliceostatin was a gift from M. Yoshida (Kaida et al., 2007) and was used at a concentration 
of 100 ng/ml 
 
6.1.11 Eukaryotic cells 
293T A derivative of human embryonic kidney 293 cells expressing the 
SV40 Tumour antigen; epithelial cell line; (DuBridge et al., 1987) 
A549  Polarised human lung epithelial cell line (Giard et al., 1973) 
MDCK   Madin-Darby Canine Kidney; polarised epithelial cell line (Gaush et 
al., 1966) 
DF-1   Chicken fibroblast cell line (Himly et al., 1998) 
 
 
6.1.12 Media and solutions 
 
Eukaryotic tissue culture media 
 
Dulbecco’s modified Eagle’s medium (DMEM) and Opti-MEM were obtained from 
PAA or Invitrogen. Complete medium: DMEM was supplemented with foetal calf serum 
(FCS) (10% v/v), 200 mM glutamine (final concentration), 100 U/ml penicillin and 10 g/ml 
streptomycin.  
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Serum-free medium: FCS was omitted from the mixture of complete medium.  
Virus growth medium: 1 µg/ml trypsin (Worthington Biochemical Corporation) and 0.14% 
bovine serum albumin (BSA; Sigma) were added to serum free medium. 
 
Bacterial culture media 
2TY    10 g/l tryptone, 10 g/l yeast extract (OXOID), 5 g/l NaCl 
2TY amp   2TY supplemented with 100 µg/ml ampicillin 
2TY kan   2TY supplemented with 25 µg/ml kanamycin 
2TY agar   2TY amp or 2TY kan with 20 g/l agar 
 
 
Other solutions and buffers 
(i) For competent cells 
CCMB    10 mM CH3COOK, 10 mM MgCl2.6H2O 80 mM CaCl2.2H2O, 
10% v/v redistilled glycerol. 20 mM MnCl2.4H2O 
 
(ii) Agarose and primer extension gel electrophoresis  
TBE (1x)  90 mM Tris-HCl, 90 mM boric acid, 2.5 mM EDTA 
 
 (iii) Nucleic acid loading solutions 
DNA loading solution (10x) 50% (v/v) glycerol, 100 mM EDTA, pH 8.0, 1% SDS, 
0.1% (w/v) bromophenol blue, 0.1% (w/v) xylene 
cyanol 
RNA loading solution  98% formamide, 10mM EDTA, 0.1% xylene cyanol, 





 (iv) Acrylamide gels 
6 % Urea Acrylamide 7 M Urea, 6% (w/v) acrylamide:bis-acrylamide (19:1), 
1x TBE; add 100 µl 10% APS (w/v) and 10 µl TEMED 
per 10 ml fresh before pouring gels 
SDS-PAGE mix  10% acrylamide resolving gel  3.3 ml 
acrylamide/bis-acrylamide (30:1), 2.5 ml 1.5 M Tris- 
HCl pH 8.8, H2O to 10 ml, 100 µl APS 10% (w/v), 10 µl 
TEMED 
   
4 % acrylamide stacking gel 1 ml acrylamide/bis-acrylamide (30:1), 1 ml 1 M Tris-
HCl pH 6.8, 5 ml H2O, 100 µl APS 10%, 10 µl TEMED 
 
(v) Protein solutions 
Laemmli’s sample buffer 20% (v/v) glycerol, 2% (w/v) SDS, 62.5 mM Tris-HCl, 
100 mM DTT, 0.01% (w/v) bromophenol blue 
PAGE running buffer  25 mM Tris-base, 200 mM glycine, 0.1% (w/v) SDS 
Western blot transfer buffer A 0.3 M Tris-base, 20% methanol 
Western blot transfer buffer B 25 mM Tris-base, 20% methanol 
1x Fix  50% methanol, 10 % acetic acid 
Coomassie stain  0.2% Coomassie Blue, 10% acetic acid, 50% ethanol 
 
 
(vi) Pulldown buffers 
TRAP lysis buffer 50 mM Tris-HCl pH 8, 25% glycerol, 0.5% IGEPAL 
CA-630, 0.1% Triton X-100, 200 mM NaCl, 1 mM 
DTT, 1 mM PMSF, 1x protease inhibitor cocktail 
(Roche) 
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TRAP dilution buffer 10 mM Tris-HCl pH 8, 0.1% IGEPAL CA-630, 150 mM 
NaCl, 0.5 mM EDTA, 1 mM PMSF, 1x protease 
inhibitor cocktail 
 
(vii) FISH buffers 
SSC (20x)  3 M NaCl, 0.3 M sodium citrate, pH 7 
Pre Hybridisation buffer 10 mM EDTA, 35 mM NaH2PO4·H2O, 60% formamide, 
2X SSC, 5% dextran sulfate, 250 ng/ml tRNA 
Buffer 1  100 mM Tris-HCl pH 7.5, 150 mM NaCl 




PBS 138 mM NaCl, 2.7 mM KCl, 8 mM Na2PO4, pH 6.7 
PBS-formaldehyde PBS containing 4% (v/v) formaldehyde 37% (Sigma) 
PBS-T PBS containing 0.1% Tween 20 (Sigma) 















6.2.1 Bacterial work 
 
Preparation of frozen competent bacterial cells  
An overnight culture of E.coli strain DH5α (5 ml) was used to inoculate a 2TY culture 
at 1:100 and was incubated at 37°C with shaking for approximately 3 h. The bacterial culture 
was harvested in a pre-chilled centrifuge at 6,000 rpm for 10 min at 4 °C.  The supernatant 
was decanted and the cells were gently resuspended in 1/4 of starting volume of CCMB. After 
incubation on ice for 4 h the bacteria were pelleted as described before and the supernatant 
was decanted.  1/12 of the starting volume CCMB was used again to resuspend the bacteria.  
Then the bacteria were dispensed into 200 μl volumes in 0.5 ml microcentrifuge tubes and 
snap-frozen in dry ice mixed with methanol.  The aliquots of frozen competent bacteria were 
then stored at -70 °C until required for transformation. 
 
 
Transformation of competent bacterial cells 
DH5α cells were thawed on ice. Typically, 50 µl of cells were added to 50 ng of DNA 
to be transformed, the mix gently flicked and incubated on ice for 30 min. The cells were heat 
shocked in a 42 ˚C water bath for 45 sec and transferred to ice for 5 min. The cells were then 
plated in pre-warmed 2TY agar plates with the appropriate antibiotic. When transforming 
kanamycin resistant plasmids, 1 ml 2TY without antibiotics was added to the cells and cells 
were incubated at 37 ˚C for 1 h with shaking for recovery prior to plating. 
 
 
6.2.2 DNA assays 
 
Preparation of plasmid DNA 
Small scale DNA preparation was carried out using Wizard SV Minipreps DNA 
Purification System (Promega) according to the manufacturer’s instructions. 
Large scale DNA preparation was performed using a Nucleobond Xtra Midi kit 
(Macherey-Nagel), again according to the manufacturer’s instructions. 
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DNA concentration was determined using a Nanodrop spectrometer and the purity 
estimated by the OD260 to OD280 ratio. 
 
 
Polymerase Chain Reaction (PCR) 
 
i) Reverse transcription 
For reverse transcription of an RNA sequence prior to sequencing or standard PCR 
amplification the RNA sample was mixed with 4 µl of the required primer (10 µM) and 2 µl 
of MQ-H2O. The mix was heated to 70 
°C for 5 min then allowed to cool in ice. The 
transcription mix was then added (5 µl 5x AMV RT buffer, 1 µl 10 mM dNTP mix (dATP, 
dCTP, dGTP, dTTP), 0.5 µl (5 U) AMV reverse transcriptase and MQ-H2O to make a final 
volume of 25 µl and the reaction mixed. The samples were incubated for 60 min at 42 °C and 
then moved to ice. In order to avoid any carryover of non-inactivated enzyme, the samples 
were processed using a PCR purification kit (QIAGEN) to remove the enzyme. 
 
ii) PCR 
For cloning of viral sequences into the pEGFP-N1 vector, the following strategy was 
applied. The fragment of interest was amplified using 5' and 3' terminal forward and reverse 
primers with additional endonuclease restriction sites by PCR. 50 µl PCR reaction mixtures 
containing up to 100 ng of DNA template, 200 nM of each primer, 1x Pfu buffer, 200 µM 
each dNTP mix (dATP, dCTP, dGTP, dTTP; Roche) and 2.5 U Pfu DNA polymerase were 
prepared. Initially, DNA was denatured for 2 min sec at 94 °C. Then for each cycle, the DNA 
was denatured at 94 °C for 60 sec, primers annealed at an appropriate temperature (based on 
the Tm value of the oligonucleotides), usually around 50 °C for 60 sec and elongated at 72 °C 
for 2 min/Kb of plasmid. This cycle was repeated 30 times, following which the reactions 
were incubated a further 10 min at 72 °C, and cooled to 4 °C. Amplified DNA products were 
processed as described below for insertion into target plasmids. 
 
Restriction enzyme digestion 
DNA was digested for 1 hour with 3-5 units (per μg of DNA) of the appropriate 
enzyme. Enzymes were used in the manufacturer’s recommended buffer and digestion was 
carried out at the recommended temperature.  
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Agarose gel electrophoresis 
 Agarose gels were prepared by dissolving 0.8-1 % w/v in TBE by heating. After 
cooling the molten agarose for approximately 15 min ethidium bromide was added at a final 
concentration of 0.5 µg/ml. Once completely set, gels were immersed in TBE and the DNA 




Visualisation of DNA 
Agarose gels were visualised by UV transillumination after staining with ethidium 




Isolation of DNA fragments from agarose gels 
Following digestion with restriction enzymes and fragment separation by 
electrophoresis, the fragments were visualized by UV transillumination and the required 
fragments were excised using a clean scalpel. Agarose slices (typically 100 μl) were 
transferred to a 1.5 ml microfuge tube and DNA was extracted using Qiagen Gel Extraction 
Kit according to manufacturer’s instructions. 
 
 
Ligation of DNA fragments  
Isolated DNA of digested vector or insert DNA fragments were mixed at a molar ratio 
of approximately 1:3 of vector to insert. Vector and insert were covalently linked by 
incubating 1h at room temperature with 400 U of T4 DNA ligase (New England Biolabs) in a 
final volume of 20 μl containing 1x T4 ligase buffer. As a negative control, insert was omitted 
from the ligation reaction, and 2 µl of the ligation reactions were used to transform 20 µl of 
competent E.coli. 
 
6.2.3 Eukaryotic cell tissue culture 
 
Passaging and seeding cells 
All cell types were grown in complete medium at 37 ˚C at 5% CO2 and passaged when 
cells became confluent. Spent media was removed and the monolayer washed once in PBS. 
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Trypsin (10 ml 0.05% trypsin, 0.02% EDTA in /PBS) was added and cells were incubated 
until they detached (approximately 2 min for 293T cells, 5 min for A549 and DF-1 cells and 
15 min for MDCK cells). Trypsinisation was stopped by adding 10 ml complete medium, 
cells were spun down at 1200 rpm for 2 min and resuspended in fresh complete medium at 
1:10.  
For seeding cells, a 10 µl sample was taken from the fresh resuspension and cells were 
counted using a haemocytometer (Weber Scientific International) to determine cell density. 
Cells were then diluted in order to obtain the appropriate density and seeded onto fresh tissue 
culture flasks or wells. 
 
 
Coating with poly-D-lysine 
 The adhesion of 293T cells to plastic surfaces is weak and coating was necessary for 
FISH and IF; procedures that require cells to remain attached after several washing steps. In 
these cases, 13 mm coverslips were placed into wells of a 24 well plate and 400 µl poly-D-
lysine (Sigma, 5 mg/ml) in PBS added to each well. After a period of approximately 15 min 
the coverslips were washed three times with PBS prior to seeding.  
 
 
6.2.4 Transfection of Eukaryotic cells 
293T cells transfections were carried out using lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. Briefly, cells were seeded at the appropriate 
density (see Table 6.10) one day prior to transfection. Lipofectamine 2000 was mixed with 
Optimem and left for approximately 5 min while the DNA to be transfected was diluted in 
Optimem. The lipofectamine 2000/Optimem mix was added dropwise to the DNA/Optimem 
mix and left for approximately 20 min. In the meantime, the medium on cells was replaced by 
Optimem. Finally the lipofectamine 2000/DNA mix was added dropwise evenly into each 
well and the transfected cells left for 24 or 48 hr before further experimental procedures. 
When cells were left for 48 hr the Optimem medium on cells was replaced by complete 
medium 24 hours post-transfection. 
For experiments that required cells to be transfected with more than one plasmid the 




Table 6.10 Transfection conditions for 24 and 6 well plates 
Per well 24 well plate 6 well plate 
Cell density 1-2x105 1x106 
Total DNA (µg) in … µl of Optimem 0.8 in 50 2-4 in 250 
Lipofectamine 2000 (µl) in … µl of 
Optimem 
1 in 50 5 in 250 
Transfection volume (µl) 100 500 





6.2.5 Viral assays 
All work involving unfixed virus was carried out in a containment level 2 environment. 
Generation of P0 viral stocks 
Reverse genetics viruses were generated using the PR8 system developed by the 
Fouchier laboratory (de Wit et al., 2004). For each well of a 6-well plate, 4 μl of 
lipofectamine 2000 was added to Optimem medium for a final volume of 100 μl. The 
lipofectamine/Optimem mix was incubated at room temperature for 5 min. 0.25 μg of each 
pDUAL rescue plasmid was suspended in a final volume of 100 μl Optimem per well. The 
lipofectamine/Optimem mix was combined with the DNA/Optimem mix after the initial 
incubation and left for 30 min at room temperature. During this incubation, 293T cells were 
harvested, counted and diluted to a concentration of 1.4×106 cells/ml in complete medium. 1 
ml of diluted 293T cells was then aliquoted into each well and 200 μl of 
DNA/lipofectamine/Optimem transfection mix added and mixed. The transfected cells were 
then moved to a designated virus handling area and incubated overnight at 37°C. The next 
morning, the medium was carefully removed and replaced with 2 ml of virus growth medium, 
and the cells were then left for a further 48 h. After noting the appearance of cells and media, 
transfected cells were then scraped into their media and pelleted by centrifugation at 3000 
rpm for 5 min. The supernatants were aliquoted to provide the P0 virus stock while the cell 
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pellets were lysed in 250 μl Laemmli’s sample buffer and boiled for 10 min to allow 
confirmation of viral gene expression by Western blotting. 
 
 
Generation of P1 viral stocks 
To generate passage 1 (P1) viral stocks in MDCK cells, T25 tissue culture flasks were 
seeded with MDCK cells and grown until to confluency. The cells were infected with 100 μl 
of P0 virus stock in 900 μl serum free medium (corresponding to a multiplicity of infection of 
between 0.0001 and 0.01) and returned to the incubator for 1 h. The inoculum was then 
overlaid with an additional 6.5 ml of virus growth medium and incubated for approximately 
48 h at 37°C. The supernatant was harvested, clarified by centrifugation (2600 rpm for 10 min 
at 4°C) and subsequently aliquoted and stored at -70°C. 
 
 
Generation of egg-grown viral stocks 
Embryonated chicken eggs were inspected by candling on day 9-10 of gestation, and 
eggs lacking a well-developed embryo discarded. The border of the air sac and the allantoic 
cavity (at the blunt end of the egg) was marked with pencil on the outside of the shell, at a 
position opposite the embryo. On day eleven of gestation, each egg was inoculated with 
~1000 PFU (or the maximum possible number of PFU for the highly defective mutants) of 
virus in 100 μl total volume of PBS. Inoculation was performed with a 16 mm, 25 gauge 
needle, injecting vertically downwards through the air sac and into the allantoic cavity, on the 
opposite side of the egg to the embryo. Prior to inoculation, the surface of the egg was cleaned 
by wiping with ethanol; afterwards the puncture in the shell was sealed with invisible tape.  
The eggs were then incubated at 37°C, tilting every 30 min for 48 h, and then transferred to 
4°C on day 13, a Home Office approved Schedule 1 technique. 
Allantoic fluid was then harvested from eggs as follows. Each egg was placed with the 
blunt end upright and the tape removed. Forceps were used to break away the egg shell and 
membranes above the air sac, and the membranes overlying the allantoic cavity were peeled 
back. A 10 ml pipette was used to extract allantoic fluid, with forceps used to keep the mouth 
of the pipette clear of membranes and other debris. Eggs were discarded if the yolk had 
ruptured during harvesting of the allantoic fluid of if an egg was showing obvious signs of 
bacterial contamination. Allantoic fluid from eggs with replicate infections was pooled, and 
clarified by centrifugation at 2500 rpm for 10 min at 4°C.  Mock-infected allantoic fluid was 
prepared in a similar fashion. Samples of allantoic fluid were aliquoted and stored at - 70°C. 
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 Due to reversions encountered occasionally with the NS1-N81 mutant virus, viral 
stocks were not passaged but obtained by re-rescuing the mutant virus each time. 
 
 
Infection of Eukaryotic cells 
 Spent media was removed from cells and cells were washed once with 1ml SFM. The 
appropriate amount of virus was added to SFM according to the desired M.O.I. to obtain an 
inoculum with a final volume of 200 µl or 400 µl for 24 or 6 well plates, respectively. Plates 
were gently agitated and cells were incubated at 37 ˚C at 5 % CO2. 30-45 min later cells were 
overlaid with 2 ml viral growth medium for virus titration or 1 or 2 ml complete medium for 
24 or 6 well plates, respectively, for further analysis. Cells were again incubated as above for 




 MDCK cells were seeded in 6 well plates (1x106 cells per well) and incubated under 
standard cell conditions overnight. A 10-fold dilution series was generated for each virus and 
typically the 10-3 to 10-8 dilutions were used for titration. Cells were washed once in SFM and 
infected with 400 µl of each dilution, each dilution corresponding to a different well. Cells 
were overlaid with 2 ml of viral growth medium diluted 1:1 with 2.4% Avicell 
microcrystalline cellulose (Avicell RC581; FMC BioPolymer; (Matrosovich et al., 2006)) in 
dH2O and plates were incubated under standard cell conditions for 48 hr.  
 Cells were then fixed in 4 % formaldehyde in PBS for 20 min and washed once in 
water before being stained with approximately 2 ml 0.1 % toluidine in dH2O blue for 10 min. 
Cells were then washed three times in water and dried before plaques were counted. Typically 
wells with a number of plaques ranging from 50 to 100 were chosen for counting. It was 
assumed that each plaque corresponded to one plaque forming unit and the viral titre was 
determined in pfu/ml.  
 
Growth curves 
Growth curves were obtained by infecting the indicated cell type (~2x105 cells per 
well of 24 well dish) with a low (MOI 0.005) or high (MOI 3-5) multiplicity of infection in a 
total volume of 200 µl in SFM.  After 1 h at 37 °C, all medium was removed and cells being 
infected for single cycle growth curves were washed for 1 min in acid buffer (150mM NaCl, 
10mM HCl, pH 3) to remove input virus before overlaying with 1 ml viral growth medium.  
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After incubation at 37 °C until the desired time points post infection, supernatant was 
harvested, spun down (3000 rpm for 5 min in a Beckman Allegra 6R centrifuge) and 
aliquoted for titration by plaque assay. 
 
 
6.2.6 Immunofluorescence assays 
Fluorescence in situ hybridization (FISH) 
(i) Viral m- and vRNA specific probes synthesis – FISH probes 
FISH probes were synthesized essentially as described in (Amorim et al., 2007). 
Briefly, 5-10 µg of plasmid DNA was linearised with the appropriate restriction enzyme and 
purified using a QIAquick PCR purification kit (Qiagen) according to the manufacturer’s 
instructions. The linearised DNA was eluted in 20 µl MQ-H2O.  
 































pCB8+ 8 - - XbaI SP6 
pCB8- 8 XbaI SP6 - - 
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The linearised plasmid was used as template for the intended probe in a transcription 
reaction that includes the components added in the order listed below. 
 
Table 6.12 Components used in the transcription reactions to generate FISH probes  
Component Amount used per reaction 
MQ-H2O Up to a final volume of 20 l 
Plasmid (linearised) 1 g 
Transcription buffer (5x) 4 l 
0.1 M DTT 1 l 
RNaseOUT 1 l 
rATP, rCTP, rGTP (10 mM) 1 l of each 
rUTP (100 M) 2.4 l 
Alexa 488/Cy3/Cy5 labelled UTP (100 nmol) 2.5 l 
 
To the above listed components, 2 l of the appropriate polymerase was added and the 
reaction was incubated for 2 hr at either 40 ˚C or 37 ˚C for SP6 or T7 polymerase reactions, 
respectively. 1 l DNaseI was then added and the reaction incubated at 37 ˚C for 15 min. The 
components listed below were then added to the reaction. 
 
Table 6.13 Components added to the transcription reaction for FISH probes generation 
Component Amount used per reaction 
EDTA (0.5 M) 1 l 
LiCl (4 M) 20 l 
Salmon sperm DNA(SSDNA), Promega, (10 
mg/ml) 
20 l 




200 l 100% EtOH was added and the mix was kept at -70 ˚C overnight. The mix was then 
centrifuged at 13000 rpm at 4 ˚C for 5 min and the supernatant discarded. The pellet was 
washed three times, each time with the addition of 1 ml 70% EtOH followed by centrifugation 
as before. The pellet was dried for 10-15 min at room temperature and finally resuspended in 
100 l of a mix containing 96.5 l Tris pH 8 (10 mM), 2.5 l RNaseOUT and 1 l DTT (0.1 
M). The pellet was left for 10 min at room temperature and the dissolved RNA probe 
aliquoted in volumes of 20 l and stored at -70 ˚C. 
 
 
(ii) FISH assay 
 Cells seeded onto coverslips and either transfected or infected were removed from the 
incubator at the appropriate time and washed once in PBS for 5 min on a rocker at room 
temperature. Cells were fixed with 4% formaldehyde in PBS for 20 min and washed twice 
with 500 l PBS for 5 min. 25%, 50% and 75% EtOH solutions were added to the cells 
sequentially for 5 min each and cells were left in 100% EtOH for 30 min at 4 ˚C for 
dehydration. Cells were rehydrated by reversing the process and adding sequentially solutions 
of 75%, 50% and 25% for 5 min each. Cells were washed twice in PBS for 5 min, 
permeabilised with 0.2% Triton X100 in PBS for 5 min and again washed twice in PBS for 5 
min. Cells were post-fixed in 1% formaldehyde in PBS for 10 min, washed twice in PBS for 5 
min and incubated with 400 l pre-hybridisation buffer for 2 hr at 37 ˚C on a rocker. During 
this time, 1.5 l of the appropriate FISH probe was added to 400 l of fresh pre-hybridisation 
buffer. The mix was vortexed for 2 seconds, boiled for 5 min, cooled on ice and then 1 l 
RNaseOUT was added to the mix. After the 2 hr incubation period, the pre-hybridisation 
buffer was replaced with 500 µl of the FISH probe mix and cells were left overnight at 37 ˚C 
in a humidified chamber. Cells were washed three times in 60% formamide/2x SSC in MQ-
H2O for 15 min at room temperature and then twice in PBS for 5 min. Cells were washed 
once in buffer 1 for 2 min and blocked with buffer 2 for at least 30 min at room temperature. 
1/10000 DAPI in PBS was added to the cells for 2 min and cells were washed three times in 






Immunofluorescence after FISH 
 Following the FISH assay described above cells were incubated with 200 l of PBS 
containing the desired primary antibody for 1 hr at room temperature with rocking. Cells were 
washed three times in PBS for 5 min before being incubated with 200 l of PBS containing 
the appropriate secondary antibody for 45 min at room temperature rocking and then washed 




Imaging using confocal microscopy 
For confocal imaging, a Leica SP1 inverted confocal microscope was used. Samples 
were viewed and imaged using a 63x1.5 lens. Images for separate fluorophores were acquired 
sequentially in order to avoid bleed-through. If the intensity was to be compared between 
samples, laser power and photomultiplier tube settings were kept constant. Images were 




6.2.7 Protein assays 
Western blots 
(i) Cell protein lysates preparation 
 When ready for analysis, medium was carefully aspirated and 1 ml PBS added into 
each well of 24 or 6 well plates. Cells were detached from wells using a syringe for 24 well 
plates or a scraper for 6 well plates, collected into 1.5 ml tubes and centrifuged at 3000 rpm 
for 5 min at room temperature. The supernatant was discarded and the pellet was 
ressuspended in 50-200 l Laemmli’s buffer. Samples were boiled for 5 min prior to be used 









(ii) SDS polyacrylamide gel electrophoresis 
 
Table 6.14 Components of resolving gels used for SDS-PAGE 
% 8 10 12.5 15 17.5 
30% acrylamide (ml) 2.7 3.3 4.2 5 5.8 
1.5 M Tris pH 8.8 (ml) 2.5 
H2O (ml) 4.8 4.2 3.3 2.5 1.7 
10% APS (l) 100 
TEMED (l) 10 
 
 
Table 6.15 Components of stacking gels used for SDS-PAGE 
Component Amount 
30% acrylamide (ml) 1 
1 M Tris pH 6.8 (ml) 1 
H2O (ml) 5 
10% APS (l) 100 
TEMED (l) 10 
 
  
Resolving gels containing 8-17.5% acrylamide with a 4% acrylamide stacking gel 
were cast in a Bio-Rad mini-protean gel electrophoresis apparatus. Protein samples were 
loaded and gels run at a constant voltage of 150 V until the bromophenol blue front had 






 (iii) Western blotting 
Gels were transferred to nitrocellulose membranes (Schleicher and Schuell Co.) using 
a Bio-Rad transblot SD semi-dry transfer cell. The transfer was set up from the cathode to the 




 Proteins were transferred at a constant current of 200 mA for 1hr and the 
nitrocellulose membrane blocked in 5% dried non-fat milk (Marvel) in PBS-T for 20 min at 
37 ˚C on a rocker. Membranes were washed twice with PBST for 5 min at room temperature 
and incubated with the desired primary antibody diluted in 3 ml PBS-T at 4 ˚C overnight or 
for 1 hr at room temperature. The primary antibody was removed, membranes washed 3 times 
in PBS-T for 5 min and incubated with the appropriate secondary antibody diluted in 20 ml 
PBS-T for 45 min at room temperature. Membranes were washed 4-5 times with PBS-T for 
10 min and washed once with PBS before imaging. Membranes were imaged using an 




293T cells were seeded onto 6 well plates, transfected and when required infected with 
the relevant virus at an M.O.I. of 10 as described above. 48 hr post-transfection the medium 
on the cells was replaced with 1 ml of cold PBS with 1x PMSF (phenylmethylsulfonyl 
fluoride, Sigma) and plates were incubated on ice for 10 min. Cells were harvested using 
scrapers, collected into 1.5 ml tubes and centrifuged at 3000 rpm for 5 min at 4 ˚C. The 
supernatant was discarded and 500 l of TRAP lysis buffer was added to the tube. The pellet 
was resuspended by scraping the tube against a rough surface for 10 seconds and incubated at 
-70 ˚C for at least 2 hr. Lysates were thawed on ice and centrifuged at 10000 rpm for 5 min at 
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4 ˚C. For input level analysis, a 25 l sample was collected from the supernatant into a fresh 
1.5 ml tube and 25 l Laemmli’s sample buffer was added. The remaining 450 l supernatant 
were transferred to a new 1.5 ml tube containing 50 l glutathione sepharose beads 
(Amersham) that had been previously washed three times by addition of 500 l TRAP 
dilution buffer followed by centrifugation at 13000 rpm for 1 min. Samples (depleted of 
agarose-binding material) were incubated for 30 min by rotating at room temperature and then 
centrifuged at 10000 rpm for 5 min. The supernatant was transferred to a new tube containing 
TRAP sepharose beads previously washed as for the glutathione sepharose beads. Samples 
were incubated for 1 hr rotating at room temperature and centrifuged at 13000 rpm for 1 min. 
The supernatant was discarded and beads were washed three times with the addition of 1 ml 
TRAP dilution buffer followed by centrifugation at 13000 rpm for 1 min. 1 ml Trizol was 
added to the beads for bound RNA analysis by primer extension or beads were boiled in 50 l 
Laemmli’s buffer for protein analysis by western blot. 
 
 
6.2.8 RNA assays 
 
RNA extraction 
1 ml Trizol was added to 24 or 6 well plates for RNA extraction from cell lysates or to 
washed GFP-TRAP beads (see above) for RNA extraction from the beads for 10 min at room 
temperature. 200 l chloroform was added, mixed by inverting the tubes and left for 5 min. 
Samples were centrifuged at 13000 rpm for 20 min at 4 ˚C. The inorganic phase at the top 
(approximately 500 l) was carefully transferred to a new tube, 500 l isopropanol was added 
and the contents gently mixed by inverting the tubes. For RNA extraction from GFP-TRAP 
beads, 10 g of carrier tRNA (Sigma) was added prior to the extraction process. Samples 
were centrifuged at 13000 for 20 min at 4 ˚C, the supernatant discarded and the pellet was 
washed once with the addition of 1 ml of 70% EtOH and centrifugation at 13000 for 15 min at 
room temperature. The supernatant was discarded and the pellet allowed to air dry before 
being resuspended in RNase free water. RNA samples from cell lysates were resuspended in 
30 l of RNase free water whereas RNA samples from beads were resuspended in 10 l of 





Primer extension assay 
 
(i) Radiolabelling of primers 
The primers used for primer extensions are listed in Table 6.1.  
 A mix of 1 l PNK 10x buffer (70mM Tris-HCl, 10 mM MgCl2, 5 mM DTT, pH 7.6), 
1 l (10 U) T4 polynucleotide kinase and 1.11 mBq 32PγATP made up to a final volume of 9 
l with MQ-H2O was added to 1 l of 10 M primer to be labelled.  The mix was incubated 
at 37 ˚C for 1 hr in a water bath followed by addition of 20 l MQ-H2O. Labelled primers 
were kept at -20 ˚C until needed. 
 
 
(ii) Transcription reaction 
 1 l of RNA from cell lysates or 4 l of RNA from GFP-TRAP beads were used for 
primer extension reactions and typically, two different IAV-specific primers were used per 
reaction in addition to a third for 5S rRNA which was included as a loading control. A mix of 
0.45 l unlabelled 5S rRNA primer (10 M), 0.05 l rRNA labeled 5S primer and 0.25 l of 
each other primer was added to the RNA sample in a final volume of 5 l made up with MQ-
H2O in the case of cell lysate RNA samples. Primers were annealed to RNA samples by 
incubation at 95 ˚C for 3 min followed by cooling on ice for further 3 min. Samples were pre-
warmed at 50 ˚C for 5 min and then a transcription mix consisting of 2 l 5x First strand 
Buffer (Invitrogen), 1 l DTT (0.1 M), 0.2 l 25 mM dNTP mix (dATP, dCTP, dGTP and 
dTTP), 1.55 l of MQ-H2O and 0.25 l (50 U) Superscript III RT was added. Samples were 
incubated at 50 ˚C for 1 hr and denatured by adding 8 l RNA loading buffer and incubating 
at 95 ˚C for 10 min. 
  
 
(iii) Visualisation of single-strand DNA 
Front and back glass plates (38 cm long) were washed with 70 % ethanol and then 
with 1 ml dimethyldichlorosilane before being assembled. 400 µl 10 % (w/v) APS and 40 µl 
TEMED was added to 50 ml 6 % polyacrylamide-urea mix (7 M Urea, 6% (w/v) 
acrylamide:bis-acrylamide (19:1), 1x TBE) and then poured. The gel was left to set for 1hr at 
room temperature. 
The gel tank was prepared and each well was washed carefully using a syringe loaded 
with TBE before 15 l of each sample was loaded into the gel. Gels were run at a constant 
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current of 35 mA for approximately 1.5 hr, placed onto Whatman blotting paper, covered with 
cling film and dried at 80 ˚C for 2-3 hr on a ThermoSavant SpeedGel SG210D gel drier. 
Autoradiograph film (Kodak X-Omat S; Kodak Ltd.) was placed onto the dried gel and 
exposed for an appropriate amount of time at -70 °C using an intensifying screen. The gels 
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